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Summary 
High content cell imaging reveals actin cytoskeleton-mediated control of the immunological 
synapse 
Cytotoxic lymphocytes rely on actin cytoskeleton remodeling to achieve their function. In particular 
cytotoxic T lymphocytes and NK cells assemble the immunological synapse (IS), a complex actin-rich 
structure that allows the interaction with target cells, such as infected cells or tumor cells, and permits 
the polarized delivery of lytic granules. Although actin cytoskeleton remodeling is known to be a 
driving force of IS assembly and dynamics, our understanding of the molecular control of actin 
remodeling sustaining IS dynamics remains fragmented. This PhD project consisted in developing a 
high-content imaging approach to unbiasedly define the metrics of IS from human T and NK 
lymphocytes and to characterize the requirements for actin cytoskeleton integrity in organizing the IS 
architecture. 
For that purpose, the stimulation and staining of cell lines and primary cells in multiwell plates and 
acquisition of a unique set of >100.000 confocal images with a fully automatized high-content imager 
was optimized. The images were analyzed with two complementary CellProfiler analytical pipelines 
to characterize the morphological features associated with different treatments and disease status. We 
first extracted 16 morphological features pertaining to F-actin, LFA-1 or lytic molecules based on prior 
knowledge of IS assembly, and included features pertaining to the nucleus. We show that IS assembly 
in Jurkat and NK-92 cells is characterized by increased F-actin intensity and cell area. For Jurkat cells, 
we report an increase in LFA-1 intensity and surface area, and for NK-92 cells an increase in lytic 
granule detection at the IS plane. We then treated NK-92 cells with seven drugs known to affect 
different aspects of actin dynamics and investigated the associated effects on IS features. We report 
concentration dependent effects, not only on F-actin intensity, as expected, but also on lytic granule 
polarization. Furthermore, using a high-resolution morphological profiling based on >300 features, we 
show that each drug inflicts distinct alterations of IS morphology. In a next step, we applied our 
experimental pipeline to primary NK cells isolated from the blood of healthy donors. Distinct 
morphological features were characterized among the NK cells from different donors, highlighting the 
sensitivity of our approach, but also revealing an unsuspected variability of immune cell morphologies 
among donors. We then further applied our approach to primary CD8+ T cells from patients with a rare 
immunodeficiency due to mutations in the gene encoding the actin regulator ARPC1B. ARPC1B 
deficiency results in decreased F-actin intensity, as well as in lytic granule polarization. This prompted 
us to assess the ability of these cells to kill target cells, which was markedly reduced. These results 
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illustrate how the systematic analysis of the IS might be used to assist the exploration of fonctional 
defects of lymphocyte populations in pathological settings.  
In conclusion, our study reveals that although assembly of the IS can be characterized by a few features 
such as F-actin intensity and cell spreading, capturing fine alterations of that complex structure that 
arise from cytoskeleton dysregulation requires a high-content analysis. The pipeline we developed 
through this project holds promises for the morphological profiling of lymphocytes from primary 
immunodeficiency patients whose genetic defect has not yet been identified. Moreover, the 
discriminative power of our high-content approach could be exploited to characterize the response of 
lymphocytes to various stimuli and to monitor lymphocyte activation in multiple immune-related 
pathologies and treatment settings. 
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Résumé des travaux 
L'imagerie cellulaire à haut débit révèle le contrôle de la synapse immunologique par le 
cytosquelette d'actine 
Les lymphocytes cytotoxiques dépendent du remodelage du cytosquelette d'actine pour atteindre leur 
fonction. En particulier, les lymphocytes T cytotoxiques et les cellules NK assemblent la synapse 
immunologique (SI), structure complexe riche en actine qui permet l'interaction avec des cellules 
cibles et la distribution polarisée de granules lytiques (GL). Bien que le remodelage du cytosquelette 
d'actine soit connu pour être une force motrice de l'assemblage et de la dynamique de la SI, la 
compréhension du contrôle moléculaire du remodelage de l'actine soutenant la dynamique de la SI 
reste fragmentée. Ce projet de thèse a consisté à développer une approche d'imagerie à haut débit pour 
définir de manière impartiale les métriques de la SI des lymphocytes T et NK et caractériser les 
exigences d'intégrité du cytosquelette d'actine dans l'organisation de l'architecture de la SI. 
À cette fin, la stimulation et coloration des lignées cellulaires et cellules primaires dans des plaques à 
puits multiples et l'acquisition d'un ensemble unique d'images confocales avec un imageur à haut 
contenu entièrement automatisé ont été optimisées. Les images ont été analysées avec deux pipelines 
complémentaires avec CellProfiler pour définir les caractéristiques morphologiques associées aux 
différents traitements et à l'état de la maladie. Nous avons d'abord extrait 16 caractéristiques 
morphologiques se rapportant à la F-actine, LFA-1 ou aux GL, sur la base d'une connaissance préalable 
de l'assemblage de la SI, et inclus des caractéristiques relatives au noyau. Nous montrons que 
l'assemblage de la SI dans les lignées est caractérisé par une augmentation de l'intensité de la F-actine 
et la surface cellulaire. Pour les cellules Jurkat, nous rapportons une augmentation de l'intensité et de 
la surface LFA-1, et de la de la détection des LG sur le plan SI pour les cellules NK-92. Le traitement 
des cellules NK-92 avec 7 drogues affectant différents aspects de la dynamique de l'actine et l’étude 
des effets associés sur les caractéristiques de la SI montrent des effets dépendants de la concentration 
sur l'intensité de l’actine et sur la polarisation des GL. De plus, un profilage morphologique à haute 
résolution basé sur> 300 caractéristiques montre que chaque drogue inflige des altérations distinctes 
sur la morphologie de la SI. Nous avons appliqué ce pipeline à des cellules NK primaires isolées du 
sang de donneurs sains. Des caractéristiques morphologiques distinctes définissent les cellules NK de 
différents donneurs, soulignant la sensibilité de notre approche, mais révélant également une variabilité 
insoupçonnée des morphologies des cellules immunitaires parmi les donneurs. Nous avons appliqué 
notre approche aux cellules T CD8+ primaires de patients présentant une immunodéficience rare due 
à des mutations dans le gène codant pour le régulateur d'actine ARPC1B. La carence en ARPC1B 
entraîne une diminution de l'intensité de l'actine et de la polarisation des GL. Cela nous a incités à 
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évaluer la capacité lytique de ces cellules, qui a été considérablement réduite. Ces résultats illustrent 
comment l'analyse systématique de la SI pourrait être utilisée pour aider à l'exploration des défauts 
fonctionnels des populations de lymphocytes dans des contextes pathologiques. 
En conclusion, notre étude révèle que, bien que l'assemblage de la SI puisse être caractérisé par 
quelques caractéristiques telles que l'intensité de l'actine et la propagation cellulaire, la capture de fines 
altérations résultant de la dérégulation du cytosquelette nécessite une analyse à haut débit. Le pipeline 
développé est prometteur pour le profilage morphologique des lymphocytes de patients atteints 
d'immunodéficiences primaires dont le défaut génétique n'a pas encore été identifié. De plus, le pouvoir 
discriminant de notre approche pourrait être exploité pour caractériser la réponse des lymphocytes à 
divers stimuli et surveiller leur activation dans de multiples pathologies et traitements. 
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Preface 
Having come from a background in microbiology and virology, immunology was not always the most 
evident of topics for me, as I had done my masters in a lab that worked on mice, where I had mostly 
done Western blots and Real-time PCR. The decision to embark on a PhD in immunology was quite 
the challenge for me, but the idea of putting in place a screen of cytotoxic cells by high content imaging 
sure was appealing. I began my PhD in the Dupré lab in January 2017, in the Valitutti team. 
The team is an expert on cytotoxic cells, and the Dupré team is an expert on the immunological synapse 
of T cells, especially in the context of primary immunodeficiencies. At the time I joined, the Dupré 
team was composed of a postdoc: Javier Rey-Barrosso, three PhD students: Delphine Guipouy, 
Raissa Houmadi and Laurène Pfajfer, and an engineer: Alice Munaretto. 
Javier Rey-Barrosso was passionate about motility and was studying the different migration patterns 
of B cell lines on Collagen and Fibronectin, as well as their ability to remain and individual cells or 
cluster based on the matrix. He did so by seeding these cells in 96 well plates and imaging them by 
TIRF microscopy. He also studied the roles of actin branching and actoMyosin contractility by using 
two drugs: the ROCK1 inhibitor Y-27632 and the ARP2/3 inhibitor CK-869. He also did live imaging 
of chemotaxis of B cells over a CCL19 gradient. Javier loved to perform his experiments and allowed 
me to observe, while giving me thorough explanations. Indeed, he was my first exposure to 
chemotaxis, as well as the potential that multiwell plates offer in terms of efficiently imaging cells 
under different conditions.  
Alice Munaretto was also working on migration, but as opposed to Javier who was working on a B 
cell line, she was working on cells from CLL patients, to assess the migratory behavior of specific cell 
populations pre- and post-treatment. To do so, she was using a protocol of barcoding to phenotype her 
cells and was assessing their migration in response to chemokines. She did so by trans well assays, 
whose readout is by flow cytometry. Observing these experiments with Alice was my first exposure 
to flow cytometry. Moreover, to minimize bias in sample readout, Alice would set up an automatic 
sample mixing and acquisition, which was the first time I saw “automated” experiments. 
Delphine Guipouy was in her last year of PhD when I met her. She was working on a specific type of 
cytotoxic Tregs referred to as ova-Tr1 T cells, that are capable of specific elimination myeloid target 
cells via their granzyme and granulysin. Delphine was highly passionate about cytotoxic cells, and she 
showed me how to set cytotoxicity assays in 96 well plate formats and how to analyze the results 
acquired by Flow cytometry. She also showed me how to perform live microscopy assays to assess 
cytotoxicity in real-time. Delphine also spoke to me about a killing experiment she had done in real-
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time, by using a high content microscope (The Operetta), where she could sort single CD8+ T cells 
and seed one cell per well in a 96 well plate, to observe their cytotoxicity over time. She also showed 
me how to perform imaging of the immunological synapse of cytotoxic cells incubated with target 
cells, on microscopy slides. 
Raissa Houmadi was also in her 3rd year of PhD, and she was working on developing a super-resolution 
microscopy approach. Indeed, she revealed how LFA-1 is spatially organized in nanoclusters and how 
this assembly is regulated by WASP to ensure proper granule docking in CD8+ T cells.  
 Laurène Pfajfer was a first year PhD student who was doing a part of her PhD at the LBI-RUD in 
Vienna, where she had worked on two primary immunodeficiencies: WIP and WDR1 to show how 
these defects lead to defective immunological synapse assembly and cytotoxicity. 
Delphine, Raissa and Laurène, as well as Loic’s background in WASp and other primary 
immunodeficiencies provided me the exposure I needed to primary immunodeficiencies, and the 
immunological synapse.  
In the context of primary immunodeficiencies, NK cells are sometimes overlooked in cell biological 
assays due to their low numbers and the difficulty to expand them. I fell in love with NK cells only by 
working with the NK-92 cell line, but I admired these cells for their cytotoxic potential. The journey 
with these cells was not easy and being the first in the lab to have to grow them and use them in 
experiments was not an easy challenge. For that I would like to thank Delphine Guipouy, for her 
advice, feedback and help.  
Despite the challenges that these cells presented, the difficulty to transduce the NK-92 cell line, not 
due to lack of trying, and their fragility and erratic behavior sometimes, I am glad have been able to 
set up the functional approaches routinely used in our lab on CD8+ T cells on the NK cells, as well as 
an approach that allows the high content imaging of the immunological synapse of these poorly 
adherent cells. Our lab is an expert of CD8+ T cells and their cytotoxicity, as well as the defects in the 
context of primary immunodeficiencies.  
Taken together, the expertise of my host team has led me to optimize several assays established in the 
lab on the NK-92 cell line and eventually primary NK cells, as well as being the first in our lab to put 
in place the protocol for conjugation assay, which has later on been applied by colleagues to expanded 
CD8+ T cells. 
Most importantly, the past three years have led me to develop the protocol of high content imaging of 
the immunological synapse of NK-92 and Jurkat cell lines, as well as primary NK cells and expanded 
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CD8+ T cells from patients suffering from a primary immunodeficiency caused by mutations in the 
ARPC1B gene of the ARP2/3 complex.  
This project would not have been possible without the help of the smart, dedicated and through 
bioinformatician Loan Vulliard, whose expertise has helped take this project to the next level. I was 
lucky to have been able to work closely with Loan during my 9-month stay at the Center for Molecular 
Medicine in Vienna, as a guest scientist in the Boztug team.  
Prior to the results section, I will briefly introduce the immune system, with a focus on cytotoxic cells 
and highlighting the role of the actin cytoskeleton and the immunological synapse in achieving the 
cytotoxic function. The second part will address dysregulations that can affect the cytotoxic functions, 
while focusing particularly on primary immunodeficiencies where the cytotoxic function is perturbed. 
The last part will comprise information of the various types of microscopy approaches, with a focus 
on high content imaging.  
In the coming pages I hope to be able to highlight the importance of the cytotoxic function, as well the 
importance of the immunological synapse in this context. I also hope to convince the people reading 
this manuscript that high content imaging is the revolutionary step that they should invest in, and that, 
with some effort, even poorly adherent cells are amenable to being imaged with this method. Most 
importantly, I hope to shed light on the importance of morphology in predicting disease. 
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Introduction 
The following pages will comprise an introduction on the immune system with a focus on cytotoxic 
lymphocytes, their mechanism of action and receptors. In particular, the role of the actin cytoskeleton 
rearrangements and the immunological synapse in supporting cytotoxicity will be presented. Next, 
pathology-related defects in cytotoxicity will be addressed with a focus on primary 
immunodeficiencies, including a chapter on the methodologies used to assess defects in the cytotoxic 
function. 
The second section of the introduction will focus on microscopy as a rapidly evolving collection of 
methodologies. In particular will be addressed how high content cell imaging applications provide 
novel opportunities to explore cell biology. This introduction will then provide a rationale for the 
implementation of high content cell imaging for the study of cytotoxic lymphocytes.  
 General overview of the immune system and immune cell activities 
The human immune system is composed of a complex association of lymphoid organs, tissues, cells, 
humoral and soluble factors, which evolve simultaneously with the environment the body is exposed 
to, to ensure its protection against pathogens. Moreover, the immune system ensures the elimination 
cancer cells, as well as ensuring tissue reparation to maintain homeostasis. Also, it ensures symbiosis 
with the microorganisms of the microbiota. 
For long, the immune system has been divided into innate and adaptive immunity, due to the types of 
cells involved, as well the specificity and duration of their effector function. However, research is 
showing that cells of both types are highly interconnected. Therefore, an increasing number of immune 
cells is to be found at the interface between the innate and the adaptive immunity (Figure 1).  
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Figure 1: Overview of the immune system. The immune system is composed of the innate arm, the 
adaptive arm and cells at the interface of both arms. Adapted from1. 
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1.1 Innate immunity 
Innate immunity is a quick reaction which follows a non-specific recognition of various 
microorganisms, and can take as little as a few hours to be put in place2. The cells implicated are tissue 
resident natural killer cells, macrophages, mast cells, monocytes, neutrophils, basophils, eosinophils 
and dendritic cells (DC). However, only natural killer (NK) cells will be detailed in a section of this 
manuscript.   
1.2 Cells at the interphase of the innate and adaptive immune systems 
Innate lymphoid cells (ILC) are a new category of cells which were discovered in the past decade. 
Three groups of ILCs exist, based on the expression of transcription factors and cytokines that they 
produce3. NK cells were officially classified as the prototypical members of the group 1 innate 
lymphoid cells (ILC), which are defined by capacity to secrete interferon gamma (IFN-γ), but not type 
2 cytokines4. Natural killer T (NKT) cells, which share surface markers of both natural killer and T 
cells. They express a semi-invariant receptor resembling that on T cells and which reacts with major 
histocompatibility complex (MHC) CD1d, as well as receptors present on NK cells such as CD1615. 
NKT cells are both cytotoxic cells and capable of releasing cytokines, such as IFN-γ, IL-4, IL-10 and 
IL-13. Tγδ cells are CD3+ T cells that express the gamma/delta alternative T cell receptor (TCR) (as 
opposed to the conventional alpha/beta). They are cells that produce cytokines and exert a cytotoxic 
activity. They recognize bacterial phosphoantigens and non-classical MHCI molecules, and in 
response can either exhibit cytotoxicity or secrete cytokines such as IFN-γ6–8.  
1.3 Adaptive immunity 
Adaptive immunity requires a longer time to take place than innate immunity, as it requires the action 
of antigen-specific cells, some of which would eventually become memory cells. Such a process 
requires several days to be put in place2. The players in this immune response are T and B lymphocytes.  
However, and as previously mentioned, innate and adaptive immune responses are interconnected. An 
adaptive immune response cannot be initiated without the dendritic cells, which are antigen presenting 
cells (APC). DCs will migrate into the lymphoid organs, where they will activate the T cells specific 
to their antigen. Through V(D)J rearrangements through their development, T cells would be endowed 
with unique and antigen specific TCR 9,10.  
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A. B lymphocytes 
B cells are CD19+ lymphocytes. B lymphocytes recognize specific antigens by B cell receptors (BCR) 
or membrane bound immunoglobulins. BCRs recognize either soluble foreign antigens or ones bound 
to cell surface. Antigens are then internalized and processed in lysosomal/endosomal compartments, 
and subsequently expressed on the cell surface as antigenic peptides bound to MHC-II molecules for 
presentation to T helper cells (discussed in the next section). Activated B cells develop into plasma 
cells, which are antibody secreting cells. 
B. T lymphocytes 
T cells are CD3+ cells that can also be CD4+ or CD8+. CD4+ T cells are known as helper T (Th) cells 
and can be further subclassified into Th1, Th2 and Th17, based on the cytokines and interleukins they 
produce. Special subsets include follicular helper T cells (Tfh) and regulatory T cells (Treg). Their 
main role is aiding in B cell activation and antibody production. Follicular helper T cells are essential 
for B cells to mature into plasma cells and achieve proper immune functions11. Regulatory T cells 
suppress immune reactions and maintain immune homeostasis. CD8+ T cells were thought to be the 
only cytotoxic cells, prior to the identification of a subpopulation of cytotoxic CD4+ T cells12. CD8+ T 
cells are cytotoxic T cells (CTLs) and will be discussed in detail in the next section. 
 
 The cytotoxic function: the weapon of defense of the immune system 
Natural killer cells and CD8+ T cells are two cell types belonging to the innate and the adaptive arms 
of the immune system respectively. Even though they, broadly speaking, appear to serve the same 
function, which is to eliminate target cell, their mechanism of action, cell surface receptors and 
regulation are not the same, and will be elaborated in detail in this section. The cytotoxic activity of 
NKT, Tγδ and cytotoxic CD4+ T cells will not be addressed.  
Cytotoxicity is achieved when the cytotoxic cells kill their targets by the means of releasing lytic 
molecules through the process of degranulation. CD8+ T cells and NK cells can kill target cells by a 
tightly regulated secretion of cytotoxic granules containing pore-forming proteins perforin and/or 
granulysin and combinations of granzyme (Gzm) family effector proteases (in humans: Gzm A, B, K, 
M and H). However, a deep immune profiling of CTLs and NK cells has shown that NK cells have 
more abundant granulysin than CTLs13. 
Lytic granules are delivered to the interface of the cytotoxic lymphocyte and target cell, and their 
exocytosis requires clearances in the actin cytoskeleton14. Released perforin monomers insert into the 
29 
 
target cell membrane and polymerize to form a pore through which granule contents including the 
effector protease enzymes are delivered, and subsequently cleave caspases to initiate cell death. 
 
2.1 Natural killer cells 
Natural killer cells are cytotoxic lymphocytes of the innate immune system, and which play a role in 
protection against viral infections and solid and hematological malignancies. They comprise about 10-
15% of circulating lymphocytes. For a long time, NK cells were simply identified as cytotoxic cells 
that could kill without prior activation. They specifically target cells that lack MHC-I expression, 
without expressing clonally-distributed antigen receptors15. Moreover, they release cytokines that 
cause an inflammatory response which mediate the response of the adaptive immune system. Further 
details on the cytotoxic activity of NK cells will be addressed in the next chapter, “cytotoxicity”. 
Two major markers to characterize natural killer cells are CD16 and CD56. That being said, it should 
be noted that approximately 90% of natural killer cells are CD16bright CD56dim and those are the ones 
capable of generating the cytolytic response, also known as antibody-dependent cellular cytotoxicity 
(ADCC) 16. The other 10% are CD16dim CD56bright and are the ones that secrete cytokines. When it 
comes to expression of lytic molecules, among NK cells, CD56bright and CD56dim CD16+ NK cells 
showed clearly different cytotoxic molecule expression patterns: CD56bright NK cells had low Gzm B, 
but high Gzm K expression, whereas the CD56dim CD16+ NK cell subset expressed high Gzm B but 
lacked Gzm K13.  
The cytotoxic activity of NK cells is tightly regulated by a complex interplay between stimulatory and 
inhibitory receptors and their ligands expressed on the target cells, which will be discussed in the 
coming section 17,18.  
A. NK cell receptors 
Natural killer cells receive signals through different receptors on target cells and use a multiple receptor 
recognition strategy and will kill cells that have an increased or a decreased expression of “self” 
proteins, and cells that express foreign proteins.  
a. Natural cytotoxicity receptors 
Natural cytotoxicity receptors (NCR) are key in recognizing virus infected and tumor cells and their 
clearance. The expression of these NCRs has been shown to correlate with the magnitude of the 
cytolytic activity of the NK cells.  
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i. CD16 
CD16 is an Fc receptor (FcγIII) present on the CD56dim population of the natural killer cells. Signaling 
through CD16 delivers a powerful signal that enables the natural killer cells to kill target cells mainly 
by cytolysis. CD16 binds to the IgG portion of antibodies. In NK cells, CD16A is expressed and co-
localizes with CD3ζ and Fc-εRI-γ, thus inducing the stimulatory signals. CD16 activation following 
binding to its ligand induces of the transcription of the genes encoding interleukin-2 receptor (IL-2R) 
and cytokines, and even though binding to anti-CD16 induces a strong cytolytic reaction, it does not 
lead to NK cell proliferation19,20. Moreover, it has been shown that the levels of expressions of CD16 
may vary, and this variation correlates with the strength of serial killing21. 
ii. NKp46 
NKp46 (also known as CD335) is a member of the natural cytotoxicity receptor family, and is, along 
with NKG2D, one of the main receptors. In1997, a 46 kDa molecule was shown to play a role in NK 
mediated cytolytic activity, cytokine secretion as well as Calcium ion mobilization22. NKp46 is 
encoded in the leukocyte receptor complex on chromosome 1923,24. NKp46 has been shown to be 
expressed on subsets of natural killer cells, while it was not expressed in T and B cells25. NKp46 
expression was shown to be decreased in post-transplant lymphoproliferative disease in all natural 
killer subsets, accompanied by an increase in programmed cell death protein 1 (PD-1), which may give 
a hint on the dysregulation in natural killer functions26. Cross-linking of NKp46 with a monoclonal 
antibody (mAb) resulted in an increase in cytolytic activity, cytokine secretion and Calcium ion 
mobilization. NKp46 molecules are coupled to intracytoplasmic transduction machinery through 
associating with CD3ζ and Fc-εRI-γ adaptor proteins that contain immune tyrosine-based activating 
motifs (ITAM).  
iii. NKp30 
NKp30 is encoded in the class III region of the MHC locus on chromosome 624. It has been 
demonstrated that NKp30 expression varies depending on the organ in which NK cells are examined: 
it is highest in spleen, lowest in liver and intermediate in blood, despite the absence of a general 
receptor down-regulation, thus suggesting either an organ-specific regulation of NKp30 receptors, or 
a preferential homing of NKp30+ NK positive cells27. Expression of the ligands of NKp30 on DCs is 
the main regulator of the supply of dendritic cells, as NKp30 can mediate the promotion or termination 
of dendritic cell maturation. One of the ligands of NKp30 is BAG6. Soluble BAG6 has been shown to 
be present in elevated levels in patients with hematological diseases 28,29. Galectin-3 has also been 
shown to be a soluble NKp30 target, and to play a role in tumor evasion from NK cells 30. B7-H6, 
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another soluble NKp30 ligand was shown to be associated with a down-regulation of NK cells in 
neuroblastoma patients31. Another NKp30 ligand is BAT6, a nuclear factor also released by tumor 
cells in exosomes rather than a soluble protein, which triggers cytokine release (tumor necrosis factor 
alpha (TNF-α), IFN-γ) and enhances NK-cell mediated killing 27,32. The cytoplasmic region of NKp30 
lacks ITAM motifs.  
iv. NKG2D 
NK receptor member D of the lectinlike receptor family (NKG2D) is a natural killer receptor that binds 
to cells which have an upregulated expression of self-proteins. It is also expressed on CD8+ T cells, 
γδ T cells and Natural Killer T cells33,34. NKG2D binds to NKG2D-L on target cells, thus activating 
an effective anti-tumor response in early stages35. However, a sustained NKG2D-L expression and 
shedding of soluble ligands counteracts NKG2D-dependent NK cell activity in later stages. Contrary 
to NKG2A, NKG2D does not bind to CD94. The ligand for NKG2D is stress-inducible MICA, a 
distant homolog MHC I, and the expression of NKG2D on NK cells is increased by IL-1534,36. The 
structures of NKG2D–ligand complexes indicate that NKG2D binds diagonally over the α1 and α2 
helices of the ligands, which bears a striking resemblance to the way T-cell receptors bind over MHC 
molecules. DAP10 is the membrane-bound signal transducing subunit of the NKG2D receptor37. It has 
been shown that one tumor evasion mechanism is the release of soluble NKp30 and NKG2D ligands, 
as well as a down-regulation of the expression of NCR ligands 38,39. 
v. NKp44 
NKp44 is another member of the NCR family, and is about 44 kDa in size. The gene encoding NKp44 
is encoded on chromosome 6. While NKp30 and NKp46 are expressed on resting and activated NK 
cells, NKp44 is exclusively expressed on activated NK cells in the presence of IL-240. NKp44 ligands 
include glycoproteins and proteoglycans expressed on the surface of target cells, nuclear proteins that 
can be exposed outside the cell, and molecules that can be either soluble or in vesicles41. In the same 
fashion as NKp46, monoclonal antibody cross-linking of NKp44 enhances the cytolytic activity of NK 
cells. NKp44, which does not contain any ITIM motif in the cytoplasmic region, associates with the 
adaptor molecules DAP12 and KARAP, which contain an ITAM motif in the cytoplasmic region40,42. 
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Figure 2: Natural killer cell surface receptors involved in cytolytic activity, and their association to 
signaling molecules24.  
 
b. Inhibitory NK receptors (iNKR) 
Regulation of the cytotoxicity of NK cells is also a crucial process and depends on killing inhibitory 
receptors (KIR), whereby the signals that NK cells receive completely bring their cytolytic activity to 
a halt. It has been shown that inhibiting the cytolytic activity of NK cells depends on the recognition 
of MHC-I molecules. Killer Ig-like KIR and NKG2A/B (heterodimer with CD94) are major human 
leukocyte antigen I (HLA-I) specific inhibitory receptors. The CD94/NKG2A/B recognize the HLA-
E molecule (a non-classical MHC-Ib) and subsequently protect the target cells from cytolysis43. KIRs 
include but are not limited the p49, p50, p58, p70 and p14017,38. However, each KIR is expressed on a 
fraction of NK cells, thus allowing the NK cells to recognize a larger pool of MHC-I deficient cells. It 
has been shown that once an NK cell is in contact with an MHC-I expressing cell, KIRs accumulate at 
the contact area in a central area surrounded by LFA-1 and ICAM-1 to drive NK cell migration44. F-
actin is a somewhat expendable player in this process, whereby it can accelerate KIR recruitment to 
the synapse but is not crucial for this process44. 
c. Costimulatory molecules 
2B4 (CD44) which binds to CD48, and NTBA are two members of the CD2 family which can play 
either an activating or inhibitory function, depending on the availability of downstream regulating 
element of the signaling pathway termed signaling lymphocyte activation molecule-associated protein 
(SAP). Both 2B4 and NTBA trigger NK cytolytic activity in cells that express high levels of NCRs45,46. 
NTBA promotes a strong production of IFN-γ and TNF-α46,47. 2B4 may also enhance the cytolytic 
activity of NK cells48. 2B4 does not associate with ITAM-bearing polypeptides but has functional 
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signaling motifs in the intracellular domain. The 2B4-CD48 interactions appear to take place at the 
center of the synapse44. Sivori and colleagues have shown that 2B4 can initiate cytolysis in the subset 
of NK cells that have a high level of NKp46 expression, without altering the expression of 2B4, but 
also that 2B4 may function as an inhibitory molecule at early stages of NK cell differentiation49,50. 
Other co-stimulatory molecules include CD80 and CD86, which have been shown to enhance the 
cytotoxic activity of NK cells51. 
 
B. NK cell cytotoxicity: from target binding to target lysis 
Natural killers were long compared to cytotoxic T cells. However, they are unique in the sense that 
they use specific NK receptors, and that their response is faster than that of CTLs. Being part of the 
innate immune system, natural killer cells do not need prior activation to achieve their cytotoxic 
function. Therefore, they do not express antigen-specific receptors, but rather the activation and 
inhibition receptors discussed in the previous chapter “NK cell receptors”. The cytotoxicity of NK 
cells can be broken down into several steps, leading to the formation of the immunological synapse 
(IS) and achievement of the cytotoxic function by release of lytic molecule content, and then 
detachment of scanning for another target cell.  
 
a. NK receptors involved in immunological synapse formation 
NK cell receptors can associate with ITAM bearing molecules. FcRγ and TCR ζ chains can form either 
homodimers or heterodimers which interact with CD16. NKp30 and NKp46 associate with FcRγ and 
TCR ζ, while NKG2D associates with DAP1052. After patrolling their environment, NK cells attach 
to a target cell through adhesion receptors, which include CD2, NKG2D and DNAM-1. By using 
tweezers and confocal microscopy, it has been demonstrated that upon NK cell contact with its target, 
NKG2D is recruited to the IS and forms a ring type of structure which marks a border in which lytic 
granules are secreted53. Moreover, stimulation through NKG2D was shown to lead to the formation of 
an F-actin ring at the periphery of the IS, and that NKG2D leads to a more stable synapse than 
CD1621,53. NKp44 associated with DAP12, a homodimer with a single ITAM motif. While signaling 
through CD16 is sufficient to cause NK cell – target conjugates and degranulation, stimulation of other 
receptors alone does not cause NK degranulation21,54,55. Other receptors only stimulate degranulation 
in pairs, suggesting a synergistic activation. CD16 binds to the Fc portions of antibodies and NK cells 
can therefore kill target cells coated with antibodies and eliminate them by ADCC. NKG2D signaling 
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leads to adhesion, granule polarization and degranulation56. DNAM-1, NKp80 and NKp65 also have 
activating potential. However, there is limited information of their signaling properties. The 
immunological synapse of NK cells will be touched upon further in the section pertaining to the steps 
of cytotoxicity.  
b. NK cell degranulation 
Degranulation of NK cells is not random process, and it has been shown that NK cells must converge 
their lytic granules to prevent bystander killing and achieve a more efficient elimination of target 
cells55. Moreover, it has been shown that receptor activation must occur in a specific sequence, as 
initial engagement of CD16 did not affect subsequent stimulation via NKG2D, whereas stimulation 
through CD16 was impaired after activation via NKG2D21. Once firmly tethered to its target, the NK 
cell undergoes a change in shape and becomes more flattened, and a lytic cleft is formed57. Following 
actin rearrangement as well as de novo actin synthesis, the MTOC undergoes reorientation to allow 
polarization of the lytic granules towards the synapse, and this is mediated by the formin homolog 
hDia, which in NK cells is not essential for actin branching58.  
DNAM-1 has been found to physically associate with lymphocyte function associated antigen 1 (LFA-
1), thus indicating that it plays a role in LFA-1 mediated signaling 59. Indeed, LFA-1 engagement was 
shown to mediate granule convergence, and to induce more targeted degranulation at the IS, along 
with CD16 than CD16 alone55. Therefore, the co-engagement of LFA-1 and CD16 leads to a 
monodirectional granule convergence, thereby reducing bystander killing rates and increasing the rates 
of specific killing. only a small fraction express the open conformation of LFA-1, and LFA-1 in NK 
cells requires activation to through the aforementioned adhesion receptors, which can induce inside-
out signaling60. LFA-1 induces a downstream signaling cascade, changes in F-actin reorganization, as 
well as an arrest signal and symmetrical spreading61. Talin is also recruited to the sites of LFA-1 prior 
to granule polarization, and, via constitutive association of vinculin (an actin-binding protein that was 
shown to act as “leaky capper” of the barbed end of the actin filament) to talin and Arp2/3, recruits 
ARP2/362–64. Moreover, talin is essential for lytic granule polarization65. Furthermore, LFA-1 also 
leads to WASp recruitment, which in turn promotes Arp2/3 mediated actin polymerization62. Lytic 
granules must converge long the MTOC, and this step is independent of actin dynamics and of 
CD107a, and is rather mediated by dynein and does not imply a commitment for neither granule 
polarization nor for cytotoxicity66. However, formation of an organized synapse where LAMP-1 is 
retrieved at the center depends on the interaction of LFA-1 with the lipid bilayer44. Following lytic 
granule polarization, they dock at the IS membrane and fuse with the plasma membrane. The docking 
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is primarily mediated by Rab27a and Munc13-4, followed by priming, which occurs as a result of 
Munc13-4-mediated activation of Syntaxin 11 or bridging of the plasma membrane with lytic 
granule66–68. Fusion occurs as a result of the formation of a complex whose components are not all 
known, but include syntaxin11, VAMP 4 and VAMP 766.  
Following lytic granule delivery to the IS, it has been shown that only a fraction of the lytic granules 
are exocytosed, and that granules are highly mobile, independently of F-actin dynamics, but may 
depend on Myosin II A(MyH9) to generate the necessary forces14,69. Indeed, MyH9 heavy chain 
knock-out impaired cytotoxicity, membrane fusion of lytic granules, and granzyme secretion70. It has 
also been shown that MyH9 constitutively physically interact with lytic granules, and lytic granule 
secretion was shown to be impaired in patients suffering from MyH9 mutations71. While Myosin IIa 
is not needed for the formation of an organized IS in NK cells, it is crucial for the final exocytosis 
step44. Following degranulation, the cell must undergo a termination process, followed by detachment. 
These steps are elaborated in details in66. Moreover, it has been shown that lytic granules require a 
pervasive actin meshwork of hypodense F-actin (which can be achieved through NKG2D and LFA-1 
co-ligation) to pass through and that the actin clearances in which they pass are granule-sized53,72. 
However, actin dynamics are independent of the presence of granules, since actin clearances are 
observed prior to granule arrival. It has also been demonstrated by super resolution microscopy that 
the center of the NK IS contains thin F-actin filaments, as opposed to the previous belief that the IS 
formation leads to F-actin clearance from the center53,72. 
 
2.2 Cytotoxic T cells: the killers of the adaptive immune system 
CD8+ T cells have a classical αβ T-cell receptor TCR. Through a random process of genetic 
rearrangements, lymphocytes express on their surface unique TCR that have single antigen specificity, 
which is their capacity to recognize one type of peptide-MHC complex. 
Progenitor lymphoid cells leave the bone marrow and reach the thymus to proceed to differentiate, 
where they undergo a negative and a positive selection. Following this selection, the remaining cells 
will be capable of recognizing APC, and not react against self-molecules. Naïve CD8+ T cells must 
be activated by CD4+ cells in order to produce lytic and effector molecules73. CD8+ lymphocytes 
recognize MHC I molecules presented on the surface of APCs, therefore most cells can be APC- as 
opposed to CD4+ T cells which recognize MHC II molecules on “professional” APC such as DC and 
B cells. Naïve T cells will give rise to several subpopulations, culminating in effector cells. Effector 
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CD8+ T cells express lytic molecules and have high migratory capacity. Following stimulation of their 
TCR, they undergo reorganization of their actin cytoskeleton, slow down their motility and establish 
firm adhesions with their targets leading to the assembly of the IS74.  
The delivery of lytic granules from CD8+ T cells is a highly regulated process, and the signaling and 
cytotoxic activity of CD8+ T cells will be elaborated in detail in the section “CD8+ T cell 
Cytotoxicity”. 
 
 
 
Figure 3: Schematic representation of T cell activation and differentiation in response to APC 
stimulation. Adapted from the thesis manuscript of Julie De Meester (Thesis, 2011). 
 
A. Receptors, adhesion and co-stimulatory and inhibitory molecules involved in 
CD8+ T cell cytotoxicity 
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The activity of cytotoxic T cells is governed by the interplay between several receptors and co-
stimulatory molecules, which will be elaborated in the following pages. 
a. The T-cell receptor 
The αβ TCR on CTLs is composed of two transmembrane glycosylated polypeptide chains belonging 
to the immunoglobulin superfamily and linked through a disulfide bond. These glycoproteins contain 
a short intracytoplasmic tail composed of 4-12 amino acids and a hydrophobic transmembrane domain 
of 20 positively charged amino acids, thus allowing the TCR to achieve a stable association with the 
negatively charged transmembrane domain of the CD3 molecules (Figure 4)75.  
 
Figure 4: The TCR and its association with CD3. The TCR is composed of the α and β chains and 
forms a complex with CD3. From the thesis manuscript of Roxana El Khazen, 2016.  
 
T cell activation requires sustained signaling by the pMHC specific to the TCR. However, the duration 
of the TCR-pMHC contact has been shown to be very short76,77. Therefore, it was proven that despite 
the rapidity of TCR-MHC interaction, sustained TCR signaling occurs via multiple rounds of TCR-
MHC binding78,79. Interestingly, as little as 1 MHC molecule can induce calcium ion increase in T 
cells, and that T cell activation can be achieved by TCR recognizing as little as 10-15 MHC molecules, 
and CTLs can kill target cells expressing 1-10 MHC molecules80–83. This can be explained by the 
proposed model of “serial TCR engagement”, which suggests that one MHC molecule could trigger 
and internalize approximately 180 TCRs, thus leading to a sustained TCR signaling despite the small 
number of MHC molecules via a sequential high TCR occupancy84. However, another model referred 
to as “kinetic proofreading” suggests a prolonged TCR-MCH interaction, leading to modifications 
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which will be amplified only by highly specific interactions85. However, it is most likely that these two 
types of interactions are not mutually exclusive and may be dependent on the number of MHC 
molecules on the APC surface. 
Briefly, the steps of TCR signaling include the translocation of LCK and Fyn, two members of the Src 
tyrosine kinase family, into the membrane following TCR engagement, which eases the 
phosphorylation of ITAM motifs. ZAP-70 also associates to ITAM motifs and activates Linker for 
activation of T cells (LAT) protein which will allow more signaling molecules to bind (Figure 5).  
However, TCR engagement is not enough and T cell activation requires signaling from co-stimulatory 
molecules. These include CD8 for CTLs, CD28 and the adhesion molecules CD2 and LFA-186.  
 
Figure 5: Pathways of TCR signal transduction87. 
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b. The role of the integrin LFA-1 in cytotoxicity 
Integrins are heterodimeric adhesion proteins, which allow leukocyte adhesion and play a role in their 
migration. Integrins play an essential role in infection control, where their absence leads to recurrent 
infections. They also have a role in immune homeostasis, and perturbations can lead to cancers and 
autoimmunity. Integrins have a crucial role in the recruitment of lymphocytes from the blood into 
infection sites, and for lymphocyte adhesion onto their target cells. Moreover, integrins make 
intracellular adhesion therefore playing a role in the activation of several signaling pathways.  
Being heterodimeric proteins, they are formed of one of 18 α and one of 8 β subunits. They can be one 
of 24 different combinations88,89. The very late after activation (VLA) family of integrins which 
comprises VLA-1 to 5 has also been identified. Of the LFA-1 family, three members have been 
identified: LFA-1, 2 and 390. In this manuscript, only the integrin LFA-1 will be addressed.  
LFA-1 is required for the migration of T and NK lymphocytes. It is composed of the CD11a (αL) and 
the CD18 (β2) subunits. LFA-1 plays a role in immunity, as its deficiency is characterized by recurrent 
bacterial infection91. LFA-1 is a transmembrane protein comprised of an extracellular domain, a 
transmembrane domain and a cytoplasmic domain. LFA-1 binds to intracellular adhesion molecule 
ICAM-1, among other ICAMs (ICAM-2 and 3, as well as JAM-1). In this manuscript, only the LFA-
1 – ICAM-1 interaction will be addressed. LFA-1 binding to ICAM-1 is a temperature-dependent 
energy requiring process, which also requires the presence of magnesium ion and an intact 
cytoskeleton92.  
ICAM-1 (CD54) is a transmembrane glycoprotein expressed on the surface of leukocytes and 
endothelial cells. ICAM-1 is required for the interaction of LFA-1 on immune cells with their target 
cells or DCs, or between the immune cells and their environment92–94. Moreover, full LFA-1 activation 
requires ICAM-1 on the target cell to provide a physical resistance to allow for F-actin flow95.  
i. LFA-1 activation 
Integrins in circulating lymphocytes are inactive and get activated through binding to chemokine 
receptors. LFA-1 activation is characterized by both affinity to ICAM-1, and avidity.  
Affinity is defined as the capacity of a ligand to bind to its receptor, depending on the available number 
of molecules. FRET experiments have revealed that the constant of dissociation between LFA-1 and 
ICAM-1 to be 17.93±1.34 nM96.  
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Avidity is defined as the strength of interaction between two molecules. The increased probability of 
an LFA-1 – ICAM-1 interaction due to the aggregation of LFA-1 molecules indirectly leads to an 
increased adhesion strength97. Avidity varies based on the conformation (openness) of the LFA-1 
molecule. LFA-1 has been described to have three conformations: the closed conformation 
corresponds to a low affinity and thus an inactive LFA-1 (Figure 6). The intermediate conformation 
corresponds to an intermediate affinity, while the open conformation corresponds to a high affinity. 
 
Figure 6: Schematic representation of the different components of the LFA-1 molecule in its 
different conformations. A. Resting, B. Intermediate and C. Open conformations98. 
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LFA-1 activation is modulated by bidirectional signaling: inside-out and outside-in signaling.  
ii. Inside-out signaling 
Inside-out signaling is mediated by intracellular signals, resulting from the activation of other receptors 
such as the TCR or chemokine receptors, to mediate extracellular changes to the adhesive state of 
LFA-199. Chemokines such as CCL19 and CCL21 only activate the LFA-1 to its intermediate 
conformation and lead to a binding to ICAM-1 with intermediate affinity100. However, to fully activate 
LFA-1 and cause T cell arrest, shear forces were shown to be necessary100 
Inside-out signaling mediated by the TCR occurs upon the formation of the IS. TCR activation induces 
Rap1 activation through ADAP and SKAP55, leading to LFA-1 inside-out signaling. As previously 
mentioned, PLC, among others, plays a role in LFA-1 activation. Inside-out signaling cascades 
increase the ligand binding affinity of LFA-1 receptors and cause their redistribution on the T cell 
surface into highly organized patch-like clusters. Comrie et al. have shown that LFA-1 in the extended 
conformation is enriched in the pSMAC, while open LFA-1 was concentrated in a smaller and more 
central ring of the IS, which will be elaborated further in section pertaining to the IS95. A recent study 
by Houmadi et al. in our laboratory, shows that the nanoscale topology of LFA-1 at the T cell IS 
consists of a belt of nanoclusters embedded in the interstices of the cortical actin cytoskeleton 
meshwork101.  
 
iii. Outside-in signaling 
Outside-in signaling refers to the final stages of LFA-1 adhesion to its ICAM-1, which initiates an 
integrin-proximal tyrosine kinase cascade of signaling events. It is caused by extracellular changes 
which regulate the adhesiveness of LFA-199. Vav1, talin, kindlin3 and ZAP70, all proteins who are 
bound to the cytoplasmic tail of LFA-1 play a role in outside-in signaling, where the changes they 
undergo lead to a signaling cascade. Extended LFA-1 is bound with a “closed” head to ICAM-1, but 
following the signaling cascade, the headpiece changes shape to allow high affinity binding to LFA-
1. This consequently increases the avidity and affinity of LFA-1 binding to ICAM-199.  
 
c. Costimulatory molecules  
The critical costimulatory receptor CD28, when engaged by its primary ligand CD80 becomes 
enriched in TCR MCs. The CD28-CD80 complex is transported to the central supramolecular 
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activation cluster of the immunological synapse , where a CD28-PKCθ arrays around this structure102. 
The adhesion molecule CD2 (LFA-2) not only facilitates T cell adhesion but also functions as a 
costimulatory molecule, by lowering the threshold for T cell activation. Following TCR activation, the 
avidity of the interaction between CD2 and CD58 is increased103. The engagement of CD2 induces 
phosphorylation of PLCγ1 via Fyn kinase thus potentiating intracellular calcium levels above those 
achieved in response to TCR triggering alone102.  
d. Inhibitory molecules 
Cytotoxic T lymphocyte antigen-4 (CTLA-4) can outcompete CD28 for binding to CD80 and CD86. 
CTLA-4 co-ligation leads to an increased threshold of T cell triggering, thus reducing the likelihood 
of activation. Programmed-death 1 receptor (PD1) generally binds with PD-L1 but can interact with 
CD80 to generate inhibitory signals. It is also a marker for exhausted antigen-specific T cells, where 
T cells have reduced proliferation and are incapable of producing cytokines. PD-1 signaling inhibits 
CD28-dependent PI3K activation and blocks Akt activation102. 
 
B. CD8+ T cell cytotoxicity: from naïve cells to professional killers 
When compared, the cytotoxicity of NK and CTLs differ in the migration dynamics, the duration of 
contact with their targets, whereby it was shown that CTLs decrease their migration speed when 
patrolling the tumor environment, and establish longer contacts with their targets, while NK cells 
establish more dynamic contacts104. The contact with an antigen presenting cell is what triggers TCR 
mediated signaling which, along with other costimulatory signals leads to the differentiation into CTLs 
in the primary lymphoid organs.  
Following the first stimulation with antigen, most effector CD8+ T cells will die, and only a fraction 
will become memory cells (Figure 7).  
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Figure 7: Changes undergone by CD8+ T cells before/after infection. Antigen-specific naïve CD8+T 
cells undergo differentiation into effector, early memory late memory and secondary memory cells 105. 
 
The pattern of expression of lytic molecules varies based on the stage of differentiation they are at13. 
20–60% of early differentiated T cells express all granzymes (GzmB expression was minimal) and 
intermediate levels of perforin., granulysin or high-levels of perforin. Late differentiated cells express 
high levels of perforin and GzmB. The accumulated expression of Gzm B, granulysin and perforin as 
T cells differentiate to effector memory cells is in line with greater cytotoxicity observed in late 
differentiated effectors compared to early differentiated central memory or naïve CD8 T cells.  
a. Differentiation into professional killers 
First, naïve CD8+ T cells must scan their environment and interact with antigen presenting cells, to 
become activated via their TCR. Such CD8/APC interactions are possible thanks to the motility of 
both the CD8 and the dendritic cells. This capacity to interact with APCs and high motility allows 
CD8+ T cells to quickly scan through DCs, wherein it is supposed that in one hour, a single DC can 
be probed by about 500 CD8+ T cells106. However, CD8+ T cells must reduce their motility and come 
to a halt in order to establish an interaction with the APC. This process is enabled by the interaction of 
their TCR with MHC molecules, where an adhesion ring is formed due to centripetal actin flow107. 
The IS of a T cell was first defined in the late 1990s, and was defined as “a molecular machine 
controlling T cell activation”108.  
CD8-APC interactions were initially thought to be a timely process, where activation of the T cell was 
thought to require long hours of CTL-APC contact, where the T cell remains in contact with one APC 
for a time ranging between 6 and 30 hours108,109. However, evidence in later years supported a more 
dynamic type of interactions, in which the CTL will have several brief and short-lived interactions 
with multiple DCs110. This has suggested the presence of a short-term memory that allows T cells to 
perform a “signal summation” from these intermittent interactions, which were termed “kinapses”111–
113. The activation signal that is subsequently generated from these interactions was shown to last for 
several hours112. However, the immunological synapse is a productive and more stable interaction 
between the T cell and the APC113. It has been shown that for T cells to be arrested and primed, they 
must interact with a DC that expresses high levels of adhesion molecules, a high quantity of co-
stimulatory molecules, as well as a high quantity of high affinity MHC-I molecules114. 
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CTL-APC interaction leads to a fast tyrosine phosphorylation cascade, thus triggering several signaling 
pathways and a Ca++ induction of the transcription of genes involved not only in lymphocyte activation, 
but also proliferation115,116. The calcium signaling depends on a stable IS, therefore on the actin 
cytoskeleton. Indeed, inhibition of actin filaments by Latrunculin B which binds G-actin reduces the 
number of TCR that can be stimulated, subsequently rendering the cell unable to maintain calcium ion 
release117. 
CD8+ T cell cytotoxicity 
CTL-mediated cytotoxicity requires a direct contact between the CTL and the antigenic peptides 
presented on the MHC-I molecules on the target cell. Following contact with the target an 
immunological synapse is formed and the lytic machinery of the CTL is quickly assembled. The 
formation of the CTL-target stable immunological synapse relies on the binding of the integrin LFA-
1 to ICAM-1 on the target cell118. TCR signaling following TCR-peptide-MHC-I engagement drives 
the ARP2/3 dependent polymerization of branched actin filaments at the edge of the site of contact 
between the T cell and the target cell.  
The MTOC polarizes towards the target cell, causing the release of soluble lytic molecules such as 
perforin and granzymes and membrane-anchored effector molecules such as the Fas ligand103,119. It 
has also been shown that polarization of the lytic molecules to the IS requires a strong TCR signal, 
whereas weak TCR signaling cannot induce granule recruitment to the IS, despite proper MTOC 
polarization120. The activity of Lck, Fyn, and ZAP-70 are all essential for promoting MTOC 
polarization to the lytic synapse, where Lck is essential for signal propagation through ZAP70103. ZAP 
70 phosphorylates LAT which recruits several proteins including SLP76, PLCγ1 and Vav1 to form the 
LAT signalosome. SLP76 and Itk mediate PLCγ1 activation, therefore inducing MTOC polarization 
and calcium ion influx, as well as inducing a cascade of signaling events which contribute to MTOC 
polarization103. Ca2+ influx into the cell is essential for degranulation, but not for MTOC polarization, 
reinforcing the observation that MTOC polarization is not a requirement for granule polarization and 
exocytosis 103. The granules are then released from the secretory cleft and into the target cell121. 
However, not all granules that are polarized will fuse with the synapse, as determined by total internal 
reflection microscopy122. Moreover, granule secretion relies heavily on the actin cytoskeleton 
remodeling, which will be addressed in detail in the next chapter. 
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2.3 Remodeling of the actin cytoskeleton governs the cytotoxicity of NK and CD8+ 
T cell cytotoxicity 
Cytotoxicity is a dynamic process which involves several steps, in which the actin cytoskeleton and 
the rearrangements it undergoes play a pivotal role.  
The actin cytoskeleton is a filamentous network composed of globular actin (G-actin) monomers, 
which polymerize to form filamentous actin (F-actin), and then these filaments may be severed. This 
involves the interplay of several actin binding proteins. This is a highly dynamic process involving 
several players. Nucleation involves the formation of actin dimers followed by actin trimers, which 
allows the start of the elongation through the process of polymerization. The next step involves 
adenosine triphosphate (ATP) hydrolysis.  
To further elongate the actin filaments, formins such as mDia in mice (hDia in humans), and FMNL1 
must interact with the barbed wire to allow monomers to be added to it, thus creating parallel elongated 
bundles123,124. Formins also acts as “leaky cappers”, whereby they slow down the elongation and 
dissociation rates of the actin filament125.  
Arp2/3 binds to the “mother” actin filament to allow the formation of a “daughter” filament in a 
dendritic fashion at a 70-degree angle. Arp2/3 is composed of seven subunits of which five unique 
components: ARP2, ARP3, ARPC2, ARPC3 and ARPC4, together with one molecule each of the 
isoform pairs ARPC1A and ARPC1B, and ARPC5A and ARPC5B. Arp2/3 generally requires 
activation by a nucleation-promoting factor from the Wiskott-Aldrich Syndrome protein (WASp) 
family, the WASp family-Verprolin homologous protein (WAVE), and the cortactin family. WASp 
bound to ARP2/3 will bind to profilin bound G-actin to perform actin nucleation, until the process is 
stopped by capping proteins126.  
On the other hand, proteins that prevent actin polymerization include cofilin and profilin. Cofilin-
mediated actin severing has been shown to be necessary in achieving T cell spreading and the 
formation of a proper immunological synapse, as well as cell motility127,128. Profilin is a protein that 
binds to the barbed end G-actin and prevents its addition to the nascent actin filament129. 
Some major players in this process can be summarized in Figure 8. 
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Figure 8: Overview of families of actin-binding proteins involved in the different processes 
pertaining to actin101. 
 
2.4 Dynamic steps of cytotoxicity 
A. Cell migration 
Chemokine receptors allow lymphocytes to sense the chemokine gradients and migrate to where their 
targets cells are. Migrating cells transform from round cells to cells with a leading edge at the front, 
and a uropod at the back. The leading edge, also named the lamellipodium, is a thin and spread 
structure, composed of highly branched actin fibers. Also in the leading edge are filipodia, which are 
protrusions with an exploratory function, and made up cross-linked actin fibers arranged in a parallel 
fashion130. The uropod is composed of actin filaments coupled to Myosin, which allows the cell to 
generate the tension necessary to migrate forward. To achieve cytotoxicity, the cytotoxic T or NK 
lymphocyte must bind to different targets and scan them. In order to do so, lymphocytes must halt their 
motility upon contact with the target106,109. Upon binding to the potential target cell, the cell’s 
machinery is shifted from locomotion towards immunological synapse formation, where actin 
polymerization continues to take place without the cell moving. The lymphocyte spreads a lamellar 
sheet over the target, and outward radial actin polymerization takes place.  
More information on the mobility of T lymphocytes can be found in131.  
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B. The immunological synapse: the platform for cytotoxicity 
Once the lymphocytes reach their target, they must establish a stable contact, which is the 
immunological synapse (discussed in the next section). Following the establishment of the 
immunological synapse, cytotoxic lymphocytes must polarize their lytic vesicles and their MTOC 
towards the area of contact in order to release perforin and create pores in the target, followed by 
granzyme release into the target64. The MTOC is polarized in a way to deliver the lytic granules in the 
open areas of the actin meshwork53.  
The immunological synapse in the cytotoxic context, is defined as the interaction between a cytotoxic 
lymphocyte and a target cell. As inferred from the previous sections, the immunological synapse 
assembly plays a crucial role in cytotoxicity and will only be discussed in that context. 
IS formation takes place when the lymphocyte halts its movement and establishes a transient but 
controlled contact with the target cell. However, the immunological synapse is far from being a static 
process, it is highly dynamic and tightly regulated and involves reorganization of cellular components 
as well as signaling proteins. 
a. Immunological synapse of CD8+ T cells 
Analysis of the structure of the mature immunological synapse of T cells has revealed a “bullseye” 
structure with radially distributed and spatially segregated rings which Kupfer has named 
supramolecular activation clusters (SMAC), where the TCR-MHC cluster in the center, surrounded by 
a ring of LFA-1-ICAM-1, which is itself surrounded by a distal ring which comprises CD45, a 
transmembrane tyrosine phosphatase132–134. These clusters are referred to, from the inside-out as: 
central, peripheral and distal SMAC (cSMAC, pSMAC and dSMAC) (Figure 10), and the bullseye 
pattern has been suggested to be a mechanism to confine lytic granules and prevent bystander killing 
44,135. The cSMAC, as its name indicates, is the center of the synapse and the area of TCR aggregation, 
and was postulated to be formed of microclusters of about 100 TCR136,137 . The pSMAC directly 
surrounds the cSMAC and is composed of proteins such as talin and LFA-1. The dSMAC is the most 
distal area, and is also referred to as radial lamellipodium that allows the cell to sense chemical and 
physical properties of the APC134,138. 
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Figure 10: Top view model of the spatial organization of the immunological synapse135. The 
immunological synapse is organized into a central, peripheral and distal supramolecular activation 
clusters (SMAC), where distinct molecules aggregate in each SMAC. 
 
Methods based on fluid supported lipid bilayers showed that in the case of CD8+ T cells, TCR-MC 
form at the dSMAC and move centripetally through the pSMAC to the cSMAC, initially aided by actin 
filaments undergoing retrograde flow and subsequently through dynein-mediated movement along the 
microtubules toward the centrosome that translocates beneath the cSMAC following TCR 
stimulation 139–141. LCK is, however, found at the dSMAC, and the cSMAC can be further divided into 
the endo-cSMAC, a poor actin region where the TCR are located, and the exo-cSMAC, a TCR poor 
region where CD28 molecules are located142,143. TCR signaling following TCR-peptide-MHC-I 
engagement drives the ARP2/3 dependent polymerization of branched actin filaments at the edge of 
the site of contact between the T cell and the APC. This drives initial T cell spreading and the 
centripetal flow of the acto-Myosin network, and aids in the retrograde flow towards the cSMAC. This 
retrograde flow may be inhibited by using Jasplakinolide, a drug that directly binds the actin filament 
and leads to the depletion of the G-actin pool. Jasplakinolide addition leads to the formation of a dense 
actin ring between the pSMAC and the cSMAC144. Centripetal actin flow also plays a role in the 
conformational change of integrins, thereby causing the T cell to adhere to its APC and plays a role in 
the outside-in signaling. Indeed, removing the synapse symmetry leads to the restoration of the 
lymphocyte motility by creating a retrograde actin flow, which in turn creates an LFA-1 focal zone 44.  
The pSMAC is made up of a lamella-like actin arc network that outlines the radial symmetric 
contractile ability of this part of the IS. It has been shown that the assembly of the pSMAC actin arc is 
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mediated by formins and organized by Myosin II into antiparallel concentric arcs143–146. Indeed, the 
role of formins validated by the fact that mDia depletion leads to failure in the formation of the linear 
actin filaments needed generate the typical concentric Myosin IIA-rich arcs, as well as the treatment 
with the pan-formin inhibitor SMIFH2, which decreases the presence of actin arcs within the 
pSMAC146. 
b. Immunological synapse of NK cells 
Most of the available information on the IS comes from the study of T cells. However, some groups 
have been interested in the study of the IS on NK cells. In NK cells, distinct IS properties have been 
identified.  
For NK cells, much like T cells, cytotoxicity is mediated by the NK cell emptying its granule content 
into the target cell. In addition to the receptor interplay mentioned above, the actin cytoskeleton plays 
a crucial role in the NK cell synapse. In NK cells, cytotoxicity requires the formation of a mature 
immunological synapse147Moreover, the fact that lytic granules exist in NK cells even prior to 
activation, the accidental release of these granules must be prevented, and the directed release of lytic 
granules must be ensured. The contact between the NK cell and its target is followed by adhesion, 
mediated by LFA-1 among other adhesion molecules147. In the absence of inhibitory signals, the stable 
IS begins to form, involving F-actin rearrangements and morphological changes to NK morphology, 
which occur downstream of Vav1, and is WASp dependent147. It has been shown that NKp46 
aggregates into clusters which are enriched at the IS. It has also been shown to play a role in F-actin 
accumulation at the IS. Even though the NK cell synapse was thought to be static and stable at the 
micrometer scale, it has been shown to exhibit local nanoscale dynamism, where actin filament 
rearrangement appears to be mediated by ARP2/3 and MyosinIIA72. As opposed to the retrograde F-
actin flow observed in T cell synapse, NK cells appear to only display short sequences of outward F-
actin polymerization72.  
While lytic granules aggregate around the MTOC, the MTOC also begins to polarize towards the 
immunological synapse, and the signals to cause this polarization include ERK, VAV1 and PYK2147. 
Lytic granules appear to be accumulated at the cSMAC, and adhesion molecules in the pSMAC57. As 
in T cells, reorganization of the actin cytoskeleton must take place for MTOC and lytic granule 
polarization to the IS, and discrete actin hypodense regions in the cytoskeleton must exist to allow lytic 
granule access to the plasma membrane14,72,147. However, these clearances are not mediated by a 
unidirectional or radial actin flow, but rather by a local nanoscale dynamism where these clearances 
are opening and closing72. ARP2/3 and Myosin IIA also play a role in the structuring of these 
clearances, where ARP2/3 depletion leads to the formation of long bundled actin filaments at the IS, 
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and MyosinII A impairment decreases the number of permissive clearances72. Interestingly, these 
clearances were observed prior to granule arrival72. Docking of the granules requires members of the 
Rab family of GTPases, such as Rab27a, and the SNARE family member Munc13-4 which interacts 
with Rab27a, as well as LFA-1 engagement72,147. The ARP2/3 complex, as well as MyosinIIA have 
also been shown to play a role in granule secretion, where their absence appears to impair exocytosis72. 
Indeed, MyosinII A not only plays a role in the actin clearances, but also in lytic granule movement 
towards the secretory domain of the cSMAC71. In NK cells, it has been demonstrated that the granule-
sized clearances are maintained after degranulation, and so were local filament dynamics, suggesting 
that the formation of these clearances is independent from granule presence, despite the necessity for 
these clearances for a successful degranulation72.  
 
Cytotoxicity resolves by the detachment of cytotoxic lymphocyte from its target. These steps can be 
summarized in the figure 9 below. 
Figure 9: Dynamic steps of cytotoxicity. The main steps of cytotoxicity include migration towards 
the target cell, conjugate formation, lytic granule polarization followed by degranulation, and end 
with the detachment from the target cell 
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 Cytotoxicity in the clinical context 
Cytotoxic T and NK cells have long been known as essential pillars in the clearance of infected cells 
and tumor cells. Dysregulation in the function of these cells can lead to harmful consequences, which 
will be elaborated in the next pages. 
3.1 Cancers 
Cancer is defined as a disease of immune dysregulation, characterized by a failed immune recognition 
leading to the proliferation of malignant cells148.  
The infiltration of a tumor by activated CD8+ T cells is considered a good prognosis and can be 
predictive of a better response to chemotherapy and immune checkpoint blockade therapy. However, 
in several cancers, CD8+ T cells are unable to access the tumor and will accumulate outside the tumor 
cell cluster. However, some CD8+ T cells can infiltrate tumors and it is speculated that the dense fiber 
region surrounding the tumor might not be able to protect against this infiltration149. However, Li et 
al. speculate that in the case of tumors that are indeed being infiltrated, it is due to CD8+ T cells that 
slow down then regain cell motility and chemotaxis149. NK cells were also demonstrated to play a role 
in cancer immunosurveilance150. Due to their potency to eliminate cancer cells, T and NK cell research 
aiming to use them as cancer immunotherapy is currently booming.  
3.2 Autoimmunity 
Autoimmune diseases are defined as aberrant responses towards “self”. They have a high prevalence 
of 7-9% in the population and affect women more than men. It is thought that women are more pre-
disposed to autoimmune diseases due to hormones as well as the direct effects of X chromosomes as 
well a sex-specific microbiota151. Autoimmune diseases can be mediated by autoantibodies or CD8+ 
T cells, but Th cells are always implicated. Autoimmune diseases are usually caused by a combination 
of genetic and environmental factors (such as infections, microbiome and UV light) which culminate 
in an imbalance between the effector and the regulatory responses152–159. They include type I diabetes, 
multiple sclerosis, rheumatoid arthritis and inflammatory bowel disease. Despite the large spectrum of 
organs they affect and their different clinical manifestations, autoimmune diseases usually undergo an 
initiation phase, often asymptomatic, followed by a propagation phase characterized by inflammation 
and tissue damaged caused by cytokine production and the imbalance between the effector and 
regulatory functions of T cells160. The last stage is the resolution, in which patients have some restored 
balanced between the regulatory and effector functions, but often relapse. Interestingly, and contrary 
to a previous belief, a larger portion than previously thought of self-reactive CD8+ T cells manage to 
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escape the process of clonal deletion161,162. Therapies for autoimmune diseases are mainly cytokine 
antagonists, which aim at establishing a long-term resolution by increasing regulatory mechanisms 
163,164. 
3.3 Primary immunodeficiencies 
Primary immunodeficiencies (PID) are a heterogeneous group of approximately 400 rare genetic 
diseases characterized by severe defects in one or several components of the innate and/or the adaptive 
immune system. The clinical presentations of PIDs are variable, but PID patients usually suffer from 
recurrent infections, cancers and autoimmunity, which may be life-threatening. Characterized PIDs 
are monogenic disorders, but more complex polygenic disorders certainly remain to be discovered. In 
this section, only an overview on PIDs will be presented, and the focus on PIDs where defects in the 
cytotoxicity or the actin cytoskeleton/immunological synapse were reported will be discussed in a later 
section. An exhaustive list of PIDs can be found in165. 
A.  Hemophagocytic lymphohistiocytosis 
Hemophagocytic  lymphohistiocytosis (HLH) is a severe condition characterized by a heightened 
inflammatory response and an expansion of polyclonal CD8+ T cells, most likely due to defects in the 
cytotoxic machinery of T and NK cells, despite their normal numbers166. HLH patients present with 
mutations is the perforin, MUNC13/4, RAB27a, LYST, Syntaxin11 genes, all of which are associated 
with the perforin-containing lytic granules in cytotoxic cells (Reviewed in 167). These defects are 
comprised in the category of primary HLH, while secondary HLH occurs as a complication of 
infection, cancer or autoimmunity. The fact that several of the mutations is some of these genes such 
as perforin were found in families has led to terming some HLH as familial hemophagocytic 
lymphohistiocytosis (FHL). These defects, summarized in Table 1, will be elaborated in further details 
in the coming pages, as they entail a defect in cytotoxicity.  
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Table 1: HLH classification, causes and underlying defects168.  
a. Perforin deficiency (FHL2) 
The pore forming 70 kDa perforin glycoprotein is encoded by the PRF1 gene on chromosome 22 and 
is stored in the lytic granules of CTLs and NK cells. Patients with complete perforin deficiency present 
with HLH symptoms, and present an impaired CD8+ T cell and NK cell cytotoxicity 169,170. Partial loss 
of perforin leads to certain malignancies, and perforin loss may lead to certain autoimmune diseases 
such as a systemic lupus erythematosus, Hashimoto’s disease and Grave’s disease171. A missense 
mutation in the PRF1 gene has also been shown to lead to neurological manifestations172. In certain 
cases where cytotoxicity of CD8+ is impaired, some CD4+ T cells may become perforin positive173. 
Perforin polymerizes and binds target cells through membrane phospholipids, forming a channel in the 
target cell membrane through which Gzms may be released. T cell gene therapy has been proposed as 
a curative mechanisms for HLH patients with perforin defects174. 
b. Munc13-4 deficiency (FHL3) 
Munc13-4, a member of Munc13 family of proteins involved in vesicle priming function, has been 
described as a positive regulator of secretory lysosome exocytosis. It is encoded by the UNC13D gene 
located on chromosome 17. Patients presented with fever, hepatosplenomegaly, pancytopenia, 
coagulation abnormality, liver dysfunction, and features of hemophagocytosis in the bone marrow or 
cerebrospinal fluid175. Confocal and TIRF microscopy imaging reveal that Munc13-4 is dispensable 
for granule polarization and docking at the IS membrane, but is required through its association with 
Rab27a for the regulated secretion of cytotoxic granules at the priming stage of the exocytic 
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pathway176,177. Therefore, Munc13-4 deficient CD8+T and NK cells exhibit defective cytotoxicity and 
express more perforin than healthy controls175,176,178. 
c. STX11 deficiency (FHL4) 
The syntaxin11 (STX11) protein is encoded by a gene on chromosome 6. Patients with defective 
STX11 present with HLH symptoms. STX11-causes defects in cytotoxicity and degranulation, and 
patients have a higher perforin expression levels than healthy controls. However, confocal microscopy 
imaging reveals that STX11 deficient cells can efficiently polarize their perforin granules but fail to 
degranulate, due to defective granule fusion with the membrane178 (Figure 11). These defects may be 
reversed by IL-2 administration179. 
 
Figure 11: NK cells from STX11 deficient patients do not fail to polarize their perforin granules 
(red) to the IS178. 
d. Munc18-2 deficiency (FHL5) 
Munc18-2, also known as syntaxin binding protein 2 (STXBP2) is encoded by a gene on chromosome 
19. Its deficiency leads to symptoms of HLH. T and NK cells deficient in Munc18-2 have impaired 
degranulation and cytotoxicity which can be in part corrected by IL-2 administration180,181. Much like 
STX11 deficiency, confocal microscopy reveals that STXBP2 mutant NK cells are capable of normal 
granule polarization (Figure 12). Moreover, Syntaxin 11 is stabilized through a STXBP2/Syntaxin 11 
interaction which is abolished in STXBP2 deficiency.  
55 
 
 
Figure 12: NK cells from a normal donor and an STXBP2 deficient patient stained for F-actin (red) 
and perforin (green) reveal a normal granule polarization in patient cells181. 
 
e. Rab27a deficiency (Griscelli syndrome) 
Rab27a is a member of a large family of Ras-related small GTPases, and the gene encoding it is located 
on chromosome 15. Loss-of-function mutations in the Rab27A gene result in Griscelli syndrome, a 
rare autosomal disorder in which patients suffer partial cutaneous albinism where a pigmentary dilution 
of the skin and the hair s observed, as well as clumps of pigment in hair shafts and an accumulation of 
melanosomes in melanocytes. Patients often develop hemophagocytic syndrome, which is the 
uncontrollable activation of lymphocytes and macrophages. Rab27a is required for granule secretion, 
as Rab27a-deficient T cells exhibited reduced cytotoxicity and cytolytic granule exocytosis despite the 
presence of a normal amount of lytic granules of the proper size182–184. Confocal microscopy images 
revealed that Rab27a co-localizes with Gzm B-containing granules183. 
f. LYST deficiency (Chediak-Higashi syndrome) 
The LYST gene is located on chromosome 1. Patients with LYST deficiency suffer from Chediak-
Higashi syndrome, a rare autosomal recessive disease characterized by partial oculocutaneous 
albinism, recurrent infections, a progressive primary neurological disease, and often causing 
HLH185,186. NK cells form LYST deficient patients show no cytotoxicity and impaired degranulation, 
similarly to T cells185,187–189. Lytic granules from LYST deficient patients show an aberrant 
morphology. There are distinct granules in patient NK cells, and not a giant granule as previously 
thought. However, they are larger than granules in normal NK cells, and they do not converge at the 
MTOC, as revealed by confocal microscopy imaging189. The granules containing cytokines, and 
cytokine release are not affected by LYST mutation189. 
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B. Severe combined immunodeficiency 
Severe combined immunodeficiency (SCID) are a group of genetic diseases caused by mutations in 
genes regulating the development and function of T, NK and often B cells. SCID patients that lack T 
cells and can be sub-classified further based on the presence or absence of NK and B cells. However, 
since antibody production from B cells requires functional T cells, patients in which T cells are absent 
usually have a combined T and B deficiency190. Moreover, within the same family, two siblings 
suffering from SCID may present with different cellular phenotypes191. SCID patients often present 
with symptoms early on, in the first weeks or months of life. They fail to thrive and suffer from viral 
and fungal infections which include infections by rare microorganisms192. One symptom that SCID 
patients present with and that physicians often overlook is lymphopenia. 
a.  B cell immunodeficiencies 
B cell immunodeficiencies, also known as antibody deficiency, are the most common type of PIDs, 
making up for about 50% of diagnosed PIDs. Clinical manifestations include a susceptibility to 
bacterial respiratory tract infections. They are characterized by the reduction or absence of serum 
immunoglobulins (Ig), or an increased Ig level but with impaired function. More than twenty Ab 
deficiency disorders have been defined, and include X-linked agammaglobulinemia and common 
variable immunodeficiency193.  
b. Innate immunodeficiencies 
Innate immunodeficiencies are usually associated with defects in phagocytes, Toll-like receptor 
mediated signaling and complements. Clinical manifestations comprise bacterial and fungal infections. 
Innate immunodeficiencies include severe congenital neutropenia, presented as an extremely low 
neutrophil count. Phagocyte defects are characterized by chronic granulomatous disease, which often 
has an X-linked inheritance. Innate immunodeficiencies also include defects in the IL-2/IFN-γ 
signaling pathway. PIDs associated with complement defects are the rarest category of PIDs, 
comprising less than 1% of all diagnosed cases, and are often associated with autoimmunity.  
 
C. PIDs related to defects in the actin cytoskeleton 
Even though primary immunodeficiencies with a defective actin cytoskeleton are not a category per 
se, we must focus on them as a group in this manuscript, since its emphasis is cytotoxic cells and 
several of these defects are causative of impaired cytotoxicity. As previously mentioned, much of the 
information available to us today on the role of the actin cytoskeleton and its regulation, especially in 
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the control of the immunological synapse, comes from the study of PID patients. In the context of my 
thesis project, we are particularly interested in the regulation of the immunological synapse, and the 
interplay between the actin cytoskeleton and the lytic granules. The genes which cause such defects 
appear to belong to same signaling pathway in several instances, as seen by similar symptoms in the 
patients and similar functional defects. Some of these defects may also be accompanied by a defective 
cytotoxic activity. 
a. Wiskott Aldrich protein deficiency 
The Wiskott Aldrich syndrome (WAS) was first described in 1953 by Wiskott, then by Aldrich in 
1954194. Both have identified that patients suffering from a defect linked to the X chromone present 
with microthrombocytopenia, eczema and recurrent otitis among other infections. In certain cases, the 
pathology of WAS would evolve to include tumors such as B cell lymphomas, and autoimmunity, and 
treatment often requires stem cell transplantation195,196. The gene behind WAS is located on the short 
arm of the X chromosome, specifically at Xp11.22–p11.23, and it encodes the WAS protein (WASp), 
a 501 amino-acid protein expressed in the cytoplasm of nonerythroid hematopoietic cells195. Neuronal 
WASp (N-WASp) is expressed in neuronal cells. WASp has been of interest for my host team in 
Toulouse, as my supervisor Dr. Loïc Dupré has had ongoing research on this protein for almost two 
decades. 
WASp is a multidomain protein comprised, from the N to the C terminus, of a WH1 domain, followed 
by a basic domain, a G protein binding domain (GBD), a proline-rich region and a VCA domain. 
WASp is autoinhibited by a set of intramolecular interactions, mainly between the basic and GBD 
domains and the VCA domain, therefore preventing binding of the Arp2/3 to the VCA domain and 
initiation of actin polymerization197. Indeed, WASp is involved in actin polymerization through the 
nucleation of nascent actin filaments in response to the TCR or chemokine receptors (Figure 13). In 
fact, WASp, (as well as the WAVE complex) controls the activation of the ARP2/3 complex. For more 
information on the detailed activation of WASp, I invite you to read197. 
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Figure 13: Wiskott–Aldrich syndrome protein activation, molecular partners, and cytoskeleton 
remodeling198. 
The role of WASp in the immunological synapse assembly has been demonstrated about 20 years ago. 
WASp is not only recruited to lipid rafts following TCR activation, but is essential for lipid raft 
clustering199. WASp deficiency also causes a decreased F-actin accumulation at the IS, as well as a 
decreased density of LFA-1 clusters at the IS57,101,200. 
Moreover, WASp deficiency was shown to cause a mild defect in the cytotoxicity of CTLs and an 
even more severe defect in NK cells. Indeed, WASp deficient cells, despite a normal expression level 
of lytic molecules, show an aberrant synapse morphology as well as a defect in the recruitment of the 
lytic molecules to the synapse, as well as the exocytosis of these molecules57,201,202. That is because 
lytic granule polarization relies on the WASp-dependent actin polarization. Interestingly, treatment 
with IL-2 corrects the defect in NK cells from WAS patients and restores their normal cytotoxic 
function, by activating WAVE2203,204. This was demonstrated by blocking WAS using the inhibitor 
Wiskostatin, which stabilizes WASp in its autoinhibited conformation and blocks its actin branching 
promoting activity. Using platinum replica electron microscopy, Orange et al. showed that treatment 
with Wiskostatin abolished the branched actin meshwork in treated NK cells, but IL-2 restored this 
branched network, suggesting that IL-2 can activate a mechanism to circumvent WASp inhibition204. 
59 
 
They also showed that IL-2 treatment is effective in restoring F-actin content and cytotoxicity in WAS 
patients. 
b. WASp Interacting protein deficiency 
WASp is found in association with WASp interacting protein (WIP), which plays a role in the control 
of WASp activation, by easing its activation by Cdc-42 and WASp recruitment to the IS205. WIP was 
shown to be recruited to the IS in NK cells200. WIP is activated by phosphorylation but interestingly, 
this phosphorylation is independent of the WIP-WASp interaction, thus suggesting an additional role 
for WIP200. It has been shown by triple-color FRET that both the activation and degradation of WASp 
are dependent on the phosphorylation state of WIP206 
The mutation in the WIPF1 gene located on chromosome 2 causes a decrease in the expression levels 
of the WIP, which consequently leads to the absence of WASp, despite the absence of mutations in 
the WAS gene. Moreover, expression of WIP in the cells of the patient restores the expression of WAS 
to normal levels207. 
The clinical presentations of WIP deficiency resemble those of WAS, which include a failure to thrive, 
eczema, thrombocytopenia, ulcerative skin lesions, pneumonia and cytomegalovirus infection207,208. 
The patient suffered from a reduced number of CD3+ cells, with a more notable decrease in CD8+ 
than CD4+ cells, as well as a reduction in B cells and an increase in NK cells. WIP was also shown to 
negatively impact the migration of T cells towards CXCL12 and CCL19, and the cells displayed a 
failure to elongate208. 
Despite the normal expression of perforin in WIP patient CD8+T cells, the cells displayed a reduced 
ability to degranulate, which translates into a defect in cytotoxicity and elimination of target cells208. 
That can be explained by the fact that the patient cells were shown to be incapable of assembling the 
IS, rendering them incapable of polarizing their lytic granules. Moreover, patient T exposed an aberrant 
actin organization, where the dominant actin structures were elongated and filamentous, and oriented 
in one direction. This evidence supports the role of WIP in the control of the actin cytoskeleton and 
lamellipodia formation, therefore an essential role in the proper assembly of the immunological 
synapse.  
c. ARHGEF1 deficiency 
ARHGEF1 is an intracellular protein that has been shown to regulate migration and adhesion through 
its regulation of G protein–coupled receptor signaling and RhoA activation. It acts by stimulating the 
release of guanine diphosphate (GDP) to allow the binding of guanine triphosphate (GTP)209. The gene 
encoding ARHGEF1 is located on chromosome 19. ARHGEF1 deficiency symptoms include 
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respiratory tract infections including pneumonia. They also showed defective antibody production210. 
One patient presented with mucoepidermoid carcinoma. 
Both patients had low B cell counts with an elevated frequency of transitional B cells, with almost no 
memory B cells. NK, CD4+ and CD8+ T cells were within the normal range, with one patient showing 
an increase in naïve CD8+ T cells and a decrease in memory CD8+ T cells. The cells from these 
patients displayed normal levels of RhoA, but reduced RhoA activity, suggesting that the defect could 
be due to a Rho regulator. F-actin levels were lower in the patients than the healthy controls. Moreover, 
treatment of patient and normal donor T cells with the ROCK inhibitor Y-27632 caused no effect on 
F-actin levels in the patients but reduced their levels in normal donors to those comparable in the 
patients, indicating a role of ARHGEF1 in the RhoA-ROCK mediated actin polymerization. 
ARHGEF1 was also shown to play a role in mediating the LFA-1 dependent T cell adhesion to ICAM-
1, but this was confirmed by siRNA not in patient cells 211. 
d. WDR1 deficiency 
The deficiency in the WD repeat 1 gene, located on chromosome 4, leads to a deficiency in the actin 
interacting protein 1 (Aip1). WDR1 is composed of 9 repeats, which are 30-40 amino acids long. The 
patients present with mucosal and skin ulcerations, respiratory tract infections, stomatitis, periodic 
fevers and one patient died of sepsis. Patients present with mild to severe lymphopenia and suffer from 
recurrent infections. It has been shown that patients with WDR1 deficiency have neutrophil adhesion 
and migration defects, but such findings are beyond the scope of this manuscript212,213.  
WDR1 promotes actin filament disassembly through cofilin, and with the involvement of coronin. 
Indeed, WDR1 binds to cofilin-loaded F-actin to induce their rapid severing. THP1 cells transduced 
with shRNA targeting WDR1 do not show a defect in actin polymerization when assessed by flow 
cytometry, most likely because of mechanisms enabling the cells to compensate for the defects caused 
by WDR1214. However, T cells from WDR1 patients left to adhere on slides coated with anti-CD3 Ab 
show increased spreading, as well as aberrant actin structures such as arcs, filopodia and spikes213. 
Increased filopodia suggest an involvement of formins. 
Even tough B cells from patients migrate normally towards a CCL19 gradient, they display an 
increased adhesion and thin protrusions. They also display an increased accumulation of polymerized 
actin in the ventral plane of the cell, as shown by TIRF microscopy213. This suggests that a WDR1 
mutation affects BCR functions. 
T cells from WRD1 deficient patients show a diminished to normal response to stimulation with anti-
CD3 antibody, which may be explained by the need for the forces generation by the actin cytoskeleton 
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to activate T cells213,214. However, the fact that WDR1 deficiency does not hinder the ability of patient 
T cells to migrate in response to CXCL12 or accomplish normal cytotoxicity suggest that WDR1 is 
not crucial in these aspects relying on TCR activation213. 
e. Coronin1A deficiency 
 The Coronin family is a family of highly conserved actin regulatory proteins. They bind to the Arp2/3 
complex, but unlike other proteins, their role the inhibition of action nucleation215. They contain 5 
WD40 repeats, and their structure is reviewed in more details in215,216. The gene encoding coronin 1A 
(Coro1A) is located on chromosome 16, and the Coro1A protein is a 57kDa protein that has the 
conserved WD repeats, and a leucine zipper motif217 
Coro1A, which is the member of the coronin family expressed mostly on hemopoietic cells, was shown 
to cause lymphopenia in mice, especially in T cells. SCID patients with coro1A deficiency were 
identified and exhibited T-B+ (NK+) SCID phenotype, as well as increased double-negative ϒδ T-
cells216,218–220. The absence of naïve CD4+ T despite the presence of a thymus cells is attributed to the 
fact that Coro1A deficiency leads to distorted mitochondria, therefore leading to apoptosis221. Coro1A 
deficient patients also suffered from upper respiratory tract infections; ear and sinus infections and 
inability to control EBV, associated with fatal lymphoproliferative syndrome and lymphoma at a 
particularly young age216,218. In one patient, this was due to a mutation in one copy of Coro1A coding 
region, as well as a heterozygous deletion of p11.2 on chromosome 16218. In this patient, this deletion 
is suggested to have predisposed her to attention deficit hyperactivity disorder. 
Early assays of two-color confocal microscopy on mouse T cells and Jurkat cells showed co-
localization between Coro1 and F-actin, within the T cell subcortical zone and in membrane 
protrusions, and that Coro1 accumulates in the protrusions caused by actin polymerization following 
cell contact with anti-CD3 Ab222.  
Coro1A plays its role in actin depolymerization in association to cofilin and WDR1. It performs its 
function mostly by redirecting the spatial organization and activity of cofilin in a way to disassemble 
older actin filaments223. 
Mace and Orange have shown by confocal microscopy that Coro1A accumulates at the IS of NK cells 
in contact with their targets (Figure 12)224. A FRAP experiment in the same study shows that Coro1A 
is recruited to the synapse along with F-actin, and that it remains there for the duration of the mature 
synapse. Knock-down (KD) of Coro1A by shRNA in an NK cell line leads to a defective killing in 
these cells, due to a defect in degranulation (granule exocytosis), as shown by the decreased levels of 
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CD107a expression168,224. However, confocal microscopy experiments show that Coro1A deficient 
cells can form conjugates with their targets, with no alteration of the size of the IS, the accumulation 
of LFA-1 at the IS and effective granule and centrosome polarization, all of which are actin-dependent 
processes (Figure12). STED microscopy revealed that Coro1A KD does not hinder ARP2/3 
recruitment but causes the accumulation of a greater density of F-actin in smaller area. This dense F-
actin accumulation at the IS may be the reason the exocytosis of lytic granules is hindered, since 
degranulation requires a pervasive actin meshwork through which the lytic granules can be released, 
and since STED microscopy reveals that Coro1A KD leads to smaller clearances, and the association 
of the lytic granules with more dense actin, making Coro1A a probable key player in the residence of 
lytic molecules in the actin hypodense regions but not their movement224. NK cells from a patient 
presenting with a Coro1A deficiency show that, similarly to what is observed in the shRNA KD, the 
actin presents a smaller area, as well as smaller and fewer clearances, leading to a defect in granule 
exocytosis (Figure 14). The patient also displays a defective cytotoxic activity. 
 
 
Figure 14: The role of Coronin1A in the immunological synapse of NK cells. A. Coro1A (red) 
colocalizes with F-actin (green) and polarized lytic granules (blue) at the NK cell immunological 
synapse. B.Coro1A KD does not alter IS size, F-actin (red), LFA-1 (green) recruitment to the IS and 
perforin (gray) and pericentrin (blue) polarization 224. C. STED microscopy reveals a smaller but more 
intense F-actin (green) area with less pervasive areas, thereby hindering granule (red) release. 
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f. Ccd42 deficiency 
Cdc42 is a RhoGTPase that acts upstream of WASp to activate it (when in its GTP bound state) and 
recruit protein kinase Cθ (PKCθ) and talin to the cSMAC and pSMAC, respectively. Indeed, GTP 
bound Cdc42 binds to WASp, thus releasing the VCA region and allowing WASp binding to 
ARP2/3225. Cdc42 is activated more effectively by the β1 integrin than by CD3, and the absence of the 
β1 integrin can be partially compensated by LFA-1226. Ezrin has been shown to play a role in its 
activation. It has been shown that following TCR engagement, Cdc42, along with WASp, is recruited 
to the IS226,227. T cells defective in Cdc42 fail to polarize F-actin at the IS when in contact with target 
cells, but this did not affect IL-2 production228. Therefore, Cdc42 has a role in multiple cellular 
processes involving the actin cytoskeleton, such as motility and endocytosis.  
Patients with mutations in Cdc42 appear to have mid frontal bossing, failure to thrive, 
hepatosplenomegaly, transaminitis, recurrent febrile episodes, urticaria-like rashes, and significant 
cytopenia229. It has also been shown that when the Cdc42 defect is in the GTPase, the defect triggers 
the formation of broad lamellipodia and stress fiber assembly, while a defect where the rate of 
GDP/GTP exchange is elevated triggers filopodia formation and stress fiber dissolution230. 
g. RhoA deficiency 
RhoA, a 23kDA protein which is active when bound to GTP, plays a role in BCR signaling and induces 
the positive selection of CD8+ T cells. RhoA plays a role in T cell development and is important for 
the survival and proliferation of T cell progenitors in the thymus, as well as playing a role in thymocyte 
adhesion231. RhoA inhibition also prevented Rac1 activation of integrins in thymocytes. Moreover, 
RhoA increases LFA-1 activation during lymphocyte migration, and most likely during the IS232. 
RhoA can bind Rho-associated, coiled-coil–containing protein kinase (ROCK) and mDia. It also plays 
a role in uropod retraction, and microtubule formation at the uropod, and its absence leads to elongated 
cell tails. It is also important for the maintenance of cell shape. RhoA is also speculated to play a role 
in the control of IS size. (Reviewed in 233). Patients with low RhoA suffer from a defective antibody 
production, and in T and B cells there is a defect in F-actin polymerization as indicated by low levels 
of F-actin upon stimulation210 
h. RhoH deficiency 
The RHOH gene located on chromosome 4 encodes an atypical, hematopoietic cell–specific member 
of the Rho GTPase family, which function as intracellular switches to transduce signals from several 
membrane receptors including the TCR and BCR. RHOH is constantly in its active GTP-bound active 
conformation because it lacks a GTPase activity234,235. Moreover, it is essential for positive thymocyte 
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selection and for pre-TCR and TCR signaling because it allows the efficient interaction of ZAP70 with 
the LAT signalosome, thus regulating thymocyte development236,237. Its interaction with ZAP70 is also 
essential for ZAP70 translocation to the IS237,238. RhoH also plays a role in reducing the migration in 
response to chemokines and maintaining the contact with APC , by increasing both Rap1 activity and 
LFA-1 adhesion239. Indeed, cells that lack RhoH migrate faster in response to chemokines, while RhoH 
relocates along with LFA-1 to the IS upon T cell:target conjugate formation239. The patients suffered 
from Epidermodysplasia verruciformis and a human betapapilloma virus (EP-HPV).Consistent with 
findings in mice, RhoH deficient patients lack naïve T cells, and ZAP70 phosphorylation in response 
to stimulation with anti-CD3 Ab is defective, further enforcing the role of RhoH in TCR signaling240. 
It is most likely that these patient cells would display a defect in there is, given the role of RhoH in 
TCR signaling and IS stimulation. 
i. DOCK2 deficiency 
The DOCK180 related superfamily includes conserved genes which are guanine exchange factors, and 
that were shown to play a role in phagocytosis, cell migration and immune homeostasis. These proteins 
harbor a DOCK Homology Region-2 (DHR-2) domain that binds and activates Cdc42, Rac or another 
Rho family member to exchange GDP for GTP241. Therefore, the DOCK family of proteins may be 
considered as guanine exchange factors (GEF). DOCK2 has been shown to be essential for the Rac1 
signaling downstream of the TCR. Mice defective in DOCK2 harbor T and B cells fail to activate via 
Rac in response to chemokines, thus leading o migratory defects and suggesting a role of DOCK2 in 
cytoskeletal organization242,243. DOCK2 patients presented with T and B cell lymphopenia, defective 
T cell proliferation, recurrent respiratory infection and pneumonia episodes244. One of the patients 
suffered multiorgan failure which caused his death. Similarly to mouse models, DOCK2deficient 
patient ells exhibit defective Rac1 activation, as well as defective migration and F-actin 
polymerization244. NK cell cytotoxicity and IFN-γ were reduced, as well as the number of circulating 
NKT cells. 
j. DOCK8 deficiency 
Director of cytokinesis (DOCK 8) is a direct interactor GEF of Cdc42 (with little activity towards Rac1 
and none with RhoA), and has been shown to mediate Cdc42 activation via its DHR-2, and was shown 
to be crucial for Cdc42 activation at the leading edge, therefore important in ameboid migration245,246. 
DOCK8 patients were reported to have SCID and be susceptible to viral (most common is herpes 
simplex virus) and cutaneous infections, therefore suggesting a defect of cytotoxic lymphocytes. 
Patients also presented with high levels of serum IgE and hypereosinophilia, low numbers of T cells 
and B cells, low serum IgM levels246–248. DOCK8 patient CD8 T cells show a decrease in naïve cells, 
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and the circulating cells display an exhausted phenotype and become unresponsive to TCR stimulation 
with anti-CD3249. Moreover, cells from these patients show a defect in proliferation, which is not 
overcome by the addition of exogenous IL-2249. Clonal expansion of CD4 T cells was also diminished. 
In cell lines, DOCK8 was shown to be expressed in NK cell lines, but not the Jurkat T cell line, 
rendering it an incompatible model for such studies, even though Jurkat cell line is the most commonly 
used T cell line. In NK cell lines, Ham et al. have shown that depletion of DOCK8 with siRNA leads 
to a dose-dependent defect in cytotoxicity, as well as a decreased redirected cytotoxicity through FcR 
and NKG2D receptors, implying a role for DOCK8 in the cytotoxic function of NK cells246.Moreover, 
they have shown that DOCK8 plays a role in the upstream step of conjugate formation, where primary 
and NK cell lines deficient in DOCK8 showed defective conjugate formation despite the normal 
expression levels of CD18246. In primary DOCK8 deficient NK cells, the defect in cytotoxicity was 
confirmed, and it was shown that, similarly to T cells, it cannot be rescued by exogenous IL-2250. 
It has been demonstrated by confocal microscopy that the CD8 T cells of mice harboring a DOCK8 
deficiency show a defect in recruitment of LFA-1 to the IS, whereby the distribution of LFA-1 is 
reported to be uneven. Moreover, DOCK8 deficient mice cells failed to polarize actin to the IS249. 
Consistent with these findings, NK cell lines in which DOCK8 expression is suppressed by siRNA or 
shRNA, as well as primary NK cells from DOCK8 deficient patients show weaker accumulation of 
LFA-1 at the pSMAC, as well a diminished F-actin accumulation, as well as a defective granule 
polarization (Figure 15)246,250. Notably, the F-actin content in DOK8 deficient cells is the same as in 
healthy cells, as opposed to WASp deficient cells in which the overall actin content is reduced. Taken 
together, these data suggest a role for DOCK in cytotoxicity. 
 
Figure 15: DOCK8 suppression leads to diminished F-actin (green) and lytic granule (red) at the 
IS246. 
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DOCK8 was also shown to be a direct interactor of WASp and talin, and to mediate their polarization 
to the IS in NK cells, therefore indicating a role for DOCK8 in actin reorganization and IS 
maturation246. However, the DOCK8 deficiency remains less severe than the DOCK2 deficiency. 
 
k. PSTPIP1 deficiency 
Proline-serine-threonine phosphatase-interacting protein 1 (PSTPIP1) gene located on chromosome 
15, also known as CD2-binding protein 1 (CD2BP1) encodes for a cytosolic adaptor protein involved 
with activation, differentiation, and migration of T cells251. PSTPIP1 also acts as a scaffolding protein 
for signal transduction towards the nucleus252. PSTPIP1 has been identified in patients with pyogenic 
sterile arthritis with PG and acne syndrome, a rare autoinflammatory disorder with autosomal 
dominant inheritance251,253,254 Patients with PSTPIP1 deficiency presented with an immunodeficiency 
phenotype, but no symptoms of autoinflammation. They also presented with recurrent viral and 
bacterial respiratory tract infections and low IgG and IgA levels (low IgM for one patient). Their T 
cells were mostly naïve T cells, there was a reduction of CD4+ T cells in one patient, and there was a 
reduction in B cell numbers252. PSTPIP1 acts a scaffold protein to allow protein tyrosine phosphatase 
(PTP-PEST) to dephosphorylate WASp255. Therefore, through its interactions with CD2 and WASp 
through PTP-PEST, PSTPIP1 plays a role in F-actin dynamics and the establishment of a stable IS. In 
one patient, CD4+ T cells showed a pre-activated F-actin status, therefore failing to modulate their 
actin cytoskeleton in response to stimulation with anti-CD3 Ab, as well as higher baseline levels of 
calcium ion than normal controls252. CD4+ T cells from patients were also more motile, which may 
explain their failure to respond to TCR/CD2 stimulation. Jurkat T cells transfected with plasmids 
encoding PSTPIP1 mutation and either left unstimulated or stimulated with antiCD3/anti-CD28 beads 
and imaged with confocal microscopy showed more baseline F-actin levels when unstimulated, but a 
failure to recruit F-actin to the IS upon stimulation252. 
l. STK4 deficiency 
Serine threonine kinase 4 (STK4), previously named Mammalian sterile-like protein 1 (MST1), 
encoded by a gene on chromosome 3, is a ubiquitous protein that plays a dual proapoptotic and 
antiapoptotic role. Its proapoptotic role is suggested by the fact that in resting conditions it is a 63kDa 
cytosolic protein which becomes cleaved by caspases256. STK4 deficient patients presented with 
neutropenia, recurrent fever and recurrent respiratory tract infections, mouth ulcers, sinusitis, eczema-
like rashes and skin abcesses256–258. Patients also presented lower levels of CD4+ and low to normal 
CD8+ T cells, as well as slightly lower B cell count, and a normal NK cell count256,257. T cells from 
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MST1 deficient patients exhibit a defect in proliferation, and higher apoptosis rates than healthy 
controls256,257. Recurrent episodes of neutropenia also suggest a role for STK4 in neutrophils. 
Unfortunately, the data on patients deficient in MST1 is limited. Moreover, MST1 was shown to play 
a role in the regulation of the IS, where it plays a role in the transport of TCR to cSMAC259. It also 
phosphorylates VASP, which is a player in the F-actin polymerization. More on the role of MST1 can 
be found in the review259 
m. RASGRP1 deficiency 
RASGRP1 is a guanine nucleotide exchange factor whose gene is on chromosome 15. RASGRP1 is 
and activator of the RAS-MAPK pathway following TCR signaling. Following TCR simulation, 
RASGRP1 translocates to the membrane and converts RAS, a GTPase, from an inactive GDP-bound 
form to an active GTP-bound form, which in turn process mediates activation of the MAP-kinase. 
Therefore, and as confirmed by mouse studies, RASGRP1 plays and important role in T cell 
proliferation and development and survival260,261. The RASGRP1 deficient patient presented with 
recurrent infections including pneumonia, failure to thrive, and finger clubbing262. The patient 
presented a decreased CD4+ T cell and B cell count, increased CD8+ T cells of which Tγδ cells were 
increased. Moreover, Tαβ CD8+ displayed an exhausted phenotype. CD4+ and CD8+ T cells displayed 
a failure to proliferate upon anti-CD3/CD28 Ab stimulation. Despite the increased expression of 
perforin and Gzm B in patient CD8+ T and NK cells, they failed to eliminate target. In NK cells, it 
was shown by confocal microscopy that this defect was due to the defective IS formation, with 
decreased F-actin accumulation, increased distance from the MTOC to the synapse and defective 
granule convergence (Figure 16), as well as reduced granule motility as shown by video microscopy. 
Defects in granule motility and convergence may be attributed to the inability of RASGRP1 to bind 
dynein. CD8+ T cells showed a reduced migratory speed in response to CXCL12 gradient, which due 
to a slower actin turnover. B cells also showed defective BCR stimulation and defective MAPK 
activation. 
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Figure 16: Defective RASGRP1-deficient NK cell IS assembly. Immunological synapse from a 
healthy donor and RASGRP1 deficient patient shows reduction in F-actin (green) accumulation, 
increased MTOC distance from IS (pericentrin; yellow) and a defect in lytic granule (red) 
convergence262. 
n. MKL1 deficiency 
Megakaryoblastic leukemia 1 (MKL1), also known as MAL or myocardin-related transcription factor 
A (MRTF-A) and encoded by a gene on chromosome 22, is a coactivator of serum response factor, 
which regulates transcription of actin and actin cytoskeleton–related genes. Indeed, MKL1 exists in 
the cytoplasm in its inactive state as a reversible complex with actin. Rho GTPase stimulation promotes 
incorporation of G-actin into F-actin filaments, thereby releasing MKL1 from G-actin and allowing its 
import to the nucleus. In the nucleus, MKL1 functions as coactivator of serum response factor (SRF) 
and stimulate SRF-mediated transcription of actin and actin cytoskeleton–related genes263,264. The 
patient presented with malignant otitis, as well as P. aeruginosa infection, chickenpox and painful skin 
lesions. Blood counts were normal, but T cells failed to activate in response to stimulation with anti-
CD3 Ab265. F-actin levels in both myeloid and lymphoid cells were reduced. shRNA inhibition of 
MLK1 in THP1 cells (DC cell line) showed depletion of F-actin, poor adhesion to fibronectin, reduced 
spreading, and defective podosome assembly, as well as impaired fibroblast migration along with 
altered cell shape and loss of cortical actin and stress fibers. In neutrophils, chemotaxis was aberrant 
and disruption of Myosin II interaction with F-actin using Blebbistatin produced impaired uropod 
retraction similar to that in MKL1 deficient cells, suggesting that MKL1 deficiency could impair 
neutrophil migration through effects on Myosin II. 
o. Moesin deficiency 
Moesin (MSN) belongs to the ezrin- radixin–moesin (ERM) proteins, which are a family of widely 
distributed membrane-associated proteins that link plasma membrane proteins with actin filaments in 
the cell cortex. They exist in the cytosol in their auto-inhibited form, and can be activated by binding 
to membrane phosphatidylinositol 4,5-bisphosphate266. Lymphocytes express primarily ezrin and 
moesin. MSN is expressed on the X chromosome. Mice with MSN deficiency exhibit lymphopenia 
and a systemic lupus erythematosus -like disease, suggesting a role of MSN in the regulation of Treg 
homeostasis267. MSN deficient patients presented with varicella zoster virus infections, as well as 
respiratory tract infections268. Blood cell counts revealed low NK, CD4+T, CD8+ T (as well as 
exhausted CD8+ T cells) and B cell count, and neutropenia and microcytopenia268,269. T cell 
proliferation following stimulation with anti-CD3/CD28 Ab was impaired. IS was not impaired in 
MSN deficient cells and neither was F-actin content, but migration and adhesion were. However, 
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cytotoxicity was not assessed, but it may be affected given that MSN is a regulator of the actin 
cytoskeleton. 
p. Rac2 deficiency 
Ras-related C3 botulinum toxin substrate 2 (RAC2) is a hematopoietic-specific member of the Rho 
family of guanosine triphosphatases (Rho GTPase) and encoded on chromosome 22. Rac2GDP can be 
activated by a GEF and RAC2-GTP drives several cellular functions through association and activation 
of downstream effector proteins. Activation of these downstream targets leads, among other, to actin 
cytoskeleton rearrangement and thymic T-cell selection. Indeed, RAC2 is involved in the cycling of 
actin between G-actin and F-actin states through interactions with cofilin and the ARP2/3 complex270. 
The patients presented with failure to thrive, recurrent pneumonia, followed by edema, proteinuria, 
urinary tract infections, cellulitis and membranous glomerulonephritis, undetectable IgA and increased 
IgG, a normal T cell count and a slightly decreased B cell count in one patient and a reversed 
CD4+:CD8+ T cell ratio and severe B cell lymphopenia in the other271,272. Rac2 is mainly studied in 
neutrophils, and patient neutrophils from Rac2 deficient patients exhibit an abnormal chemotaxis, and 
constantly high levels of F-actin, suggesting that the role of Rac2 in actin cycling between its two 
forms is impaired272,273. 
q. Myosin deficiency 
Myosins are actin-dependent molecular motors that use the energy of ATP hydrolysis to move along 
actin filaments. Myosin II in non-muscle cells plays important roles in cytokinesis and cell migration, 
and the most abundant form is IIA (MyH9). Indeed, to migrate forward the cell must retracts its trailing 
edge by combining both the acto-myosin contractility and the disassembly of adhesions at the rear 
(uropod)125. The actin filaments generated via ARP2/3 elongation are organized by Myosin II into 
antiparallel concentric arcs in the pSMAC, as revealed by SIM imaging of Jurkat cells and primary 
mouse T cells274. It has been shown that upon LFA-1 binding to ICAM-1, LFA-1 associates with 
MyH9275. Treatment with Blebbistatin, a MyH9 ATPase inhibitor, and siRNA inhibition of MyH9 
both result in a polarized cell morphology, in which the uropod was extended in length as opposed to 
shorter uropods in untreated cells. This suggest that MyH9 binding to LFA-1 and the force it exerts is 
essential for the LFA-1 de-adhesion at the uropod275. However, MyH9 association to LFA-1 is not 
required for LFA-1 activation nor its recruitment to the leading edge of the cell. 
In 2004, Jacobelli et al. Showed that MyH9 function is essential for maintenance of the uropod and for 
T cell motility but is dispensable for synapse formation, even though Ilani et al. show that it is recruited 
to the IS and essential for its sability276,277. However, mouse experiments revealed that siRNA 
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inhibition of MyH9 leads to more spread IS, suggesting that MyH9 plays a role in constricting IS size, 
as well as playing a role in pSMAC and cSMAC formation regardless of the concentration of MHC 
available, but not for TCR microcluster transport278. Conversely, Yu et al. demonstrate that Myosin is 
required in the TCR transport in the first two minutes of IS formation, and that its inhibition by 
Blebbistatin affects the directed TCR movement279. Treatment of Jurkat cells with Blebbistatin and 
shRNA inhibition in primary CD4+ T cells and observation with TIRF microscopy of supported planar 
lipid bilayers reveals, on the other hand, that MyH9 activity is required for centripetal TCR 
microcluster movement, but not for microcluster formation277. Ilani et al. also show a role for MyH9 
in TCR signaling277. Moreover treatment with Y-27632, which inhibits Myosin-II contractility by 
specifically targeting rho-associated protein kinase (ROCK) leads to a perturbed IS280. In NK cells it 
was shown that NK MyH9 deficiency causes an inability of NK cells to properly polarize their granules 
to the immune synapse and subsequently degranulate and lyse target cells281. Moreover, it was shown 
to polarize at the IS but its absence does not affect Is formation. MyH9 constitutively associates with 
lytic granules and plays a role in their fusion with the cell membrane, as shown by siRNA inhibition 
or Blebbistatin treatment70. MyH9 also plays a role in B cell migration but not BCR signaling, as 
shown by use of Blebbistatin and mouse models282. Mutations in the motor domain Myosin II heavy 
chain lead to MYH9-related disease, characterized by hematologic defects such as 
macrothrombocytopenia and in some cases cataracts, deafness, and glomerulonephritis283. However, 
mutations in the tail domain of Myosin IIA lead to no relevant clinical symptoms284. 
r. ARPC1B deficiency 
The actin nucleator ARP2/3 is composed of 7 subunits (Figure 17) The Arp2 and Arp3 subunits act as 
monomers from which new actin filaments elongate in a 70-degree orientation and recruit and 
hydrolyze ATP285. The remaining subunits (the isoforms ARPC1A, ARPC1B (encoded by a gene on 
chromosome 7), ARPC5, and ARPC5L, and ARP4) organize to form the structural core of the 
complex, providing an interface for binding to preexisting actin filaments and regulatory cofactors. 
Indeed, activated WASp binds to ARP2/3 and delivers the first G-actin via its VCA domain, and 
WAVE binds to the complex as well286,287. 
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Figure 17: Crystal structure of the ARP2/3 complex from Baus taurus access protein data 
bank:1K8K288 
 
Patients with ARPC1B deficiency present with a very early onset of 2 months on average. The first 
patients with an ARPC1B mutation were reported in 2017, and more have been reported since then. 
ARPC1B deficient patients presented with failure to thrive (due a partial growth hormone impairment), 
recurrent bacterial and viral infections and hemorrhages, platelet abnormalities, eosinophilia, 
enterocolitis, small vessel vasculitis, eczema and other indicators of inflammatory/immune disease, 
and such a phenotype was described as “WAS-like”288–291. The patients presented with an increased 
amount of B cells, and decreased CD4+ and CD8+ T cells, including a reduction of naïve T cells289.  
ARP2/3 was recently shown to colocalize with actin at the IS and at lamellipodia, suggesting that the 
defects observed in ARPC1B deficiency may be attributed to defects in cytoskeletal organization, 
especially that ARPC1B cells display a defect in actin polymerization 288,291,292. Moreover, in patients 
with ARPC1B deficiency, levels of ARPC1B in PBMCs are reduced and the distribution is, as revealed 
by confocal microscopy, in large patches instead of an even distribution along the actin cortex288. 
APRC1B deficient patient T cells fail to spread radially on an ICAM-1/Anti-CD3 Ab coated surface, 
and they emit thin filopodia, which are under the control of formins, as can be inferred from their 
abolishment upon treatment with SMIFH2274,288,292. Moreover, they require more time to form weak 
conjugates and a very narrow, F-actin poor contact area with target cells, due to the failure to 
accumulate or deplete F-actin288,292. Treatment of T cells with the ARP2/3 inhibitor CK-666 - which 
like CK-869maintains the ARP2/3 complex in an inactive state blocking formation of the short pitch 
Arp2-Arp3 dimer - was shown to reduce T cell cytotoxicity, as well as reduced actin accumulation as 
compared to the inactive CK-689292,293. Inhibition with CK-666 also abolished lamellipodia (which 
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were replaced by small blebs), and treated cells showed a slower migratory speed292. Therefore, the 
ARP2/3 complex is involved in CTL migration and cytotoxicity.  
ARPC1B deficient T cells show a reduced migration in response to CXCL12, reduced degranulation, 
reduced centrosome polarization and a reduced ability to lyse targets, which are due to defective TCR 
signaling, as well as a reduced Gzm B content292. Of note, even though ARPC1B deficient cells could 
secrete granules, the defect in degranulation can be traced back to the fact that only a minority of lytic 
granules are polarized to the IS. Some ARPC1B deficient CTLs (perforin positive) showed a loss of 
CD8 as well. ARPC1B deficient CD16negCD56bright NK cells also show defects of degranulation and 
cytotoxicity, which may be partially restored with IL-2289.  
The study of patients with several immunodeficiencies related to the cytotoxic function lead to the 
observation that ARP2/3 is a key player in the regulation of the cytotoxic function in lymphocytes. 
Therefore, it would be interesting to study the response of the ARPC1B deficient cells to different 
levels of activation by anti-CD3 and assess their cytotoxic potential under these different levels of 
activation.  
  
Figure 18: PID-associated actin regulators 
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 Methodologies to assess defects in cytotoxicity.  
To assess the defects in cytotoxic lymphocytes in patients or mouse models, different methodologies 
exist. In this chapter, the methods employed to assess functional defects in the PIDs mentioned in this 
chapter will be elaborated, following the logical order of the steps of cytotoxicity. 
A defect in actin content or polymerization may be assessed by flow-cytometry, as done for WDR1, 
DOCK2, DOCK8 , Rac2 and ARPC1B 214,244,250,273,291.  
Defects in lytic granule content are generally assessed by flow cytometry, as was done for 
RASGRP1262.  
Conjugate formation capacity can be assessed by flow cytometry or immunofluorescence, as was done 
for DOCK8 and Coro1A respectively224,250. 
The immunological synapse is typically monitored by confocal microscopy. It has been shown that 
WIP deficient cells display actin organization and form improper IS208. WDR1 deficient cells are more 
spread and form actin arcs213. Coro1A cells form a synapse of normal size while Myh9 deficient cells 
appear to spread more than control cells and ARPC1B deficient cells display a failure to spread 
radially224,278,292. DOCK8, PSTPIP1, RASGRP1 fail to recruit actin to the IS246,252,262. Coro1A 
deficient cells can successfully recruit LFA-1 to the IS, which is not the case for DOCK8 deficient 
cells224,246. Granule convergence at the MTOC appears defective in Lyst deficient cells, and the 
granules appear larger in size that controls294.  
Defective degranulation can be monitored by flow cytometry, by monitoring the levels of CD107a 
exposure by flow cytometry, as was done for WIP, Coro1a, Rab27a and Lyst183,185,208,224. It can also 
be monitored by observing the recruitment of lytic granules to the IS, where it has been shown that 
while Munc13-4, Munc18-2, Coro1A can usefully polarize their granules to the IS, DOCK8 and 
STX11 and MyH9 deficient cells fail to do so176–178,181,224,246,249,250,281. 
Finally, the ability of cytotoxic cells to eliminate target cells can be assessed by flow cytometry, where 
it has been shown that WASp, WIP, Coro1A, DOCK8, Rab27a, Munc18-2, Lyst and ARPC1B have 
impaired ability to eliminate target cells with respect to healthy controls180,182,202,208,224,246,250,292. 
Table 2 below summarizes the criteria used to assess IS defects in cytotoxic cells by 
immunofluorescence. 
Defect Assessment measurement 
Actin Organization Actin intensity at IS 
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Cell Spreading Cell area 
Radial spreading Cell width to length comparison 
Lamellipodia formation Cell Roundness 
Granule polarization Distance from lytic granules to IS 
Granule size Individual granule size measurement 
Degranulation Granule fusion with the IS 
LFA-1 recruitment LFA-1 intensity at the synapse 
Table 2: Main criteria used in the assessment of a defective immunological synapse in cytotoxic 
lymphocytes by immunofluorescence. 
This shows that there is currently no systematic and unified process of detecting defects in the cytotoxic 
activity of lymphocytes, and that several tests are usually performed to assess it. Therefore, there is a 
need for an approach which can predict a functional defect in the cytotoxic activity of NK and CD8+ 
T cells.  
 Microscopy imaging of biological objects 
In the previous section, I have tried to highlight the importance of the cytotoxic function of T and NK 
cells, as well as the important role of the immunological synapse in the context of cytotoxicity. In the 
next section, I will highlight the importance of microscopy in immunology, as well as the advantages 
of high content imaging pipelines as opposed to traditional low throughput microscopy.  
The human eye is highly capable of viewing different objects of varying sizes. However, the smallest 
it can see is an object of around 100µM, when that object is about 25 cm away. 
The human eye is thus incapable of seeing infectious organisms such as bacteria, without an object 
that would enhance their size. For that reason, the microscope, which was invented by Antoni Van 
Leeuwenhoek and Robert Hooke, has proven to be a vastly useful tool. A microscope is therefore a 
tool that allows one to see samples while enhancing their size through one or multiple lenses. Any 
sample that allows light to pass through it may be viewed with a microscope. 
5.1 The basics of microscopy 
A. Light sources to illuminate a sample 
Every microscope essentially needs a light source, and the light is composed of an electromagnetic 
wave having a specific wavelength, and photons. Lights can illuminate a sample either directly 
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(transmission) or can be reflected through a mirror before hitting the sample (reflection). Light can be 
divided into two main categories: brightfield and fluorescence.  
Widefield microscopy consists of the microscope forming an image of the object on the camera. For 
widefield imaging, traditional lighting methods include xenon, mercury and halogen lamps, combined 
with excitation and emission filters, as well as shuttering devices which control the duration of 
elimination. Light emitting diodes (LEDs) are also a cheap and stable alternative. LEDs can be turned 
on and off rapidly, eliminating the needs to shutters 295.  
Fluorescence microscopy relies on the use of fluorophores (fluorescent dyes) which absorb one 
wavelength of light and emit another. Techniques to introduce fluorescence to biological cells include 
fluorescent antibodies which bind to specific proteins (a process termed immunofluorescence), and 
genetic manipulation to introduce fluorescent proteins into the cell. LEDs can also be used for 
fluorescent microscopy due to a narrow emission spectrum, as have been designed to provide 
illumination at very specific wavelength bands from UV to infrared295,296. Confocal microscopy is also 
used to illuminate fluorophores, where the sample is illuminated by a laser beam at a single point in 
the focal plane297.  
 
B. From an object to an image 
When light passes through lenses, the image can be enlarged to different sizes, depending on the 
magnification of a given lens. Light exits a lens and rays parallel to the optical axis may only be 
converged onto one focal point if the lens is spherical. The objective lens typically determines the 
magnification and resolution of an image, as well as the sensitivity of the microscope with regards to 
how much light will be collected from the sample. Magnification refers to how large the final collected 
image will be with respect to the sample.  
The object being detected by a microscope is referred to as a sample, and it should be placed on a 
support in order to be illuminated. Therefore, an essential characteristic of a sample is that it should 
allow the passage of light.  
The human eye is the structure that detects the image in the context of a simple light microscope. 
However, most commonly used nowadays is a camera, which also allows saving images. However, 
noises may occur and interfere with proper image detection. Notably we name the black noise 
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generated by the camera, the reading noise caused by the electronic signal amplification and the 
photonic noise due to the random nature of the light.  
The term “resolutive” is employed to refer to a microscope that can detect two close points as separate. 
In other terms, the resolution of a microscope is defined as the smallest distance between two points 
of a sample at which they can still de distinguished as two separate points. This distance, as 
demonstrated by Abbe in 1873, has been shown to depend on the light diffraction from the sample 
through the lens. The formula to determine resolution is: 
d = λ / NA, 
where λ is the wavelength of light and NA is the numerical aperture of the objective lens.  
Technological advancements in the field of microscopy are always aiming to increase the resolution. 
 
5.2 The timeline of microscopy in biology 
The discovery of microorganisms through microscopes began in the 17th century with the Dutch 
scientist Antony Van Leeuwenhoek, who created lenses with 300x magnification, and used single 
lenses to view his samples, and referred to what he saw as “animalcules”. Hooke, a contemporary of 
Van Leeuwenhoek, also created settings that allowed object magnification and imaged seeds, the eyes 
of a fly and the structure of a cork. He however used compound lenses, which resulted in more 
aberrations due to the lenses themselves at the time.  
In the nineteenth century, the theoretical and technical aspects of the modern light microscope were 
developed. The most notable are diffraction-limit theory, aberration-corrected lenses and an optimized 
illumination mode called Köhler illumination. 
In 1868, Abbe invented the apochromatic lens, using more fused lenses, which better corrected 
chromatic and spherical aberrations. In 1883, he collaborated with Schott, a glass chemist, to produce 
the first lenses that were engineered with sufficiently high quality to produce diffraction-limited 
microscopes. 
Fritz Zernike developed phase contrast microscopy in the 1930s to overcome the poor contrast of 
transparent biological samples298. Smith and invented Nomarski invented differential interference 
contrast (DIC) in 1955, as an alternative to phase contrast299. The images produced are exceptionally 
sharp in comparison with other transmission modes. DIC is still the current standard technique for 
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imaging unstained microbiological samples in having an exceptional ability to reveal the boundaries 
of cells and subcellular organelles. 
To improve contrast in biological samples, stains have proved to be quite a useful tool, especially 
stains that allow staining of specific parts of a sample. 
The first reported staining of a biological sample was reported by von Gerlash in 1858, who managed 
to differentially stain the cytoplasm and the nucleus of brain tissue with carmine. Golgi introduced 
silver staining in 1873, through which he visualized the nervous system. In 1884, Gram introduced the 
Gram staining, which is until now still used to stain different bacteria. However, the revolution in 
microscopy staining of biological samples occurred upon the introduction of fluorescent stains. Stokes 
was the first to define fluorescence in 1852, as the emission of light at a wavelength different from that 
of excitation. In 1941, Albert Coons published the first work on immunofluorescence, where he used 
a fluorescein-derivative-labelled antibody and showed that it could still bind to its antigen300. This was 
the first steps towards the use of fluorescent antibodies as highly specific stains.  
The first natural fluorescent stain used was green fluorescent protein (GFP), isolated from jellyfish in 
1962301. However, it was not expressed outside of jellyfish until 1994, when it was incorporated into 
a promoter gene for β-tubulin and shown to be useful in determining expression levels302. A real 
breakthrough was optimizing a method to fuse the genes of a protein of interest with a GFP and express 
this in a cell while also leaving it relatively unperturbed. This was performed in 1994 by Wang and 
colleagues by fusing green fluorescent protein GFP to the bcd transcription factor in Drosophila303. 
Blue and yellow fluorescent proteins were produced by mutating GFP, while red fluorescent protein 
was produced from Anthzoa, a species of coral, in 1999304,305. In 1980, Roger Tsien introduced the first 
calcium probe, capable of detecting cell membrane voltages and ion concentration306. 
In 1946, Förster postulated that if a donor and acceptor molecule were sufficiently close together, non-
radiative transfer of energy could occur between the two, now known as Förster resonance energy 
transfer (FRET)307. Fluorescence can be used as a metric of putative molecular interaction through 
FRET in the event that the donor and acceptor molecule are fluorescent dyes. Stryer & Haugland 
showed in 1967 that this phenomenon could be used as a molecular ruler over a length scale of 
approximately 1–10 nm308. Since then, FRET has been widely used to image molecular interactions 
and the distances between biological molecules, and also in fluorescence lifetime imaging309. 
In 1964, Curtis introduced the principles of interference reflection microscopy (IRM), where the 
interference of reflected light waves generates images with high contrast and definition. This technique 
has been improved and is now used to study cell adhesion or cell mobility on a glass coverslip310. 
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With all these advancements came the fluorescent microscope, specifically designed for samples to be 
stained and imaged with fluorescent dyes or probes. Fluorescent imaging techniques include confocal 
microscopy, total internal reflection fluorescence (TIRF) introduced in the 1980s, fluorescence 
recovery after photobleaching (FRAP) introduced in the 1970s, and two-photon and light-sheet 
microscopy. TIRF microscopy is based on the principle that when excitation light is totally internally 
reflected in a transparent solid at its interface with liquid, the evanescent wave (an electromagnetic 
field), is generated in the liquid at the solid-liquid interface and is the same frequency as the excitation 
light. The intensity of the evanescent wave exponentially decays with distance from the surface of the 
solid, and only fluorescent molecules within a few hundred nanometers of the solid are efficiently 
excited311. 
Two-photon scanning laser microscopy was introduced by Denk in 1990 and has since been used to 
observe molecules in live tissues312.  
The confocal microscope was invented by Minsky in 1955 but the nomenclature “Confocal” was first 
used by Brakenhoff in 1979, to refer to a microscope where the illumination is in a diffraction-limited 
spot within the specimen, and where the detection is also confined by positioning an aperture in front 
of the detector in a position that would be optically conjugate to the focus spot313. Confocal microscopy 
aims to eliminate the signals from fields other than the imaging plane, through the use of a pinhole, 
which would be situated in front of the detector. Laser-scanning confocal microscopes typically use 
point detectors instead of cameras to record an image point by point and are therefore less sensitive. 
To overcome this limitation, systems which scan multiple focus spots across the sample 
simultaneously and image the resulting emission on a camera have been designed. The spinning disk 
confocal is the most common, and it uses a disk of pinholes which sweep across the sample in a way 
that a revolution of the disk scans over every point in the sample during a single exposure314. Spinning 
disk confocal microscopes have gained popularity given their high speed and sensitivity.  
Even though the imaging of biological samples had come a long way, the size of the smallest object 
that could be imaged was still a limiting factor. Two objects could be separated (or resolvable) as long 
as the nearest-neighbor separation of the dye is greater than the limit of the optical resolution. In other 
words, the wavelength of the light used, as well as the objective used were the barrier to imaging single 
molecules. Hell and Wichmann were the first to show that it was possible to break the diffraction limit 
with a technique he called stimulated emission depletion microscopy (STED), and Hell and Klar 
implemented it in 1999 315,316. Alexa dyes also came to use in the late 1990s and are more fluorescent 
than the dyes previously used. Alexa derivatives coupled to phalloidin can be used to visualize F-actin, 
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and may also be used to detect antibodies317. Currently, a common approach to stain cells is indirect 
immunofluorescence, where the cells are fixed, labeled with a primary antibody specific to the protein 
to be detected, followed by staining with secondary antibodies, which generally have a broad 
specificity and can be coupled to Alexa dyes.  
In 2006, two new techniques were introduced. Photo-activated-localization microscopy (PALM) was 
used by Hess and Betzig, in which photoactivable proteins which change colors when exposed to UV 
light change colors318,319. The main difference is that Hess and colleagues used TIRF while Betzig and 
colleagues used confocal microscopy. In 2006 as well, Rust and colleagues showed that by using a 
technique called stochastic optical reconstruction microscopy (STORM), they could generate a super 
resolution by using a Cy5/Cy3 switchable probe320. When the probe is illuminated by a red laser, Cy5 
is kept in a dark state, while the pair is brought back to an exited state by a green laser. 
Advancements have also been made in 3D imaging microscopy which allow the reconstitution of cells 
and even organoids. However, they will not be addressed in this manuscript.  
The timeline of microscopy is summarized in Figure 19 below. 
 
Figure 19: The timeline of microscopy 
5.3 High content imaging: A game changer 
One problem microscopy has faced is the time image acquisition and processing can take. This is true 
especially in a time where screens have become highly popular as an approach, and the fact that 
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phenotypic analysis can be a powerful technique to reveal information. Indeed, phenotypic analysis 
has been employed by Brenner who performed a screen on Caenorhabditis elegans to assess how 
different mutations could impact behavior, and by Nüsslein-Volhard and Wieschaus who performed a 
screen on the Drosophila melanogaster embryos to assess the effect of different mutations on the 
number and the polarity of the segmental patterns of the larva321,322. However, these screens were 
manual and consequently laborious, which explains the need for an automated approach. Screens may 
be conducted in several different ways and may include biochemical assays, neurite growth assays, as 
well as translocation and differentiation assays (reviewed in323).  
Screens can also include specific inhibitions with small interfering RNA (siRNA), short hairpin RNA 
(shRNA) and CRISPR cas9 screens, and include genome wide screens324–326. Indeed, Carlin and 
colleagues have designed an siRNA screen and images samples using fluorescence lifetime imaging 
microscopy (FLIM), which is the optimized FRET technique to image protein interactions, and 
monitored the activity of Cdc42 and its interactors327. However, CRISPR cas9 screens are growing in 
popularity since shRNA and siRNA may generate off-target effects and incomplete inhibition328 
High content screens are a useful tool in the identification of small molecules that may be used for 
drug development, as well as determining interactions between different proteins or compounds. 
 
A. High content imaging: microscopy at a large scale 
 High content imaging (HCI), a term which began to be employed in the early 2000s, combines 
approaches of automated imaging and image analysis of cells and cellular organelles, to quantify 
phenotypic and functional parameters, usually linked to genetic or pharmacological perturbations. 
High content imaging, with its corresponding analysis methods, has become increasingly popular in 
the fields of drug or chemical compound discovery, as well as identification of gene functions, 
especially because it allows for quick, efficient and lower cost screens329–336.  
Some low content imaging approaches may be amenable to screening by high content imaging. 
Sieprath and colleagues have optimized an HCI protocol on fibroblasts seeded in 96 well plates, where 
they use live imaging to assess the levels of reactive oxygen species as well as mitochondrial 
membrane potential and mitochondrial morphology337. Szalai and Engedal have optimized a protocol 
for the assessment of real-time cell proliferation and death in a prostate carcinoma cell line338. Massey 
has developed an HCI approach to measure target engagement in living adherent cells based on the 
principle of altered protein thermal stabilization or destabilization in response to ligand binding339. 
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HCI has several biological applications and may be used to answer different biological questions. The 
following pages will focus on the questions that may be answered with HCI, and the tools needed for 
such screens. 
a. HCI screens may be used to define gene function.  
Bai et al. used an siRNA HCI screen to knock-down 26 genes whose function was not previously 
assessed, in a prostate carcinoma cell line and showed that 25 of these genes affected cytoskeletal 
organization or cell shape340. Indeed, they used 14 morphological including parameters pertaining to 
F-actin, cell shape and area. Chia et al. showed, by using an HCI on a genome-wide siRNA screen in 
human embryonic stem cells (hESC), that PRDM14 is a crucial transcription factor required for the 
maintenance of hESC identity and the re-acquisition of pluripotency in human somatic cells341. It has 
been shown that an HCI RNA screens can be useful to determine genes involved in mitotic spindle 
formation in yeast342. Indeed, an HCI screen coupled to gene knock-down has served to identify 
mutants with aberrant spindle morphology, by using 78 spindle-specific features for the analysis, as 
well as to identify new candidate genes that may play a role in spindle disassembly. 
Billmann et al. have used an RNAi screen in Drosophila, to screen for modulators of the cell cycle. 
They started with a genome-wide RNAi screen where, following image analysis for nuclear and mitotic 
parameters, they selected 300 candidates to connect novel genes to known regulators of the cell 
cycle343. 
b.  HCI screens can be effective in determining gene interactions.  
Genetic interactions can be assessed by using pairwise gene perturbations to generate interaction 
profiles. An image-based genome-wise RNAi screen in Drosophila cells has identified 168 genes 
whose phenotypic profiles are sensitive to MEK, involved in the MAP/ERK pathway344. Genes may 
also be co-depleted by RNAi and imaged by HCI to determine genetic interactions and generate 
correlation networks. Using this technique, it was determined that there is a link between Ras signaling 
and chromatin remodeling345. 
Chong et al. have applied an HCI screen to budding yeast open reading frame (ORF) – GFP collection, 
where each of the ∼4,100 strains carries a unique fusion gene construct in which an ORF is fused to 
the GFP gene, generating a full-length protein with a COOH-terminus GFP fusion, whose expression 
is driven by the endogenous ORF promoter346. They also introduced a cytosolic RFP, to create an 
automated platform to quantify the abundance and localization of these fusion genes, instead of the 
manual quantification that was applied347. Their results led to the generation of the abundance 
82 
 
localization map with 2834 proteins connected to at least one of the 16 quantitative localization scores 
that they defined for each protein and which reflect 16 defined subcellular compartments. 
  
c. HCI screening is a useful tool to assess alterations to cell morphology in response to chemical 
compounds.  
Coupling treatment with compounds to genetic perturbations may reveal how genes are sensitive to 
specific inhibitions344. 
Bray and colleagues showed that it is possible to use six fluorescent dyes to perform what they describe 
as “Cell Painting”, in which they can reveal eight cellular components and organelles331. Subsequently, 
they could extract roughly 1500 morphological features to describe their cells, and profile them 
accordingly. They then show that it is possible to profile cells treated with different chemical 
compounds and detect even subtle morphological differences.  
A recent study by Caldera et al. has shown that it is possible to benefit from the interactome of the 
physical interactions of more than 16000 proteins and perturb them with chemical compounds, which 
they summarized in a 3D perturbation space348,349. For that, they applied an HCI approach in the 
adherent MCF 10A cell line and showed that it is possible to use cell morphology to evaluate the 
interaction between different perturbations in high dimensionality space. 
HCI may be used to determine levels of protein interactions in response to different chemical 
compounds. Preistly et al. have developed an immunocytochemical protocol in which they use HCI to 
determine the specific binding of Dickkopf-related protein 1, whose elevated levels have been linked 
to Alzheimer’s disease350. Using HCI they measured the specific binding of the protein to its receptor 
in response to treatment with different inhibitors.  
 
d. HCI screens are a powerful tool to image disease models. 
Schulte and colleagues show that high content imaging screens can be used to build a Huntington’s 
disease model and identify compounds which can rescue dystrophic neurite formation351. Puls and 
colleagues have shown that it is possible to develop a 3D model of tumor invasion that is amenable to 
high content imaging screens, in which they could test potential drugs335. 
Zahir et al. have recently shown that it is possible to use a high content imaging screen coupled to 
morphological profiling to assess the response of different strains of E. coli to different antibiotics352. 
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Chakraborty et al. have shown that it is possible to design a FRET screen to determine the constant of 
dissociation between LFA-1 and ICAM-1, by using an LFA-1 molecule coupled to AF488 and an 
ICAM-1 molecule coupled to AF55596. 
 
The advantage that high content screens offer is the large assay format, where samples may be placed 
in 96 or 384 well plates instead of the traditional microscopy slides. Moreover, robotics has also been 
developed to minimize sample processing time and human error. High content imaging relies on 
fluorescence. Therefore, the typical fluorescent antibodies, proteins and dyes that are used in low 
throughput microscopy are commonly used. HCI may be used to establish a process of machine 
learning, where image “fingerprints” are extracted to define a specific cellular morphology, 
corresponding to a specific biological state. Once these fingerprints have been established, prediction 
models may be used to extract features from images and predict biological states353. Supervised 
training models refers to using a part of a whole set of images in order to establish these fingerprints, 
and then apply these models to the set and test their predictive performance. These steps can be 
summarized in figure 20, and image-based profiling will be elaborated further in the HCI analysis 
section. 
 
 
Figure 20 : A typical high-content workflow pipeline354. 
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B. Instrumentation: High content imaging requires specialized devices 
Several companies have now worked on building high content imaging devices, to account for the 
growing need for such technologies in both basic research and drug discoveries. 
ThermoFisher Scientific introduced the “ArrayScan” in 1999 and have over the years continues to 
produce several high content analyzers. They have recently released their latest model: the Cellnsight 
CX7 LZR high content analysis platform, which comprises fluorescence microscopy, as well as 
automated image analysis tools to extract relevant information from the imaged samples. Their latest 
system is endowed with objectives that range from 2x to 60x magnification, a seven-color laser 
illumination source for confocal imaging with spinning disk technology, a 5 color LED array for 
brightfield imaging and HCS Studio Cell Analysis Software which allows a user-friendly image 
acquisition setup and result analysis. 
From: ThermoFisher website. 
 
BioTek have also developed two automated cell imagers: the Lionheart LX and the Lionheart FX 
automated microscopes. Both have objectives that can go up too 100x (oil immersion), can image more 
than 20 fluorescent colors, are endowed with image-based and laser-based autofocus, and allow for 
fluorescence, brightfield and high contrast brightfield microscopy. The Lionheart FX also allows color 
brightfield and phase contrast microscopy, and is endowed with CO2 and pressure chambers, and 
temperature control. The Lionheart FX allows for fluorescent imaging in four channels and 
illumination with twenty filter/LED cubes, and can images cells in microscope slides, Petri dishes, 
flasks and microplates. They also offer “Cytation5”, which can go up to 60x magnification in 
fluorescence, brightfield, high contrast brightfield, color brightfield and phase contrast. It offers 
temperature and CO2 control, and has aSony CMOS camera and imaging LED cubes and filter cubes 
to detect a wide range of fluorophores. Images acquired with BioTek devices can be analyzed with the 
Gen5 software.  
From: the BioTek website 
 
Molecular Devices offer the ImageXpress Pico automated cell imaging system, where images can be 
acquired by either brightfield or fluorescence with objectives that range from 4x to 63x magnification, 
humidity, temperature, CO2, O2 controls and pre-configured analysis protocols to facilitate image 
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analysis. It is illuminated with LEDs and has a Sony CMOS camera. It offers digital confocal 
deconvolution, which enhances image contrast, thus decreasing exposure time and allowing for 
imaging of clearer cell structures, therefore a more robust image analysis.  
From: Molecular Devices website 
 
Logos Biosystems offers “Celena®” X high content imaging system, which offers laser autofocus, 
live cell assay support, objectives that range from 1.25x to 100x, a vast selection of LED filter cubes 
adapted to a wide array of fluorophores. It offers fluorescence imaging in four channels, brightfield, 
color brightfield, and phase contrast imaging, and a user-friendly interphase for both image acquisition 
and data analysis. It has a monochrome CMOS and an optional dual camera module.  
From: Logos Biosystems website. 
 
GE Healthcare Life Sciences offer the IN Cell Analyzer 6500HS system which comes as a successor 
to previous models, and which features the IRIS confocal technology for a better visualization and 
segmentation of biological objects, especially in thicker samples. It is a high content screening 
confocal microscope adapted for fixed and live-cell imaging and is illuminated with four lasers and 
has a sCMOS camera. Objectives range from 2x to 100x magnification, and the autofocus is 
maintenance is laser-based. The acquisition software of this device is user-friendly, and image analysis 
is performed with the IN Carta software, which also has an intuitive interface.  
From: GE Life Sciences website 
 
Another high content imaging system is the Opera Phenix™, developed by Perkin Elmer. It is a 
confocal microscope endowed with a Nikpow spinning disk with dual view confocal optics and up to 
four sCMOS cameras that allow simultaneous acquisition in up to four channels, with the advantage 
of a low signal: background noise ratio, a wide dynamic range and high resolution. 
Being a spinning disk confocal microscope, it has an array of illuminated pinholes equally paced to 
illuminate the whole field of view and positioned at one of the microscope's intermediate image planes 
will create a de-magnified array of tiny excitation focal volumes at the nearest objective lens object 
plane. The spinning disk optics and precise excitation laser and camera synchronization lead to 
minimal phototoxicity and photobleaching. This minimalized spectral cross-talk allows for high 
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quality images and a reduced acquisition time (Figure 21). This microscope also offers the advantage 
of water immersion objectives, which capture more photons, thus increasing image resolution. 
Moreover, the system has a fast laser-based autofocus, thus ensuring the maintain of focus throughout 
different fields. The system also benefits from a CO2 chamber and temperature control, to allow live 
cell imaging.  
 
Figure 21: Schematic representation of the confocal light path of the Opera Phenix high content 
screening system. The projection of non-overlapping excitation pinhole patterns onto the sample 
achieves the separation of excitation and emission wavelength in space. Excitation lasers are placed 
into two groups in a way that adjacent laser lines are separated, and are focused through different 
quadrants, to allow the emission light passage only through the pinhole disc in the respective quadrant. 
From: The Perkin Elmer website 
 
C. High content imaging analysis requires specialized software 
Companies developing and selling HCI microscopes usually develop in parallel compatible analysis 
software that may be purchased in parallel. Such software are specifically designed for the analysis of 
data from HCI screens. They are generally user-friendly and easy to navigate and may include pre-
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designed analysis pipelines. They may be used to detect specific phenotypes of alterations to cell 
morphology or intensities of a fluorophore. However, such software may not be adapted for more 
complex questions which go beyond basic biology and require knowledge of bioinformatics to a 
certain extent. Therefore, there is the need for software that are more adapted to deal with such 
demands. 
a. CellProfiler 
CellProfiler is an open source image analysis software, developed by the Carpenter lab at the Broad 
Institute of Harvard and MIT. It allows the user to measure, simultaneously, several parameters related 
to cell size, shape, intensity and texture. Moreover, it is specifically designed to perform the analysis 
of data incoming from screens, in a high throughput and automated manner355–358. CellProfiler is an 
easy to use software which can be installed on a personal computer to analyze a small number of 
images, while a larger number of images will have to be processed on a cluster. The details on how 
the software works, its advantages and its applications can be found in 355. Caldera et al. have used 
CellProfiler to analyze fluorescent microscopy images of cells treated with an array of drugs and 
extracted 78 morphological features (out of 438) to position each treatment within the 78-dimension 
morphological space348. 
b. EBImage 
EBImage is an image processing toolbox for R whose features include multi-dimensional image 
processing, a range of fast image processing functions, support of more than 80 image formats, fast 
interactive image display. It allows for automated phenotyping of images by performing the steps of 
segmentation, feature extraction and statistical analysis, as used in the screens by Breinig et al, and 
Heigwer et al. 344,359,360.  
 
High content imaging screens have come a long way in recent years. The first screens were 2D, but 
the need to mimic in-vivo conditions has led to the development of microscopes and image analysis 
software capable of handling 3D structures. The advantage that 2D screens offer are the simplicity and 
the lower cost, but cells cultured and subsequently imaged in 2D layers lose some of their 
morphological properties, giving 3D screens an advantage in terms of physiological value361–363. One 
limitation of high content screens is the difficulty to apply them to cells in suspension, thus hindering 
the study of several diseases such as lymphomas or primary immunodeficiencies.  
 3D screens will not be addressed in this manuscript.  
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D. Image analysis pipeline in high content imaging screens 
As previously mentioned, high content imaging screens generate a significant bulk of data to be 
processed, which require analysis to quantify the phenotypes of interest. ImageJ and Metamorph, can 
be a tedious tool to analyze many images, even with the use of macros. That is because any change 
that needs to be made to the analysis pipeline will require a direct intervention with the code (Matlab, 
Java), which may be prone to errors. Therefore, they will not be discussed in this manuscript. However, 
they have been reviewed in 355.  
There are however specialized tools for HCI data analysis and image-based cell profiling. In image-
based profiling, hundreds of morphological features are measured, and the morphological profile refers 
to this collection of measurements364. The typical analysis work flow for image based profiling can be 
divided into eight main steps364. Assuming the cellular model, fluorescent probes and image 
acquisition have been performed successfully, the transition from images to phenotypes can take 
place365 
The typical workflow of image-based cell profiling is represented in figure 22 below and will be 
elaborated in the following pages.  
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Figure 22: Representative workflow for image-based cell profiling. Image-based cell profiling 
involves eight main steps which lead to the transformation of images into quantitative information 
from which conclusions can be drawn364.  
 
a. Image analysis 
First, image analysis must transform images into measurements (features) describing the state of each 
cell. Every image must undergo field of view illumination correction, as intensities can vary between 
the center and the edges of a field of view, due to optic artifacts. This process recovers the true image 
to avoid corruption of an accurate segmentation and intensity measurements366. Illumination correction 
can be achieved by building corrections from dark and bright images with no sample acquired along 
with the imaged samples, in a process termed “prospective methods”367. However, such an approach 
often yields an incomplete correction. Alternatively, retrospective single-image methods can correct 
illumination by calculating corrections on a per image basis, which can alter relative intensities364. 
Retrospective multi-image methods correct illumination by using the totality of the images acquired 
in an experiment364,367,368. This approach usually produces more robust results. Next, the images must 
undergo segmentation, which allows the distinction between pixels that belong to the object of interest 
and background pixels. This approach is typically used in CellProfiler analyses and requires 
adjustments for each experiment. Segmentation can be model-based and performed manually based 
on visual parameters, or by machine learning, where a classifier is trained to find the optimal 
segmentation solution. Next is feature extraction, which measures the phenotypic characteristics of 
each cell. It includes shape features such as boundaries on nuclei and cells, perimeter, area and 
roundness. Intensity-based features are computed from actual intensity values per channel, on a single 
cell basis and separately within each segmented compartment. They include simple statistics such as 
minimum, maximum and mean intensity. Texture features are used to quantify the regularities of 
intensities in an image and rely on mathematical equations such as cosines and correlation 
matrices364,368. Microenvironment features include counts and special relationships among cells in a 
given field of view.  
b. Image quality control 
The second step is image quality control, and an automated approach must be put in place to remove 
defective images. It has to be done a field of view level to account for blurring, saturation and the 
presence of debris. Cell-level quality control must also be performed to remove cells that exhibit a 
highly unusual phenotype. Outliers can be detected in a model-free fashion by the use of robust 
90 
 
statistics such as the mean and media, or multivariate methods such as principal component analysis 
(PCA) and Mahalanobis-based outlier detection. The latter is based on robust estimation of mean and 
covariance matrix to detect outliers364,369. Model-based outlier detection is based on training a model 
to detect outliers.  
c. Processing the extracted features 
The third step is the processing of extracted features, which must consider several factors in order to 
yield the proper conclusions. Features extracted may present with non-finite values, which can be 
problematic for statistics and machine learning approaches. Therefore, cells with such values may be 
removed if they are a minority, or the feature itself may be removed if it appears to be missing in a 
large proportion of the sample. A third way, which should generally be avoided as it may create a bias 
and false conclusion, is the imputation of missing values. The effect of the plate layout must also be 
corrected, to account for artifacts that may be present in a plate or across a batch. Ideally, samples 
should be placed in random positions in the plate, and in different positions in multiple replicated. 
However, this is not a practical approach in the absence of robotic sample dstribution. Caicedo et al. 
recommend using a two-way median polish to correct for these effects when the samples are 
randomized, via iterative median smoothing of rows and columns to get rid of positional effects, 
followed by the division of each well value by the plate median absolute deviation to generate 
a B score364. Local smoothing may also be applied via 2D polynomial regression or running averages. 
Batch effect must also be corrected via standardization and quantile normalization to plates if the 
samples are placed in a random order in each experiment. Otherwise, canonical correlation analysis 
could be applied. Feature transformation and normalization must be applied to features that display 
varying shapes of statistical distribution. These include logarithmic transformations used to obtain 
approximate normal distributions for features that have highly skewed values or require range 
correction either by the logarithmic functions or one of its adaptations, or relative normalization 
whereby the population is scaled and centered with respect to one part of the population in which 
statistics have been computed. Cofounding effects must also be removed for subtle phenotypes, to 
avoid masking a phenotype of interest368. 
d. Dimensionality reduction 
The fourth step involves dimensionality reduction, which aims to remove related, redundant or 
uninformative features. Feature selection includes finding correlated features by computing the 
feature-feature correlation matrix and keeping only the features with the largest mean absolute 
correlation364. Replicate correlation filtering keeps only the features that provide the highest additional 
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information content. Minimum redundancy–maximum relevance adds a constraint based on mutual 
information to the selection algorithm. The resulting selected features have high replicate correlation 
while preserving a diverse set of measurements. Support-vector-machine-based recursive-feature 
elimination involves a support vector trained machine that is trained to weigh feature usefulness. 
Linear transformation methods can be performed to achieve lower-dimensional subspaces of higher-
dimensional data that maintain information content. An additional step of decorrelation must be 
implemented in the case of a technical bias, such as the choice of features to measure. In that instance, 
the output space becomes biased as well, as should be accounted for.  
From the fifth until the eighth step, the pipeline becomes less straightforward, as steps may be skipped 
or reordered, based on the experimental setup and the answers sought. 
e. Single-cell data aggregation 
The fifth step is single-cell data aggregation, from which population-level morphological states can 
be concluded. Aggregation can rely on the mean profile which assumes a normal feature distribution 
and where a profile is built from the means of each feature for the entire population. It can also rely on 
the median profile, which can provide more robustness for non-normal distributions and minimize 
outlier effect. It appears to perform better than other profiling strategies364. KS profile compares the 
probability distribution of a feature in a sample with respect to negative controls by using the KS 
nonparametric statistical test and yields a profile where the KS statistics reveal how the sample behaves 
differently with respect to the control. Next is subpopulation identification and aggregation, where 
cells are first identified and clustered according to their morphological phenotypes from single cell 
profiles. This can be either supervised or unsupervised. Single cell data points are then classified to 
one of the identified subpopulations and aggregated to calculate the number of cells within each of the 
identified subpopulations.  
f. Profile similarity measurement 
The sixth step is measuring profile similarity, to compare experimental conditions. Similarity 
metric calculation involves three main types of metrics which allow a simpler data visualization and 
analysis. They include distance measures to calculate how far apart two features are in the feature 
space and quantify the magnitude between two given profiles. They include Euclidian, Mahalanobis 
and Manhattan distances. Similarity measures compute a statistical estimation of how likely two 
profiles are to be related and to find groups that share common properties. They include Pearson’s 
correlation, cosine similarity and Spearman’s and Kendall’s rank correlations. Machine learning-based 
learned similarity measures involve training models with prior knowledge about the samples to 
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highlight patterns that may not be discriminated by regular metrics. Concentration-effect handling 
must be taken into consideration to identify similarities among different compounds that may occur at 
different concentrations. Titration-invariant similarity score computes a score between each dose and 
the negative control, and the scores are sorted in a concentration-dependent fashion. Maximum 
correlation is practical when a small number of concentrations is used, and the correlation matrix is 
computed between all concentration pairs370. The maximum value is used as the dose-independent 
similarity score.  
g. Assay quality assessment 
The seventh step is the assessment of the assay quality. Comparison to ground-truth relies on the 
use of known similarities between pairs of treatments. Classification accuracy may be applied if 
treatment results are known to fall into specific classes, and concentrations of the same treatment are 
expected to cluster together. Replicate reproducibility should also be achieved, where the similarity 
between replicates should be higher than the similarity to profiles of other treatments or conditions364. 
Effect size computes the difference between the positive and negative controls but may lead to a bias 
as some phenotypes which do not particularly distinguish a control may be ignored.  
h. Downstream analysis and result interpretation 
The final step is downstream analysis, which allows the interpretation of the results of morphological 
profiling. Clustering is an effective way to extract meaningful relationships between different 
morphological profiles. Hierarchical clustering is the most commonly used strategy to identify 
correlation as well as positive and negative connections, and is computed by a similarity matrix which 
can reveal patterns in the data371,372. The data from the heat map is structured as a dendrogram to link 
features together based on proximity in the feature space. Next comes data visualization, which 
usually takes the form of a 2D (sometimes 3D) map to reduce dimensionality and allow for an easier 
interpretation and less crowding. While tools to represent data in more than two dimensions have been 
used, which include the Chernoff faces and the pixel-based techniques, they are a mere visual tool 
where the user is let to interpret the data. Visualization can include data projections or hierarchical 
visualizations. Data projection includes the following: 
i.  Linear dimensionality reduction: Principle component analysis 
PCA is a linear dimensionality reduction technique which has long been the most employed tool, as it 
relies on simple linear algebra and is faster than most other methods. It consists in finding a low-
dimensional embedding of the data points in a way to best preserve their variance, as it was measured 
in the high-dimensional space, and representing them as a new set of orthogonal and uncorrelated 
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variables called the principal components373,374.A comprehensive and recent review on PCA was 
published in 2016 by Jolliffe and Cadima374.  
ii. Non-linear dimensionality reduction 
The need and usefulness of new tools is being recognized, in order to extract not only linear 
relationships between input dimensions (as in PCA), but any kinds of relationships. Such non-linear 
dimensionality reductions include but are not limited to the following: 
a) Isomap 
Also known as complete isometric feature mapping, the Isomap consists of a three-step algorithm. The 
first step determines neighboring points, the second estimates the geodesic distances and the third 
applies multidimensional scaling to the distances in the matrix, thus culminating in an embedding of 
the data in a d-dimensional Euclidian space. This technique is well elaborated in 375 
b) Diffusion map 
Diffusion maps were introduced by Coifman and colleagues in 2005. Diffusion maps consist in 
computing the data set into the often low-dimensional Euclidian space, where the Euclidian distance 
between two points in the embedded space would be equal to the diffusion distance between the 
probability distributions which are centered at those points376.  
c) t-distributed stochastic neighborhood embedding 
t-distributed stochastic neighborhood embedding (t-SNE) has stochastic neighbor embedding (SNE) 
as its basis, which converts the high-dimensional Euclidean distances between datapoints into 
conditional probabilities (pj|i) that represent similarities. The mathematical aspect of SNE is elaborated 
in 377. The limitation of SNE is the crowdedness of the data points and a suboptimal cost function, 
whereas t-SNE is an improvement since it uses a symmetrized thus simpler cost function and a student-
t rather than a Gaussian distribution. t-SNE is elaborated in further detail in 377. 
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Figure23: Visualization of 6000 handwritten digits from the MNIST data set by t-SNE 377 
 
However, the disadvantage of tSNEs is that such a representation causes the loss of large scale 
information such as the inter-cluster relationships, while it is precise for local structures rather thatn 
global trends378. Therefore, a tSNE might not be the best adapted method to extract meaningful 
relationships between large-scale clusters 
d) Uniform manifold approximation and projection 
When compared to other tools, the uniform manifold approximation and projection (UMAP) proved 
to have not only the fastest run times and highest reproducibility, but also and most importantly, the 
most relevant organization of clusters379. They are a recent technique, introduced by McInnes and 
colleagues in 2018. The algorithm of UMAPs assumes a uniform distribution of the data in a 
Riemannian manifold, that the Riemannian metric is locally constant, and that the manifold is locally 
connected380. The subsequent manifold, which has a fuzzy topology, can then be made into a low 
dimensional projection.  
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Figure 24: Visualization of 6000 handwritten digits from the MNIST data set by UMAP 380. 
 
Several more methods of nonlinear dimensionality reduction exist, and they are reviewed in 377,381. 
 
The last step in classification and result interpretation is classification, which may be only applied if 
the transfer of labels from annotated samples to unknown data points is possible. If this is possible, 
classification can provide meaningful information and insights into the effects of given compounds or 
treatments. The most commonly used classification rule in morphological profiling experiments is the 
nearest-neighbors algorithm, which finds the closest data points in the collection of annotated samples 
and recommends a label for the new sample, as well supervised prediction models such as neural 
networks and random forest classifiers.  
Supervised prediction models follow certain paths to predict a “correct answer”, and classifiers can be 
generated to recognize cells with a phenotype of interest. The training set must be chosen with as many 
cells as possible, and not only from the control group, to avoid overfitting. The number of rules or 
features where the cutoff for a decision are then set and refined repeatedly until the classifier reaches 
the desired accuracy368. An increased number of rules usually correlates with more accurate predictions 
of the classifier.  
Neuronal networks mimic human brain behavior and provide powerful modeling algorithms that 
allow or non-linearity between feature variables and output signals382. The network has a layer of input 
nodes which receive features variables from raw data, and a layer of output nodes. The more complex 
the classification, the more layers are required. The data is split into a training and a test set, to assess 
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the predictive ability of the network. Deep learning models are composed of multiple layers of latent 
variables, where hierarchical structuring can be found from complex images383. Deep learning methods 
can overcome the limitations associated with extracted feature sets by jointly learning optimal feature 
representations and the classification task directly from pixel level data. More complex network such 
as convolutional networks are considered deep learning methods and have achieved an accuracy of 
prediction higher than the human eye384. 
Random forest classifier algorithms use a series of classification or decision trees to map the features 
of a samples and profile it in a class output. The decision trees consist of branches which are features 
conjugated in paths where a particular combination will trickle down to a class output. Random forest 
classifiers rely on uncorrelated decision trees with random combinations of features to reduce data 
variance and reduce overfitting the data to the training set385,386.  
Unsupervised methods aim to find internal structure or relationships in a data set instead of trying to 
determine how best to predict a “correct” answer and reveal clusters and associations within the data 
set without any prior teaching model. They are useful especially when class data labels are unavailable. 
They include hierarchical clustering on principal components, because PCA allows the reduction 
of the number of variables without losing important information and is a very stable method compared 
to other unsupervised machine learning techniques387,388. Unsupervised clustering finds clusters 
without a pre-determined number of clusters and the data is divided into clusters in a way where the 
data within one cluster bares high similarity among themselves, and dissimilarity to data in other 
clusters389.  
The performance of a classifier can be determined by comparing the prediction of the classifier to the 
expected outcome. These include binary classifications and multilabel classifications. The F1 score is 
a measure that can express the counts of true positives, false positives and false negatives390.  
 
E. Statistics 
The performance of a high content screen is usually quantified with statistical parameters. When 
performing a high content screen, it is assumed that the data is normally distributed, and logarithmic 
transformations (usually log2) are often applied in the pre-processing stage, to generate data that is 
more symmetrically distributed around the mean, to facilitate the understanding between positive and 
negative values391,392 
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The next step involves dealing with outliers and can be achieved in two ways: classical and robust. 
Instead of eliminating outliers, Robust statistics, which have gained in popularity in high content 
screens, may be applied. Robust statistics are less sensitive to outliers as they use the median and 
median absolute deviation instead of the mean and standard deviation. This diminished the effect of 
outliers on the final results392. The robustness of a technique can be determined by a breakdown point, 
which is the number of outliers allowed before the parameters become no longer representative of the 
original dataset. The median and median absolute deviation have a breakdown point of 50, while the 
mean and standard deviation have a breakdown point of 0%, implying that robust statistics can 
successfully handle a data set where 50% of the data points are outliers392.  
Data must be normalized to account for and reduce assay variability, as well as to eliminate false 
positives and negatives which may be caused by plate patterns391. Data normalization can be control-
based, where the positive and negative controls are used as the 100% and 0% bounds respectively, 
and the features of the other data points are calculated with respect to these values. The activity of the 
sample can be calculated as percent of control or normalized percent inhibition. 
Non-control-based data normalization is favored in high content screens, as it assumes that most 
samples are inactive and serve as their own control. IT can be calculated as percent of samples, robust 
percent of samples, Z-score or robust Z-score. The Z-score accounts for signal variability in the 
samples. This method is usually favored as it leads to a better understanding of the overall activity but 
can be quite misleading in screens where the basal activity shifts upwards.  
Data analysis must also consider variability detected in experiment-wise patterns. Median polish 
accounts for row and column effect (the spatial trends in a plate), and the B-score utilized to account 
for inter-plate variability uses the residual values calculated in median polish and the mean absolute 
deviation368,391,392. Background correction must also be applied by calculating the average activities 
within each well and generating a background surface for each experiment. Well correction is 
performed in a similar manner to background correction, but the fitting is performed for each individual 
well, proving to be successful for hit selection392. Diffusion-state model corrects variability in 
environmental factors such as temperature or humidity distribution across well and is generated from 
a control column. 
Quality control statistics include signal/background which is the ratio of the mean of the positive 
control to the mean of the background signal, signal/noise which is similar to signal/background byt 
takes into account signal variability, signal window which measures the data range in an assay, assay 
variability ratio which measures the data variability in the positive and negative controls, the Z’-
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factor which assumes a normal distribution to account for variability in the control wells, the Z-factor 
which is a modification of the Z’-score where the sample mean and standard deviation replace that of 
the negative control, and the SSMD, which relies on probability and statistics and has been shown to 
be more effective that Z’ and Z scores in handling controls with different effects392,393. 
To assess HCI results, specific statistical analyses must be employed to analyze and interpret the large 
amount of data generated. The different analysis methods and requirements include normalization, 
logarithmic transformation and quality control.  
To compare any two treatments, a multidimensional perturbation value (mp-value) may be 
calculated. The difference between a treated condition and a control is considered as activity, while no 
difference is considered inactivity. An mp-value to the Mahalanobis distance is assigned, and 
permutation tests are used to determine statistical significance. This is done by a permutation approach, 
where under the null hypothesis, shuffling the replicate labels would not result in a drastically different 
Mahalanobis distance between the two groups, while if the treatment replicates are significantly 
different, the Mahalanobis distance would likely be smaller after randomly shuffling the replicate 
labels120. Significance values are interpreted in the same way as significance values from parametric 
statistical analyses, where an mp-value < 0.05 is considered significant.  
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Implementation of a high content imaging pipeline to study the 
immunological synapse of cytotoxic lymphocytes 
Rationale 
Despite the great advancements made in the field of high content imaging in terms of techniques and 
analysis, these assays lack standardized protocols. The work towards standardization is however in 
progress.  
The cytotoxic function is highly important, and a tightly regulated process. Moreover, the 
immunological synapse involves a complex interplay between a plethora of molecules, in order to 
drive the successful delivery of lytic molecules into the target cells. All the aforementioned research 
suggests a crucial role for the actin cytoskeleton and the process of polymerization and 
depolymerization in maintaining immune homeostasis, and that cytoskeletal defects such as defective 
immunological synapse and cytotoxicity may lead to several life-threatening illnesses. In the context 
of primary immunodeficiencies, the data is not systematic, and the analysis methods vary. Current 
advancements in the field of imaging and image analysis have made high content imaging of a large 
number of samples feasible, with a good image resolution that allows the detection of subtle 
morphologies, and robust statistics specially designed for such approaches. However, microscopy is 
not widely used among immunologists, but the advancements made in that field have undeniably 
helped our understanding of the mechanisms governing the cytotoxic activity, actin dynamics and the 
assembly of the immunological synapse.  
Taking together the crucial role of the immunological synapse in cytotoxicity, and the findings that 
perturbations of the cells can alter morphology, the following could be hypothesized the following:  
 
• The immunological synapse of CD8+ T cells and NK cells should present different 
morphological features  
• Different perturbations to the actin cytoskeleton of cytotoxic lymphocytes should yield distinct 
immunological synapse morphologies.  
• The immunological synapse of ARPC1B deficient patients should have a morphology that is 
distinct from that of normal donors  
 
Driven by the importance of the role of the immunological synapse in cytotoxicity and the need for a 
systematic method to screen for PIDs that may display a defective cytotoxic activity, I have 
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elaborated a new high content imaging and analysis pipeline of the immunological synapse. This 
pipeline could be a first step to assess defects in the immunological synapse assembly, from which 
functional defects may be inferred. Such a pipeline, which overcomes the bottleneck of low throughput 
microscopy typically used to image the immunological synapse, could be systematically applied to 
screen cytotoxic lymphocytes from PID patients and adapted to screen other types of immune cells.  
Objectives 
Therefore, the objectives of my thesis project were the following: 
1. Set up a high content imaging and analysis pipeline of the immunological synapse of cytotoxic 
lymphocytes 
2. Provide an understanding of the actin-driven mechanisms regulating IS architecture in 
cytotoxic lymphocytes 
3. Apply this pipeline in the clinical context, by providing an insight as to how the IS architecture 
may vary in patients with actinopathies. 
4. Assess how a defect in the IS morphology could imply a functional defect in cytotoxicity 
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Results 
I first started by optimizing assays on the NK-92 cell line and primary NK cells isolated from the 
PBMCs of normal donors. 
Indeed, the review by Emily Mace entitled: “Cell biological steps and checkpoints in accessing NK 
cell cytotoxicity” 66 , as well as the expertise of our lab on lymphocytes inspired me to set up functional 
assays to assess the main steps of cytotoxicity in NK cells. During the first year of my PhD, I learned 
a lot about the cytotoxic function, and had the chance to establish assays on a new cell type that was 
not used in our lab.  
Indeed, I have established a methodology where the functional steps of cytotoxicity can be assessed in 
parallel. Migration, conjugation and cytotoxicity were amenable to assessment high throughput 
cytometry readings in 96 well plates. However, the step of imaging the immunological synapse which 
is done by low throughput confocal microscopy revealed to be tedious in terms of the time required 
for image acquisition, the analysis approach to adopt and the parameters to analyze. I was therefore 
driven to test the feasibility of staining the immunological synapse in a high content format, to match 
this assay format to that of the other steps. It was also interesting to benefit from imaging the cells in 
a high content format and apply a compatible analysis. For that reason, I imaged the IS using the Opera 
Phenix microscope, and its compatible analysis software Harmony, to analyze the individual wells.  
However, the number of parameters that may be analyzed by such approaches remain limited, and the 
analysis on a per well basis can hide some interesting phenotypic features. It was evident that a more 
powerful bioinformatics approach was needed to extract hundreds of relevant IS features on a per cell 
basis, and with statistics on hundreds of cells. With my thesis supervisor, we therefore established a 
close collaboration with the Menche lab at the CeMM in Vienna, to benefit from their expertise in 
morphological profiling in high content imaging screens348.  
I will first start by showing the results of experiments that I set up and optimized on the NK-92 cell 
line and primary NK cells isolated from PBMCs, followed by the setup of a high content imaging 
approach of the IS. This approach should be overcome the technical bottleneck of low throughput 
imaging, and its power in terms of the number of cells and the parameters to be analyzed, and resolutive 
power should lead to identifying meaningful biological morphological features of the immunological 
synapse.  
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1. Setting up assays in the NK-92 cell line 
Cell migration is a crucial step in the function of cytotoxic cells. Indeed, cytotoxic cells migrate along 
a chemokine gradient. 
Our results show that NK-92 cells migrate in response to CXCL12, even at low chemokine 
concentrations (Figure 24a). However, the response to chemokines appears to stop beyond a certain 
threshold. Indeed, cells appear to stop responding to the two highest CXCL12 concentrations tested. 
Alternatively, cells may undergo chemorepulsion, as shown in other cell models at high chemokine 
concentrations, which has been previously described for mature T cells394 
In order to achieve their cytotoxic function, NK cells must establish conjugates with their targets. 
Conjugate formation is assessed by flow cytometry by staining NK cells and K562 target cells with 
two different stains and assessing the percentage of NK cells bound to K562 cells.  
Our results show that NK-92 cells establish conjugates with their targets after 15 minutes of incubation, 
and conjugate formation seems to plateau at 45 minutes (Figure 24b). 
Our lab has quite an expertise in confocal microscopy imaging of cytotoxic lymphocytes. Therefore, I 
had the opportunity to perform staining of NK-92 cells incubated with their targets to visualize the 
formation of the immunological synapse. Our results show that upon formation of the immunological 
synapse, NK-92 cells polarize their lytic granules towards the area of contact with the target cell 
(Figure 24c). After 1hour of incubation, the mean distance between the lytic granules and the synaptic 
area is about 4.3μm, providing support to the visual observation that NK-92 cells do not polarize all 
their lytic granule content. 
Also benefitting from the expertise of our lab in performing cytotoxic assays, I could perform killing 
assays where NK-92 cells and stained K562 cells are incubated for 4 and 24 hours and evaluated by 
flow cytometry. Cells are also stained with 7AAD which only stains dead cells and allows the 
discrimination of alive cells. The percentage of lysis is determined by evaluating the residual number 
of 7AAD-/stain+ K562 cells. Our results indicate that NK-92 cells are efficient at eliminating target 
cells starting 4 hours, and it appears that to achieve maximum cytotoxicity an excess of effector NK-
92 cells is needed with respect to target cells (Figure 24d). Indeed, we observe a better killing 
efficiency at a 5:1 effector to target ratio than 1:1. I was also the first in the lab to set up IRM and TIRF 
microscopy imaging of NK-92 cells in 8-well chambers for a collaboration, with the help of Javier 
Rey-Barrosso and Astrid Canivet-Laffitte from the microscopy platform. Our results show that most 
WT NK-92 cells spread efficiently over a coating of ICAM-1 and anti-NKp30 Ab and form an IS 
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where they display a large peripheral belt of tight adhesion and a less adherent central patches, and 
that lytic granules dock in these loose adhesion patches (Figure 24e). We report a defect in synapse 
formation and granule docking in NK-92 cells knocked down for a yet unpublished gene, so these 
results may not be disclosed. The manuscript revealing the role of that gene has been submitted. 
 
 
 
Figure 24: Functional assays on the NK-92 cell line. A. % migration of 10000, 20000 and 50000 
NK-92 was determined in response to a CXCL12 gradient (n=2). B. % conjugate formation between 
NK-92 cells and target K-562 cells was determined over the course of 1 hour, at 15-minute intervals 
(n=3). C. Confocal microscopy images of an NK-2 forming a conjugate and an immunological synapse 
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with a target cell, and stained for F-actin (green), perforin granules (yellow) and nuclei (DAPI). Scale 
bar: 10 μm. Mean distance of lytic granules to the synaptic interface was calculated in 30 cells. D. 4 
and 24h cytotoxicity assays to determine the lytic activity of NK-92 cells against target cells (n=3). 
Student’s t-test was used to determine statistical significance. Values represent means and the error 
bars show SD. Significance is noted as *P<0.05, **P<0.01, ***P<0.001, ****P<0.0001. E. 
Representative image of an NK-92 cell forming a synapse imaged by IRM and lytic granules (red) 
imaged by TIRF microcopy using lysotracker.  
 
2. Setting up assays in primary NK cells. 
Once assays were set up and optimized in the NK-92 cell line, the next logical step was to apply them 
to primary NK cells. 
For that, I tried to optimize the expansion on primary NK cells from PBMCs by using a feeder system, 
like the expansion of CD8+ T cells using a feeder system routinely performed in our team. PLH cells, 
which are EBV transformed lymphoblastoid cell line, kindly provided by DR. Martin Villalba were 
used as feeder cells.  
The expansion process was not optimal, as it does not yield large numbers of NK cells, and the cells 
are only viable for two weeks and needed stimulation with feeder every 2-3 days. Moreover, the 
protocol is optimized for NK cells isolated from umbilical cord blood which yields a much higher 
starting number of PBMCs than a 10ml blood tube. Moreover, there are other expansion protocols 
using another type of irradiated feeder referred to as NK cell feeder (NKF)395,396, which I could not 
try.  
However, I could manage to set up functional assays on the primary NK cells.  
Even though primary NK cells appear to be spontaneous migrators, they are also capable of a specific 
migratory response towards both CXCL10 and CXCL12 (Figure 25a). They are also capable of 
forming conjugates with target K562 cells, and similarly to NK-92, the % of primary NK cells forming 
conjugates appears to increase over time (Figure 25b). The expanded primary NK cells appear to be 
cytotoxic and capable of efficient ADCC, even at 4h and in a surplus of target cells (Figure 25c). Our 
results also show that an excess of primary NK cells is not needed to efficiently eliminate most target 
cells, and a ratio of 2 NK cells for 1 K562 cell efficiently removes all target cells at 24 hours. Primary 
NK cells could also be assessed by confocal microscopy for the formation of the immunological 
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synapse when conjugated with target K562 cells, and to polarize their lytic granules (Figure 25d). 
However, the % of granules polarized and the mean distance to the IS was not assessed in these cells.  
I also performed some microscopy experiments on NK cells isolated from frozen PBMCs of normal 
donors and a PID patient for a collaboration where a reduced lytic granule content and a defect in 
granule polarization were observed, but these have not yet been published and the gene name and 
specific results shall not be disclosed in this manuscript.  
In conclusion, I was the first to set up the functional assays routinely performed on CD8+ T cells in 
our lab on an NK cell line and primary NK cells, and add the conjugation assay. However, if our lab 
is to start performing experiments on primary NK cells (especially from patient material), the 
expansion of primary NK cells should be tested using the feeder system developed by Bae an Lee396.  
Figure 25: Functional assays on primary NK cells. A. % migration of 50000 primary NK cells was 
determined in response to CXCL10 and CXCL12 (n=2). B. % conjugate formation between NK cells 
and target K-562 cells was determined over the course of 2 hours (n=2). C. 4 and 24h cytotoxicity 
assays to determine the lytic activity of primary NK cells against target cells (n=2). Student’s t-test 
was used to determine statistical significance. Values represent means and the error bars show SD. 
Significance is noted as *P<0.05, **P<0.01, ***P<0.001, ****P<0.0001. D. Confocal microscopy 
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images of an NK cell forming a conjugate and an immunological synapse with a target cell, and stained 
for F-actin (green), perforin granules (yellow) and nuclei (DAPI). Scale bar: 10 μm.  
 
Seeing how important the immunological synapse is for the cytotoxicity process, we posited that 
imaging the immunological synapse under different conditions can be predictive of the cytotoxic 
potential of CD8+ T cells and NK cells. However, traditional confocal microscopy revealed to be 
limited in terms of the conditions that were amenable to imaging, and the limitation of the parameters 
that can be assessed, as well as the time required for image analysis.  
These optimizations led to the development of my main project, which is the establishment of a high 
content imaging approach of the immunological synapse under different conditions, to determine the 
role of the actin cytoskeleton in regulating cytotoxic activity.  
We established a close collaboration with the Institut de Recherche en Santé Digestive (IRSD), who 
had acquired the Opera Phenix, to set up the high content imaging on the IS. This collaboration, as 
well as a close collaboration with the Menche team at the Center for Molecular Medicine (CeMM) in 
Vienna made it possible for me to conclude my PhD work in a scientific paper that is soon to be 
submitted (to Nature Communications), and of which I will share co-first authorship with Loan 
Vulliard, a PhD student in bioinformatics in the Menche lab. 
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3. High content imaging of the immunological synapse 
 
Morphological profiling of human T and NK lymphocytes identifies 
actin-mediated control of the immunological synapse 
Yolla German,1,2,3,4+ Loan Vulliard,5+ Aude Rubio,2,6 Kaan Boztug,4,5,7,8 Audrey Ferrand,2,6 Jörg 
Menche5 and Loïc Dupré*1,2,3,4  
The detection and neutralization of infected cells and tumors by cytotoxic 
lymphocytes is a vital immune defense mechanism. The immunological 
synapse orchestrates the target recognition process and the subsequent 
cytotoxic activity. Here, we present an integrated experimental and 
computational strategy to systematically characterize the morphological 
properties of the immunological synapse of human cytotoxic lymphocytes. 
Our approach combines high-content imaging with an unbiased, data-
driven identification of high-resolution morphological profiles. Such 
profiling discriminates with high accuracy immunological synapse 
perturbations induced by an array of actin drugs in both model cell lines 
and primary lymphocytes. It reveals inter-individual heterogeneity in 
lymphocyte morphological traits. Furthermore, it uncovers immunological 
synapse alterations in functionally defective CD8+ T cells from 
immunodeficient patients carrying ARPC1B mutations. Our study thus 
provides a foundation for the application of morphological profiling as a 
powerful and scalable approach to monitor lymphocyte activation status in 
experimental and disease settings. 
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The immunological synapse (IS) is a complex 
cellular structure that sets lymphocyte activation 
and function during encounter with antigen-
presenting cells and target cells. The canonical IS 
is characterized by a symmetrical architecture 
consisting of concentric rings of F-actin and 
integrins, while the antigen receptors occupy a 
central position1,2. The lymphocyte spreading 
associated with IS assembly, as well as the 
molecular organization defining IS architecture, 
rely on actin cytoskeleton dynamics. In cytotoxic 
lymphocytes, including CD8+ T cells and NK 
cells, the IS is particularly important because it 
sustains the polarized delivery of cytolytic 
molecules such as perforin and granzymes 
towards target cells3. Indeed, activation of the 
integrin LFA-1 via an inside-out signaling from 
the T-cell receptor (TCR) in T cells, and several 
stimulatory receptors in NK cells4–7, leads to the 
formation of a tight adhesive ring allowing 
confinement of the degranulation process. 
Additional layers of control of lytic granule 
delivery at the IS are their polarization via the 
orientation of the microtubule organizing center 
8,9 and their restricted passage through pervasive 
actin cytoskeleton clearances10. Given the key 
events occurring at the IS, this structure is a 
window of choice to monitor lymphocyte 
activation and function. Indeed, the positioning 
and dynamic behavior of multiple receptors and 
signaling molecules have been characterized 
within the IS11, and alterations of the its 
architecture have been reported in multiple 
disease settings12,13. However, the various 
microscopy approaches employed so far to 
characterize spatial organization of the IS have 
remained low throughput and have been restricted 
to the analysis of a limited number of 
morphological features. A more systematic in-
depth assessment of the IS would better exploit 
this structure as a pivotal read-out for the 
characterization of lymphocyte activation and 
function. 
Recent advances in high content imaging (HCI) 
now allow for the profiling of cells at a much 
richer level of detail and in an unbiased fashion. 
It has therefore been widely employed in cancer 
and toxicology research, in particular for 
screening drug effects on adherent cell lines and 
implementing genetic screens based on the 
siRNA, shRNA and CRISPR technologies14–17. 
However, HCI has not yet been applied to the 
study of leukocytes because of the difficulty to 
overcome the relatively poor adherence of these 
cells.  
In this study, we report the implementation of an 
HCI approach that allows the high-resolution 
confocal imaging of T and NK cells stimulated 
over 2D surfaces functionalized with ICAM-1 
and stimulatory antibodies, and the effect of 
pharmaceutical and genetic perturbations on the 
IS morphology. In addition to extracting a 
previously studied features related to staining of 
F-actin, LFA-1 and perforin, we develop an 
unbiased analytical approach allowing high-
dimensional profiling and clustering of IS 
morphologies. Our data shows non-identical 
perturbations caused by drugs affecting different 
facets of actin cytoskeleton remodeling and 
highlights that actin cytoskeleton integrity is 
required not only for lymphocyte spreading but 
also for lytic granule polarization and LFA-1 
distribution. Application of our HCI pipeline to 
lymphocytes isolated from human blood reveals 
distinct morphological profiles in individual 
healthy donors. Furthermore, our method allows 
characterizing synapse defects in untransformed 
CD8+ T cells from ARPC1B-deficient patients, 
illustrating its potential to identify disease-related 
synapse alterations and to predict functional 
defects, such as cytotoxicity.  
Results 
Morphological profiles of T cell and NK cell 
immunological synapses.  
In order to systematically analyze the 
morphological profile of lymphocyte 
populations, we here sought to develop an 
adapted HCI workflow. It consisted in seeding 
cells of interest on stimulatory surfaces in 
microwells of 96- or 384-well plates, fixation and 
staining with combinations of fluorescent dyes 
and antibodies. Confocal images were acquired 
on an Opera Phenix high-content screening 
system and analyzed with CellProfiler18 to 
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automatically segment individual cells and 
extract features pertaining to cell morphology and 
each of the fluorescent markers (Fig. 1a). As 
proof of concept, we first applied our approach to 
NK-92 and Jurkat cells, two human cell lines 
commonly used as models for NK cells and T 
cells, respectively. Cell morphologies were 
compared upon interaction with a neutral poly-L-
lysine (PLL) surface or co-stimulation with the 
LFA-1 ligand ICAM-1 and stimulatory 
antibodies (Ab) in order to evoke IS assembly. 
Upon co-stimulation with ICAM-1 and anti-
NKp30 / NKp46 Ab, NK-92 cells spread, emitted 
F-actin-rich peripheral pseudopodia and 
polarized perforin-containing granules towards 
the center of the cell to substrate interface (Fig. 
1b and Fig. S1a). These observations are in line 
with the characteristics of the IS from cytotoxic 
lymphocytes11,19, therefore validating our high-
throughput stimulation and staining procedure. 
Based on literature describing the IS and 
reporting a polarization of F-actin and lytic 
granules in NK cells20–22, we first selected 
quantitative features pertaining to the F-actin and 
perforin stainings and extracted them as mean 
values per field of view averaged across 3 
experiments. We also included features related to 
the nucleus, available since the DAPI staining 
was used in a primary nucleus segmentation step 
before the identification of the cytoplasms around 
the nuclei (Fig. 1c and Table S1). Increase in F-
actin intensity and cell area were prominent 
features of the stimulation, as compared to the 
PLL condition. Furthermore, the number of 
perforin-containing granules detected at the cell 
to substrate interface increased upon stimulation, 
which is indicative of their polarization towards 
the IS. Interestingly, this polarization process was 
associated with a relative spreading of the area 
covered by lytic granules, supporting the notion 
of multiple docking domains at the synapse23. Our 
analysis also highlights that increase of nucleus 
area is a typical feature of the IS in the NK-92 
cells. Interestingly, nucleus area appears to 
increase along with F-actin intensity when 
assessed across 3 experiments (Fig. 1d), 
suggesting that nucleus flattening and F-actin 
polymerization are related events, probably as 
components of the cell spreading mechanism. Of 
note, the absolute values for F-actin intensity 
were higher in one of the 3 experiments, possibly 
resulting from differences in staining quality. 
This indicates that absolute value for staining 
intensities across experiments should be 
considered with caution. To further estimate 
morphological heterogeneity in individual cells, 
F-actin intensity was assessed on a per-cell basis 
(Fig. 1e), rather than on a per field of view basis. 
The unimodal increase of F-actin intensity driven 
by the stimulation of NK-92 cells indicates a 
relatively homogenous activation and IS 
assembly in these cells. It also validates our 
approach to consider mean cell measurements on 
a per field of view basis.  
We then applied our HCI workflow to Jurkat 
cells, which were co-stimulated with ICAM-1 and 
anti-CD3 Ab. We selected 12 features pertaining 
to the F-actin, LFA-1 and DAPI stainings to 
monitor hallmarks of the T cell IS11. As compared 
to the neutral PLL stimulation, LFA-1/CD3 co-
stimulation led to cell spreading, assembly of a 
peripheral F-actin ring-like structure and 
redistribution of the integrin LFA-1 as an inner 
belt at the cell to substrate interface (Fig. 1f and 
Fig. S1b), which are characteristic for the IS11,24. 
Our quantification over multiple fields showed 
that similarly to NK-92 cells, F-actin intensity, 
cell area, LFA-1 intensity and LFA-1 area are 
prominent features of the Jurkat cell IS (Fig. 1g 
and Table S2). Likewise, F-actin and LFA-1 
intensities correlated in individual fields of view 
with a Pearson correlation coefficient of 0.50 
(Fig. 1h). At the single cell level, F-actin clearly 
increased in response to the ICAM-1 and anti-
CD3 Ab stimulation, despite noticeable 
heterogeneity in both stimulated and unstimulated 
cells (Fig. 1i). When taken together, the data 
collected on the 
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Fig. 1 | High content imaging of the immunological synapse in lymphocytic cell lines. a. Schematic representation of 
the High content imaging pipeline. b. Representative images of NK-92 cells seeded on Poly-L-Lysine (PLL) or ICAM-1 
plus anti-NKp30 / NKp46 Ab, stained for F-actin (green), perforin (yellow) and the nucleus (DAPI). Scale bars: 
10 μm. c. Selected IS features analysed as fold change of ICAM-1 plus anti-NKp30 / NKp46 Ab over PLL. The data 
represent the mean of three separate experiments (n= 933-5860 cells). d. Mean nucleus area in pixels and median F-actin 
intensity per image across PLL and ICAM-1 plus anti-NKp30 / NKp46 Ab conditions. e. F-actin intensity distribution per 
cell across PLL and ICAM-1 plus anti-NKp30 / NKp46 Ab conditions. f. Representative images of Jurkat cells on PLL or 
ICAM-1 plus anti-CD3 Ab, stained for F-actin (green), LFA-1 (red) and the nucleus (DAPI). Scale bars: 10 μm. g. Selected 
IS features analysed as fold change of ICAM-1 plus anti-CD3 Ab over PLL. The data represent the mean of triplicates (n= 
125-940 cells). h. Median F-actin and LFA-1 intensity per image across PLL and ICAM-1 plus anti-
CD3 Ab conditions. i. F-actin intensity distribution per cell across PLL and ICAM-1 plus anti-CD3 Ab conditions.  
 
assembly of the IS in NK-92 and Jurkat cells 
highlight F-actin intensity rise and cell spreading 
as common traits. However, in line with the 
distinct appearance of their actin rich peripheral 
protrusions, Jurkat cells, but not NK-92 cells, 
became rounder upon activation. Furthermore, 
while NK-92 flattened their nucleus, the effect 
was not marked in Jurkat cells, indicating a 
distinct cell spreading behavior. Overall, our data 
validate the reliability and power of HCI with 
high spatial resolution to unbiasedly define the 
morphological profiles of lymphocytes in 
response to stimulatory regimens.  
 
Cytoskeleton drugs induce non-identical 
alterations of the NK cell IS.  
Given the prominent actin remodeling activity 
sustaining IS assembly, we next exploited our 
HCI approach to monitor how pharmacological 
modulation of cytoskeletal dynamics would affect 
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IS architecture. NK-92 cells were treated with 
seven drugs known to target distinct aspects of 
actin and acto-Myosin dynamics, which were 
used at 3 concentrations in order to detect 
possible dose-dependent effects. NK-92 cells 
were pre-treated with drugs for 30 minutes before 
seeding on ICAM-1 and anti-NKp30 / NKp46 
Ab. In a first step, the effects of these drugs on the 
previously selected quantitative morphological 
features of the IS were assessed. 
Upon treatment with Latrunculin B, which binds 
actin monomers and inhibits actin 
polymerization, a concentration-dependent 
decrease in F-actin intensity was detected as 
compared to the untreated control (Fig. 2a), in 
concordance with an expected reduction in actin 
polymerization. However, IS assembly was not 
fully impeded as revealed by a minor reduction of 
cell area. Remarkably, Latrunculin B treatment 
elicited an increase of the number of perforin 
granules and the area they occupied at the cell to 
substrate interface. This might reflect impaired 
exocytosis and accumulation of aberrantly 
 
Fig. 2 | Drug treatments yield changes to immunological synapse morphology. Graphs representing the fold change of 
IS parameters and representative images of NK-92 cells seeded on ICAM-1, anti-NKp30 and anti-NKp46, stained for F-
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actin (green), perforin granules (yellow) and nuclei (DAPI) and treated with three concentrations 
of a. Latrunculin b. Jasplakinolide, c. Blebbistatin, d. Y-27632, e. CK-968, f. Wiskostatin, and g. SMIFH2 with respect to 
the untreated control. h. Untreated control. The data represent the mean of triplicates for each concentration (1425-5541 
cells). Scale bars: 10 μm.  
 
spread lytic granules at the IS. Such explanation 
is in agreement with the role of actin dynamics in 
facilitating the docking and exocytosis of lytic 
granules21,25. Upon treatment with Jasplakinolide, 
which stabilizes actin, a mild decrease in F-actin 
intensity was detected at 1 µM, supporting the 
notion that actin turnover is required to fuel 
polymerization26,27(Fig. 2b). A higher 
concentration of 2.5 µM was tested but could not 
be exploited because of its apparent detrimental 
effect on cell viability. In comparison to 
Latrunculin B, Jasplakinolide treatment elicited 
an increase in the perforin-related features, 
confirming that actin turnover is required for lytic 
granule exocytosis25,27. Treatment with the 
Myosin inhibitor Blebbistatin induced a slight 
increase in F-actin intensity at 5 and 10 µM (Fig. 
2c). More strikingly it increased the number of 
granules detected at the synapse and the area they 
occupied, consistent with previous findings that 
Blebbistatin hinders granule exocytosis without 
affecting their polarization28,29. Treatment with 
the ROCK inhibitor Y-27632 affected F-actin 
intensity, cell area and lytic granule features 
similar to those elicited by Blebbistatin treatment 
(Fig. 2d), in agreement with the activity of ROCK 
as an upstream regulator of acto-Myosin 
contractility. Upon CK-869 treatment, a 
concentration-dependent decrease in F-actin 
intensity was detected (Fig. 2e), showing, as 
expected, that ARP2/3 complex inhibition 
reduced actin polymerization30. Moreover, CK-
869 treated cells displayed reduced radial 
spreading, as shown by decreased area and 
increased cell width to length ratio, indicative of 
a severe impairment of IS assembly. A distinct 
property of CK-869 treatment was a reduction in 
the number of and area covered by perforin 
granules, possibly reflecting the inability of CK-
869 treated cells to polarize lytic granules towards 
the stimulatory surface because of defective IS 
assembly. Upon treatment with Wiskostatin, an 
inhibitor of WASP, which drives ARP2/3-
dependent actin branching, a slight increase in F-
actin intensity was measured for the two lowest 
concentrations (Fig. 2f). In comparison with CK-
869, Wiskostatin displayed minor effects on 
perforin features. This suggests that the ARP2/3 
activator WASP plays a limited role in the overall 
actin polymerization rate at the IS and in lytic 
granule polarization and secretion24,31. Treatment 
with the pan-formin blocker SMIFH2 led to a 
concentration-dependent increase in F-actin 
intensity (Fig. 2g). Low-concentration SMIFH2 
treatment resulted in an increase in perforin 
intensity and area. Collectively, these data 
indicate that drugs affecting different facets of 
actin remodeling differentially altered the 
assembly of the NK cell IS. 
To further assess whether the morphological 
alterations inflicted by the drugs could be 
distinguished one from another, we trained a 
random forest classifier based on the 13 selected 
features. The image set was split to carry out a 
parameter optimization and to validate the 
performance of the model. The obtained overall 
accuracy of 69% and 𝐹1 score of 0.7 confirmed 
that our method performed relatively well at 
distinguishing the morphological effects of the 
actin drugs. The confusion matrix shows that 
most drugs were predicted with high accuracy 
based on the corresponding image features, while 
the morphological effects of Blebbistatin and Y-
27632 could not be easily distinguished, in line 
with their highly related mechanism of action 
(Fig. S2a). It also confirmed F-actin intensity as 
a major discriminating feature and identified cell 
eccentricity and roundness as key features to 
account for the morphological alterations induced 
by the drugs (Fig. S2b). 
Overall, our comparative image-based analysis of 
the effects of different drugs affecting actin and 
acto-Myosin dynamics reveals that distinct 
effects on actin turnover and polymerization yield 
distinguishable IS morphologies but converge in 
affecting lytic granule positioning. This supports 
the notion that multiple actin-dependent steps 
control lytic granule docking and exocytosis32.  
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High-resolution morphology profiling of NK 
cells upon drug treatment.  
To further enrich our morphological analysis of 
the IS in the context of drug treatment, we 
considered additional morphological features 
beyond the previously analyzed quantitative 
features. From 1898 measured features, a set of 
383 features was retained following filtering of 
non-informative and redundant features. In order 
to visualize the information contained in this large 
feature set, as well as to quantify the significance 
of morphological changes upon drug treatment as 
compared to untreated cells, we applied a UMAP 
dimensionality reduction. This allows the 
visualization of all cell images, recapitulating in a 
‘morphological space’ the relation between the 
morphology they display, by summarizing the 
variation of the 383 features into two dimensions 
(Fig. S2c). By examining the relation between 
these features, we saw that both the different 
types of measurements acquired, and the different 
biological objects studied provided 
complementary and non-redundant information 
about the global changes occurring between 
images and between treatments (Fig. S2d).  This 
also showed that none of these morphological 
features were repeating technical confounders, 
such as experimental plate position effect or cell 
count. As clearly visible in the morphological 
space, images of cells treated with Latrunculin B, 
Jasplakinolide and CK-869 clustered away from 
the untreated cells and from one another, most 
likely owing to these drugs having prominent and 
distinct 
 
 
Fig. 3 | Morphological profiling of the NK cell immunological synapse upon drug treatment. Drug-treated NK-92 cell 
images were analysed with CellProfiler for an array of measurements and visualized using UMAP to position drug treated 
cells with respect to untreated cells from the same row. a. Latrunculin b. Jasplakinolide, c. Blebbistatin, d. Y-
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27632, e. CK-968, f. Wiskostatin, and g. SMIFH2. h. Confusion matrix and class-wise performance on held-out data of a 
random forest model trained to predict drug treatment based on the morphology of NK-92 cells seeded on ICAM-1, anti-
NKp30 and anti-NKp46. i-j Total and average importance for the prediction of morphological features per measurement 
type and biological object described of NK-92 cells seeded on ICAM-1, anti-NKp30 and anti-NKp46 and treated 
with i. CK-869 or j. SMIFH2.  
 
effects on the ability of NK-92 cells to assemble 
the IS (Fig. 3a, b and e). In comparison, 
morphologies of cells treated with Blebbistatin, 
Y-27632, Wiskostatin and SMIFH2 appeared to 
be less distinct from the untreated condition and 
to cluster at close vicinity to one another (Fig. 3c, 
d, f and g). The three concentrations assayed per 
treatment fell into distinct sub-clusters, clearly 
indicating dose-dependent effects, as detailed for 
CK-869 and SMIFH2 (Fig. S2e and f). All drug-
evoked morphological profiles were found to be 
significantly distant from the untreated state. 
Indeed, the median robust Mahalanobis distances 
between the fields of view per treatment and their 
matching negative controls are larger than 
expected at random (Fig. S2g)33,34. To get insight 
into the nature of the changes that are causative of 
the observed clusters on the UMAP 
representation, we trained a random forest 
classifier on the set of 383 features. This achieved 
a satisfactory performance, as shown on the 
confusion matrix (Fig. 3h) with an 𝐹1 score and 
an accuracy of 0.89 and 89%, respectively. The 
importance of each feature for the classification 
was proxied by the average increase in accuracy 
obtained by including the given feature in a 
decision tree. In particular, our analysis shows 
that CK-869 treatment mostly affected nucleus 
and cytoplasm shape descriptors (Fig. 3i), while 
SMIFH2 treatment altered radial intensity 
distributions in the cytoplasm (Fig. 3j). Only four 
features described intensities in the cytoplasm 
within our feature set. Interestingly, those few 
features were in average increasing the model 
accuracy the most, strengthening the necessity, 
but not sufficiency, of actin intensity 
measurements to profile the IS. Features 
pertaining to lytic granules also played a 
determinant role in reinforcing model accuracy, 
providing further evidence of a tight regulation of 
lytic granule distribution at the IS. Our data 
therefore demonstrates the ability of the unbiased 
profiling to identify relevant spatially localized 
events and characterize perturbed cell states with 
high-resolution power. 
Morphological profiling of primary human 
NK cells upon drug treatment.  
We next applied our HCI approach to assess the 
susceptibility of primary human lymphocytes 
from different donors to cytoskeletal drugs. For 
that purpose, NK cells were purified from the 
peripheral blood of three normal donors, treated 
with four concentrations of either CK-869 or 
SMIFH2, and stimulated with ICAM-1 and anti-
NKp30 / NKp46 Ab (Fig. 4a). Although the 
untreated cells from the three different healthy 
donors displayed variation in morphology, an 
actin-rich IS with the lytic granules concentrated 
in one area towards the cell periphery was 
observed upon stimulation. The four tested 
concentrations of CK-869 caused a marked 
decrease in F-actin intensity in the NK cells from 
the three donors, demonstrating the capacity of 
our approach to detect actin cytoskeleton 
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Fig. 4 | CK-869 and SMIFH2 treatments alter immunological synapse architecture and lytic granule polarization in 
primary NK cells. a. Representative images of primary NK cells isolated from PBMCs of three normal donors seeded on 
ICAM-1, anti-NKp30 and anti-NKp46, stained for F-actin (green), perforin granules (yellow) and nuclei (DAPI) and either 
untreated or treated with four concentrations of CK-869 or SMIFH2. Scale bars: 10 μm. b-c Graphs representing the fold 
changes of immunological synapse parameters of primary NK cells treated with (b) CK-869 and (c) SMIFH2 with respect 
to untreated controls. The data represent the mean of 4 replicates for each drug concentration (60-409 cells). 
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Fig. 5 | High content imaging of the immunological synapse in ARPC1B deficient CD8+ T cells. a. Representative 
images of CD8+ T cells from normal donors and ARPC1B deficient patients seeded on ICAM-1 and either 1 or 10 μg/ml 
anti-CD3 and stained for F-actin (green), perforin granules (yellow), LFA-1 (red) and nuclei (DAPI). Scale 
bars: 10 μm. b. Characteristics of the immunological synapse of CD8+ T cells of the two ARPC1B deficient patients 
represented as fold change with respect to the average of the three normal donors seeded on ICAM-1 and 1 μg/ml anti-
CD3. The data represents the mean of 6 replicates for each donor (10687-19353 cells) c. UMAP projection of CD8+ T 
cells morphological profiles from the two patients and the three normal donors seeded on ICAM-1 and10 μg/ml anti-
CD3. d. Confusion matrix and class-wise performance on held-out data of a random forest model trained to discriminate 
between patient and normal donors based on the morphology of CD8+ T cells seeded on ICAM-1 and 10 μg/ml anti-
CD3. e. Total and average importance of morphological features per measurement type and biological object described for 
the prediction of patient and normal donor CD8+ T cells seeded on ICAM-1 and 10 μg/ml anti-CD3. f. Specific lytic 
activity of patient and normal donor CD8+ T cells incubated with P815 cells coated with 10 μg/ml anti-CD3 after 4 h and 
24 h. Values represent the mean of triplicates and error bars show SD. Significance is noted as *(P <0.05).  
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alterations in primary lymphocytes. Notably, the 
area covered by the perforin granules, taken as an 
absolute value or divided by the cell area, was 
increased in the CK-869 treated NK cells from the 
three donors, showing a clear dose-dependent 
response (Fig. 4b). This effect is opposite to what 
was measured in the NK-92 cells, highlighting 
contrasting responses of model cell lines and 
primary cells. Moreover, the four tested 
concentrations of SMIFH2 also caused a decrease 
in F-actin intensity in the NK cells from the three 
donors, thereby highlighting the importance of 
formins for actin remodeling at the IS (Fig. 4c). 
SMIFH2 treatment also strongly affected the 
distribution of perforin granules. Interestingly, in 
NK cells from donors 1 and 2, a dose dependent 
reduction of both perforin granule number and 
covered area was observed, a response opposite 
to that to CK-869. In contrast with donors 1 and 2 
, low concentrations of SMIFH2 resulted in an 
increase of perforin granule number and covered 
area in NK cells from donor 3. It should be noted 
that lower number of perforin granules were 
detected in the untreated cells from this donor, 
possibly influencing the response to the tested 
drugs. Those observations highlight the potential 
of HCI to identify features underlying inter-donor 
variability upon stimulation and treatment of 
lymphocytes populations, which may be 
explained by the phenotypic variation of each 
donor’s NK cells35. Together, the dataset 
collected on primary NK cells demonstrates that 
HCI is amenable to the morphological profiling 
of primary human lymphocytes in the context of 
drug treatments and that it can discriminate 
specific responses from individual donors.  
Immunological synapse defect is associated 
with impaired cytotoxicity in CD8+ T cells 
from ARPC1B deficient patients. 
We then reasoned that the HCI approach might be 
adapted to characterizing lymphocyte 
impairments in the context of pathology. For that 
purpose, we implemented a morphological 
profiling of CD8+ T cells isolated from two 
patients suffering from a primary 
immunodeficiency caused by mutations in 
ARPC1B, which encodes one subunit of the 
ARP2/3 complex. Cells from the two patients and 
three normal donors were stimulated with ICAM-
1 and either 1 or 10 µg/ml anti-CD3 Ab, and 
stained for perforin and LFA-1, F-actin and the 
nucleus. ￼ images suggests that the CD8+ T cells 
from both patients spread less than control cells 
and failed to assemble a typical IS (Fig. 5a). 
Analysis of 16 selected morphological features 
highlighted that F-actin intensity was decreased 
in T cells from the two patients, as compared to 
the cells from the normal donors, following 
stimulation with anti-CD3 Ab at both 
concentrations (Fig. 5b and Fig. S3a). This is 
comparable to the data collected above in cell 
lines and primary cells upon treatment with the 
ARP2/3 inhibitor CK-869. Cells from the two 
patients however displayed distinct 
morphological aberrations. While cell area was 
mostly affected in cells from patient 1, implying 
an impaired spreading ability, cell roundness was 
prominently decreased in patient 2, most likely 
resulting from aberrant peripheral actin spikes. T 
cells from patient 2 displayed an increased 
number and dispersion of perforin granules, 
similarly with what we observed in primary NK 
cells treated with CK-869. However, fewer 
perforin granules were detected in T cells from 
patient 1. Their dispersion was reduced in 
absolute terms but increased when normalized for 
the cell area, the latter being reduced. LFA-1 
intensity was increased in the T cells from both 
patients and LFA-1 was localized at the cell rim 
rather than at the cell to substrate contact area, 
suggesting abnormal distribution of adhesive 
forces. Our morphological profiling clearly 
establishes that CD8+ T cells from the two 
considered ARPC1B-deficient patients have 
severe impairments in IS assembly. The distinct 
synaptic alterations revealed by our approach in 
the two patients could not be explained by 
differences in the phenotype of the cells, which 
showed similar expression of CD8, perforin, 
LFA-1, and granzyme B (Fig. S3 f-i). To further 
enrich our analysis, we applied once more a 
UMAP approach to explore the morphological 
space, which evidenced a marked segregation of 
the two patients from the control donors, but also 
among each other (Fig. 5c and Fig. S3b). This 
analysis therefore reinforces the finding that 
patient T cells have aberrant synaptic traits and 
that the nature of these aberrations is distinct 
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between the two patients. Interestingly, we 
noticed that even though the normal donors 
clustered closely to each other, donor 3 did not 
overlap with the other two at either anti-CD3 Ab 
concentration, confirming that heterogeneity in IS 
morphology exists among normal donors, as 
observed above for NK cells. A first random 
forest model showed that we could determine the 
concentration of anti-CD3 Ab used to stimulate 
the cells with an accuracy of 95% and 𝐹1 score of 
0.95 (Fig. S3c), and indicated that IS assembly 
varied according to the concentration of anti-CD3 
Ab (Fig. S3d). This was associated with changes 
in shape and radial distribution in the cytoplasm, 
while cytoplasm intensities were the most 
discriminative feature category in average, fitting 
a scenario in which TCR stimulation strength 
would differentially remodel the actin 
cytoskeleton and associated synapse morphology. 
A second model showed that our approach is 
powerful enough to distinguish patient cells from 
normal donor cells seeded on ICAM-1 and 10 
µg/ml anti-CD3 Ab by achieving a perfect 
classification on a validation set (Fig. 5d), 
distinguishing ARPC1B deficient cells mostly on 
the basis of textural and intensity distribution 
changes within the cytoplasm (Fig. 5e). 
Moreover, some features changed not only 
between ARPC1B patients and normal donors but 
were as well discriminating between patient 1 and 
patient 2 (Fig. S3e), further reinforcing that the 
two patients have distinct IS architectures. The 
aberrant IS characterized in the patients through 
the morphological profiling approach alluded to a 
possible functional defect. We therefore assessed 
the cytotoxic activity of CD8+ T cells towards 
anti-CD3 Ab-coated P815 target cells. Whereas, 
normal CD8+ T cells started to kill target cells in 
four hours, CD8+ T cells from the ARPC1B 
deficient patients failed to do so. The patient 
derived CD8+ T cells remained defective at 
killing target cells over a prolonged 24-hour 
incubation (Fig. 5f). This indicates that the T cells 
from the patients most likely fail to secrete lytic 
molecules, despite a normal content in perforin 
and granzyme B (Fig. S3g and i). Our results 
therefore indicate that the defects in IS 
organization characterized in both patients are 
leading to a severe impairment of the cytotoxic 
activity.  
Discussion 
By combining automated cell imaging with 
computational image analysis pipelines, HCI 
provides novel opportunities to systematically 
analyze cellular mechanisms15,36,37. Howeverm, 
the potential of such approach has not yet been 
explored for the study of immune cells. We here 
tailor a HCI approach for the high-resolution 
morphological profiling of various human 
cytotoxic lymphocyte population, and focus on 
the imaging of the IS as a mean to capture the 
activation state and effector potential of these 
cells. We validate our HCI approach by 
identifying distinct morphological signatures 
evoked by a panel of actin-targeting drugs. We 
further reveal the power of our HCI approach to 
discriminate individual donors on the basis of 
immune cell morphological traits. We also 
exemplify the clinical applicability of such 
approach by identifying cytotoxic lymphocyte 
aberrations in patients with a severe congenital 
immunodeficiency.  
Although we use a minimalistic 2D static 
approach based on the adsorption of stimulatory 
molecules on the surface microwells, it proves to 
robustly stimulate the assembly of morphological 
structures qualifying as IS. We show that various 
human lymphocyte populations, including model 
cell lines, cells freshly isolated from the blood, as 
well as expanded primary cells can be stained and 
imaged with an automated confocal microscope 
at high resolutive power in a 384-well format, 
allowing the analysis of several samples, 
activation conditions and perturbations in 
parallel. Computationally, we use robust statistics 
and work at an image-level resolution, typically 
gathering a few dozens of cells imaged over four 
z planes representing the 2-µm section of the cells 
most proximal to the stimulatory substrate. While 
most morphological profiling studies have been 
limited to average profiles over wells or 
replicates14,37,38, a few approaches have defined 
profiles based on single cells 39,40. We here rather 
consider the variability in morphology displayed 
in each image by including measures of 
dispersion that are proven to be beneficial for 
morphological profiles and could potentially be 
further improved by adding a higher order joint 
statistical moment 41. From an analytical point of 
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view, we elaborate two complementary methods. 
First, we focus on a pre-defined set of 
morphological features based on prior knowledge 
and including cell and nucleus shape parameters 
as well as intensities of F-actin, LFA-1 and 
perforin at the synaptic plane. We show that such 
method can be applied to relatively low numbers 
of images and provides meaningful identification 
of discriminative features when comparing 
experimental conditions. Second, we implement a 
high-resolution and unbiased morphological 
profiling pipeline, from which novel relevant 
features can be identified and from which high-
performance classifiers can be trained to 
discriminate cell states corresponding to different 
stimulations, drug treatments or genetic defects. 
Beyond the methodological advance provided in 
this study, we present data relevant to the 
understanding of lymphocyte activation in both a 
fundamental and medically relevant perspective. 
Among the pre-defined set of morphological 
features, we identify increase of F-actin as a 
hallmark of T and NK lymphocyte stimulation by 
combinations of ICAM-1 and antibodies directed 
against CD3 or NK receptors, respectively. This 
is in line with the previously established role of 
the actin cytoskeleton in driving the cell 
spreading behavior supporting IS assembly42,43. 
The further investigation of the role of actin 
cytoskeleton remodeling by the treatment of NK 
cells with a drug array reveals distinct 
morphological alterations upon targeting actin 
polymerization, depolymerization and Myosin II. 
Our data also point to converging morphologies 
induced by some of the drugs with distinct modes 
of action, possibly related to a limited number of 
configurations of the cytoskeleton, as recently 
described in an adherent neuroblastoma cell 
line36,44. Strikingly, most tested drugs yield 
prominent alteration of the distribution of 
perforin-containing granules, indicating that the 
different facets of actin cytoskeleton dynamics 
are all important to regulate the polarized delivery 
of lytic granules at the IS 25,45. 
Owing to the distinct morphological profiles 
observed for each drug, and the detection of dose-
dependent effects, both in cell lines and primary 
cells, such an approach could be applied in the 
context of immunotherapeutic drugs. A striking 
finding of the application of morphological 
profiling to lymphocyte populations is that it 
reveals a previously unappreciated level of 
heterogeneity in cellular morphological traits 
among individuals. When considering the data 
pertaining to the NK cells freshly isolated from 
the blood, we cannot rule out that morphological 
differences arise from distinct activation states of 
the cells from different donors. However, in vitro 
stimulation and expansion of T lymphocytes, 
which is expected to robustly drive cells towards 
a differentiated phenotype46, was also associated 
with distinct morphological traits. Further 
analysis of larger cohorts of donors and sorted 
subpopulations of lymphocytes will be required 
to precisely appreciate the degree of 
morphological heterogeneity among individuals 
and lymphocyte subsets. The detection of distinct 
morphological profiles among healthy 
individuals certainly highlights the extreme 
sensitivity of the HCI approach to characterize 
and compare cell populations. A further 
illustration of this property is provided by the 
characterization of IS alterations in T lymphocyte 
populations isolated from 2 patients with 
ARPC1B deficiency. Interestingly, again, our 
approach points to distinct morphological 
alterations in the cells from the 2 patients 
considered. Such differences might be inherent to 
the severity of the ARPC1B genetic defect. 47,48 
The study of larger cohorts of patients, which 
would be compatible with the herein developed 
approach, would be required to answer such 
question.  
CD8+ T cells from ARPC1B patients display an 
aberrant IS morphology including defects 
pertaining to the distribution of perforin granules 
and LFA-1. Comparably to other studies, we 
show a reduced cell area and a failure to spread 
radially and emit lamellipodia upon TCR 
stimulation47. The lack of lamellipodia formation 
was also observed upon NK-92 and primary NK 
cell treatment with CK-869. Our data reveals 
increased accumulation of lytic granules at the IS 
for one patient, which could indicate a defect in 
granule exocytosis, opposed to a decrease in 
perforin related parameters for the other patient, 
most likely indicative of failed lytic granule 
polarization. These observations are in agreement 
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with a recent study showing defective lytic 
granule polarization and degranulation in 
ARPC1B deficient CD8+ T cells49. The detection 
of such IS defects is suggestive of a possible 
alteration of the cytotoxic activity. Our data 
shows that ARPC1B deficient cells fail to 
eliminate target cells, as recently reported49. This 
illustrates the potential of HCI to provide 
guidance for the implantation of complementary 
low throughput assays to assess defects at the 
functional and molecular level. At this stage, we 
cannot generalize the case of the ARPC1B 
deficiency in establishing a systematic 
relationship between IS alteration and functional 
defect. However, it is interesting to mention that 
multiple primary immunodeficiencies have been 
found by us and others to associate IS defects and 
functional impairments50–53. Previous reports 
have also shown that PIDs where the IS is 
defective fail to eliminate target cells51,53,54 The 
systematic analysis of multiple such pathologies 
and corresponding cellular models would 
certainly provide a unique opportunity to 
establish rules linking morphology to function.  
Overall, we provide here an innovative HCI 
approach to unbiasedly interrogate the biology of 
lymphocyte populations. It provides a rich way to 
identify and interpret details of the IS architecture 
and surpass current approaches in detecting 
morphological traits of specific lymphocyte 
populations, as illustrated by the distinct 
morphological profiles identified among the 
primary lymphocytes of individual donors. This 
hold promises to stratify patients based on 
specific morphotypes of lymphocytes or other 
leukocytes. Therefore, we thoroughly report both 
the experimental and computational methods 
employed and provide all scripts used in the 
analysis to maximize the reproducibility of the 
approach developed herein. We hope this 
encourages further research leveraging the 
application of HCI to blood-derived cell subsets, 
for potential translation in the field of cancer 
therapy and personalized medicine.  
Materials and methods 
Cell lines and primary cells  
Jurkat cells were cultured in RPMI (Gibco) 
supplemented with 10% FBS, 1% 
penicillin/streptomycin, 1% sodium pyruvate, 1% 
non-essential amino acids and 1% HEPES (all 
from Thermo Fisher Scientific). NK-92 cells were 
cultured according to the recommendations from 
ATCC. Primary NK cells were purified from 
freshly isolated PBMCs using the MagniSort 
Human NK enrichment kit (Invitrogen) and 
maintained in RPMI supplemented with 5% 
human serum, 1% penicillin/streptomycin, 1% 
sodium pyruvate, 1% non-essential amino acids 
and 1% HEPES. Primary CD8+ T cells were 
purified from frozen PBMCs of 3 healthy donors 
and 2 ARPC1B deficient patients by negative 
selection using the EasySep Human CD8+ T cell 
enrichment kit. CD8+ T cells were stimulated in 
RPMI supplemented with 5% human serum, 1% 
penicillin/streptomycin, 1% sodium pyruvate, 1% 
non-essential amino acids, 1% HEPES 1 µg/ml 
PHA and 100 IU/ml IL-2. CD8+ T cells were 
expanded for further rounds every 2 weeks with a 
mixture of irradiated PBMCs from 3 normal 
donors. Peripheral blood from healthy donors and 
patients was obtained in accordance with the 1964 
Helsinki declaration and its later amendments or 
ethical standards. Informed consents were 
approved by the relevant local Institutional 
Ethical Committees. 
Culture and staining conditions used for High 
content imaging  
CellCarrier Ultra tissue culture treated plates 
(Perkin Elmer) were coated with either 0.01% 
PLL (Merck) or a combination of 2 µg/ml ICAM-
1 (R&D Systems), 1 µg/ml NKp30 (R&D 
systems, MAB18491) and 1 µg/ml NKp46 (BD 
Biosciences, 557487). NK-92 cells were cultured 
in IL-2 free medium overnight. 15000 NK-92 and 
5000 primary NK cells were seeded per well and 
left for 30 min at 37°C to adhere and form the 
synapse. Cells were fixed with 3% 
paraformaldehyde (Merck) and stained with anti-
perforin Ab and phalloidin-AF 488. Goat anti-
mouse AF 555 was used to reveal perforin 
staining. Nuclei were stained with DAPI.  
NK-92 were treated with 5, 10 and 50 µM 
Blebbistatin, 10, 25 and 50 µM CK-869 (Merck), 
0.1, 1 and 2.5 µM Jasplakinolide (Merck), 0.1, 
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0.25 and 0.5 µM Latrunculin B (Merck), 50, 100 
and 250 µM SMIFH2 (Merck), 10 50 and 100 µM 
Wiskostatin (Merck) and 5, 10 and 25 µM Y-
27632 (Merck) for 30 min at 37°C and washed 
twice in PBS before seeding onto the plates and 
letting them adhere for 30 min. The same 
procedure was applied to primary NK cells 
treated with 5, 10, 25 and 50 µM CK-869 and 25 
50, 100 and 250 µM SMIFH2. 
CellCarrier Ultra multiwell tissue culture treated 
plates were coated with either 0.01% poly-L-
lysine or a combination of 2 µg/ml ICAM-1 and 
10 µg/ml anti-CD3 (eBioscience). 10000 Jurkat 
or 5000 CD8+ T cells were seeded per well and 
left for 15 min at 37°C to adhere and form the 
synapse. Cells were fixed with 3% 
paraformaldehyde and stained with anti-LFA-1 
(BioLegend, 301202) and phalloidin-AF 488 
(Thermo Fisher Scientific) in permeabilization 
buffer (eBioscience). Goat anti-mouse AF 647 
antibody (Thermo Fisher Scientific, A-21240) 
was used to reveal LFA-1 staining. CD8+ T cells 
were in addition stained with anti-perforin and 
goat anti-mouse AF 555 (Life technologies) was 
used to reveal perforin staining. Nuclei were 
stained with DAPI (Thermo Fisher Scientific). 
Stained cells were kept in PBS at 4°C until 
imaging. 
Image acquisition and processing 
Images were acquired on an automated spinning 
disk confocal HCS device (Opera Phenix, Perkin 
Elmer) equipped with a 40x 1.1 NA Plan 
Apochromat water immersion objective and a 
sCMOS camera. For each well, 40 randomly 
selected fields and 8 stacks per field (0.5 µm step) 
were acquired. Stacks of images were combined 
with maximum projection for four focal slices (z 
from 1 to 4 with a 0.5 µm step), then assembled 
in sets of images per field of view corresponding 
to DAPI, phalloidin and LFA-1 or perforin 
depending on the cell type imaged. These datasets 
were processed, and measurements were made 
using CellProfiler 3.018 (see Supplementary Files 
[CellProfiler pipeline]). In brief, we assess the 
image quality, log-transform the intensities for 
experiments with high background noise, correct 
the illumination on each image based on 
background intensities, avoid DNA precipitations 
by multiplying intensities on DAPI channel by 
phalloidin intensities before segmenting cell 
nuclei using global minimum cross entropy 
thresholding. We perform a secondary 
segmentation of the cytoplasms using the 
watershed method55 and global minimum cross 
entropy thresholding on the phalloidin channel. 
Image sets with low maximal DNA intensity or 
showing no nucleus were discarded. Cells having 
more than 30% of their cytoplasm surface at less 
than 5 pixels of another cell were removed, in 
order to ignore clusters of cells and to focus on 
single cells displaying an IS. We segmented small 
actin speckles in the cytoplasm at more than 3 
pixels from the membrane as well as speckles of 
perforin and secondary objects spanned around 
the nuclei by LFA-1 staining. Additionally, 
primary NK and expanded CD8+ T cells 
associated with less than 2 perforin granules were 
excluded from the analysis. Finally, we measured 
colocalization of these objects, intensities in the 
nuclei and cytoplasms, granularity on all 
channels, textural and shape features, intensity 
distributions, distance and overlap between 
objects and counted speckles neighbors less than 
10 pixels away. We then kept the average and the 
standard deviation of these features per field of 
view. This led to 1898 and 2076 morphological 
features in NK92 and Jurkat cells respectively. 
For primary NK cells and expanded CD8+ T cells, 
features related to actin speckles were excluded, 
as they were not found to be informative, 
resulting in 2386 and 1517 features, respectively.  
Stacks of images were combined with maximum 
projection for four focal slices (z from 1 to 4 with 
a 0.5 µm step), then assembled in sets of images 
per field of view corresponding to DAPI, 
phalloidin and LFA-1 or perforin depending on 
the cell type imaged. These datasets were 
processed, and measurements were made using 
CellProfiler 3.018 (see the pipelines provided).  
In brief, we assess the image quality, log-
transform the intensities for experiments with 
high background noise, correct the illumination 
on each image based on background intensities, 
avoid DNA precipitations by multiplying 
intensities on DAPI channel by phalloidin 
intensities before segmenting cell nuclei using 
global minimum cross entropy thresholding. We 
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perform a secondary segmentation of the 
cytoplasms using the watershed method55 and 
global minimum cross entropy thresholding on 
the phalloidin channel. Image sets with low 
maximal DNA intensity or showing no nucleus 
were discarded. Cells having more than 30% of 
their cytoplasm surface at less than 5 pixels of 
another cell were removed, in order to ignore 
clusters of cells and to focus on single cells 
displaying an IS. We segmented small actin 
speckles in the cytoplasm at more than 3 pixels 
from the membrane as well as speckles of 
perforin and secondary objects spanned around 
the nuclei by LFA-1 staining. Additionally, 
primary NK and expanded CD8+ T cells 
associated with less than 2 perforin granules were 
excluded from the analysis. Finally, we measured 
colocalization of these objects, intensities in the 
nuclei and cytoplasms, granularity on all 
channels, textural and shape features, intensity 
distributions, distance and overlap between 
objects and counted speckles neighbors less than 
10 pixels away. We then kept the average and the 
standard deviation of these features per field of 
view. This led to 1898 and 2076 morphological 
features in NK92 and Jurkat cells respectively. 
For primary NK cells and expanded CD8+ T cells, 
features related to actin speckles were excluded, 
as they were not found to be informative, 
resulting in 2386 and 1517 features, respectively.  
Data processing and visualization 
We subsequently conducted analyses in R 3.5.1 
with the data visualization package ggplot2 3.1.1 
and Microsoft Excel (Version 1902). We further 
selected a smaller set of informative 
morphological features and checked the quality of 
processed images by (i) removing wells with low 
maximal DNA intensity and cell count, (ii) 
removing features and images generating missing 
values and (iii) removing constant features in the 
study dataset or the subset of negative controls 
used as reference.  
From these images passing our quality checks, up 
to 16 raw summary variables were extracted 
based on their interpretability and on their known 
relevance to describe ISs. The fold changes 
compared to unstimulated or untreated controls 
were further reported and displayed in the form or 
radar charts.  On the other hand, for all features, 
per-image values 𝑋 were transformed 
successively with the following functions 𝑓1 and 
𝑓2, with 𝑋𝐶𝑜𝑛𝑡𝑟𝑜𝑙 the negative controls in 𝑋 on 
which the data is normalized: 
𝑓1(𝑋)  = log (𝑋 + 1 − min(𝑋)) 
𝑓2(𝑋) = 𝑋 −
median(𝑋𝐶𝑜𝑛𝑡𝑟𝑜𝑙)
mad(𝑋𝐶𝑜𝑛𝑡𝑟𝑜𝑙)
 
  
To remove redundancy in the set of features used 
for downstream analyses, we ensured that the 
selected variables were not excessively linearly 
correlated. To do so, all features were ordered 
from highest to lowest median absolute deviation 
(hence by variation in the experiment compared 
to negative controls). Starting from the top of this 
list, all other features linearly correlated to the 
first feature with a Pearson’s coefficient higher 
than 0.6 were excluded. We sequentially went on 
with the next remaining feature in the list and 
iterated until the acquisition of a small and 
informative set of uncorrelated features.  
This set of features was used for visualization and 
quantification of the overall morphological 
changes induced by perturbations. We then 
reduced the dimensionality of the data using the 
UMAP algorithm56 to 2 dimensions for 
visualizations and 3 dimensions for computation 
of the statistical significance of morphological 
effects in the drug screen on NK92. This pipeline 
succeeded in selecting a wide range of features 
that were not excessively biased by confounders 
(Fig. S2d).   
Robust Morphological Perturbation Value 
To quantify the significance of overall changes in 
morphology between a perturbed state and a 
reference state (healthy or untreated cells), we 
define the Robust Morphological Perturbation 
Value. This extends the concept of 
Multidimensional Perturbation Value33, which 
defines a single value summarizing the statistical 
significance of morphological changes in 
multidimensional spaces, by using robust 
statistics and the minimum covariance 
determinant34 decreasing the sensitivity to 
technical (unfiltered artifacts) and biological 
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outliers (images displaying extreme 
morphologies or uncommon cell states). In brief, 
the RMPV is obtained for 𝑋 the set of all filtered 
and uncorrelated features and 𝑋𝑊𝑇 the subset of 
the data corresponding to images of the reference 
population in five steps. First, the minimum 
covariance determinant estimator 𝑀(𝑋𝑊𝑇) is 
calculated to describe the variation of 
morphologies observed in the reference set, using 
its implementation in the R package robustBase 
version 0.93. Second, this value is used to 
determine 𝑅, the robust Mahalanobis distance of 
each images of 𝑋 to 𝑋𝑊𝑇 [arXiv:1904.02596 
[stat.ME]]. Third, the median value ?̃? =
median(𝑅) was obtained for each drug tested. 
Fourth, for 2000 iterations the labels of the 
condition and the reference were randomly 
permuted to obtain an empirical distribution of ?̃? 
under the assumption that there was no difference 
between the multivariate location and scatter of 
the morphological parameters of the perturbation 
and the reference. Finally, the RMPV is defined 
as the empirical p-value obtained from these 
distributions after FDR adjustment for testing 
changes in multiple conditions and indicates the 
probability of observing at least half of the images 
displaying morphological changes of a similar 
intensity if the perturbation was similar to the 
reference.  
Random forest classification and 
interpretation 
Using the set of informative and uncorrelated 
morphological features – previously used for 
dimensionality reduction, we trained a random 
forest classifier57 using the R package 
randomForest version 4.6. 
Using the set of informative and uncorrelated 
morphological features – previously used for 
dimensionality reduction, we trained a random 
forest classifier57 using the R package 
randomForest version 4.6. Each forest included 
1000 decision trees. The data was split in 6 folds 
of equal size, each containing all possible 
classification label. To select the optimal number 
mtry of variables selected at each split, we 
incremented the parameter value from 20 to 90 by 
steps of 10 and assessed the performance using 
the macro 𝐹1 score as defined below in a 5-fold 
cross-validation scheme. One extra fold was used 
as validation set to estimate the performance of 
the model after selection of the optimal 
parameters and retraining on all of the 5 folds 
used for cross-validation. In the case of the drug 
screen on the NK-92 cell line, we used a similar 
approach using the 13 features of known 
relevance in describing the IS as input, and testing 
mtry values from 1 to 13 with steps of 3. Overall 
the performance was evaluated using the macro 
𝐹1 score:  
𝐹1 =  
1
𝑛
∑
2 × 𝑇𝑃𝑖
2 × 𝑇𝑃𝑖 + 𝐹𝑃𝑖 +  𝐹𝑁𝑖
𝑛
𝑖=1
 
where 𝑛 is the number of categories in the 
classification, and 𝑇𝑃𝑖, 𝐹𝑃𝑖 and 𝐹𝑁𝑖 are 
respectively the number of true positives, false 
positives and false negatives for category 𝑖 in the 
validation set. To interpret the feature importance 
in the prediction, we extracted the mean decrease 
in accuracy obtained when including each feature, 
either for the prediction of a given class or overall 
using micro averaging. The total and average 
importance of features split in distinct groups 
based on the type of measurements and biological 
object described were calculated as well. These 
feature groups were defined based on the 
corresponding CellProfiler measurement types 
and biological objects. Features that did not 
describe the cytoplasm, nucleus, perforin 
granules or actin granules were counted in the 
“Other” biological object category. Similarly, 
features that did not correspond to the “Texture”, 
“AreaShape”, “RadialDistribution”, 
“Granularity” or “Intensity” measurements were 
grouped under the term “Other”. 
Cytotoxicity assay  
Target P815 cells were stained for 30 min with 
Cell Tracker green CMFDA (Thermo Fisher 
Scientific) and coated with 10 µg/ml anti-CD3 
(eBiosciences, 16-0037-81) for one hour at 37°C. 
They were also treated with 0.2 µg/ml of 
aphidicolin to prevent their proliferation. P815 
were incubated with effector CD8+ T cells in U-
bottom 96 well plates at an effector: target ratio 
of 1:1 for 4 and 24 hours58. Cells were then 
stained with Amino-Actinomycin D (7-AAD) 
(BD Biosciences) to discriminate dead and alive 
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cells using the MacsQuant VYB (Miltenyi) and 
analyzed with FlowJo. The number of residual 
alive CMFDA+ / 7-AAD- cells was assessed to 
calculate cytotoxicity. Student’s t-test was used to 
calculate significance. 
Phenotypic analysis 
Expanded CD8+ T cells from normal donors and 
ARPC1B-deficient patients were stained with 
fluorochrome-coupled antibodies recognizing the 
extracellular markers CD8 (BioLegend, 344718) 
and LFA-1 (BioLegend, 363404) for 30 min at 
4°C. Intracellular staining was performed 
following fixation and permeabilization, with the 
following antibodies perforin (BioLegend, 
308110) and granzyme B (BDPharmigen, 
561142) for 45 min at 4°C. The data were 
acquired on MacsQuant Q10 (Miltenyi) and 
analyzed with FlowJo. Student’s t-test was used 
to calculate significance. 
Data availability 
All the CellProfiler pipelines and morphological 
measurements used in this analysis are made 
available on FigShare with the DOI 
10.6084/m9.figshare.11619960 [already 
available for reviewers with the following private 
link: 
https://figshare.com/s/3c06753839d77783a899].  
Code availability 
The analyses can be found and reproduced using 
the Docker image and scripts provided on Github 
and identified with the DOI 
10.5281/zenodo.3518233. 
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Supplementary Fig. 1 | Individual channels and z planes of single cells isolated from representative fields of view.  
a. Maximum intensity projection (MIP) of a representative field of view of NK-92 cells seeded on PLL (top) or ICAM-1, 
anti-NKp30 and NKp-46(bottom), with zoom on a single representative cell stained for F-actin (green), perforin granules 
(yellow) and nuclei (DAPI) imaged at 4 z-planes with a step of 0.5 μm and its MIP.Scale bars: Field of view 50 μm and 
single cell 10 μm. b. MIP of a representative field of view of Jurkat cells seeded on PLL (top) ICAM-1, anti-CD3 (bottom), 
with zoom on a single cell stained for F-actin (green), LFA-1 (red) and nuclei (DAPI) and imaged at 4 z-planes with a step 
of 0.5 μm and its MIP. Scale bars: Field of view 50 μm and single cell 10 μm. 
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Supplementary Fig. 2 | Drug treatment leads to distinct immunological synapse phenotypes in NK-92 cells. a. 
Confusion matrix and class-wise performance of a random forest model trained to predict drug treatment based on 13 hand-
picked morphological features of NK-92 seeded on ICAM-1, anti-NKp30 and anti-NKp46. b. Importance of the 13 
morphological parameters for the classification described in panel (a). c. UMAP representing the clustering of all the drugs 
and the untreated conditions. d. UMAP representing the relations between confounders and morphological features, 
obtained by fitting the UMAP on the transpose of the data underlying panel (c). e-f. Violin plots representing the effect 
size of drug concentrations on morphological features for (e) CK-869 and (f) SMIFH2. g. FDR-corrected Robust 
Morphological Perturbation Value (RMPV) of the different drugs. 
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Supplementary Fig. 3 | Distinct immunological synapse phenotype in CD8+ T cells from ARPC1B-deficient patients. 
a. Characteristics of the immunological synapse of the CD8+ T cells of the two ARPC1B deficient patients represented as 
fold change with respect to the average of the three normal donors seeded on ICAM-1 and 1 μg/ml anti-CD3. The data 
represents the mean of 6 replicates for each donor (7525-17725 cells). b. UMAP of cells of the ARPC1B patients and the 
normal donors seeded on ICAM-1 and 1 μg/ml anti-CD3. c. Confusion matrix and class-wise performance of a random 
forest model trained to predict the concentration of anti-CD3 antibodies based on the morphology of normal donors 
lymphocytes stimulated with ICAM-1 and either 1 or 10 μg/ml anti-CD3. d-e. Total and average importance of 
measurement type and biological object described in the prediction of whether images corresponded to (d) normal donors 
CD8+ T lymphocytes seeded on ICAM-1 and 1 or 10 μg/ml anti-CD3 or (e) to normal donors, patient 1 or patient 2 
lymphocytes stimulated with ICAM-1 and 10 μg/ml anti-CD3. f-i Phenotyping of expanded CD8+ T cells of ARPC1B 
patients and normal donors showing mean fluorescence intensity of (f) CD8, and (g) perforin, (h) LFA-1, and (i) Granzyme 
B in the CD8+ population. Values represent the mean of duplicates and error bars show SD. Significance is noted as ns 
(P> 0.05), ** (P<0.01) and ***(P<0.001).  
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Supplementary Table 1 | Mean values and fold increase of immunological synapse parameters in NK-92 cells. Mean 
values of individual parameters pertaining to the immunological synapse in NK-92 cells seeded on PLL or ICAM-1, anti-
NKp30 and anti-NKp46, and the fold change of the ratio of each mean value on the stimulated condition with respect to 
PLL. Intensity is measured in arbitrary units and area in μm2. 
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Supplementary Table 2 | Mean values and fold increase of immunological synapse parameters in Jurkat cells. Mean 
values of individual parameters pertaining to the immunological synapse in Jurkat cells seeded on PLL or ICAM-1 and 
anti-CD3, and the fold change of the ratio of each mean value on the stimulated condition with respect to PLL. Intensity is 
measured in arbitrary units and area in μm2. 
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Supplementary table 2. Mean values and fold increase of immunological synapse parameters in Jurkat cells. 
Mean values of individual parameters pertaining to the immunological synapse in Jurkat cells seeded on PLL or ICAM-1 
and anti-CD3, and the fold change of the ratio of each mean value on the stimulated condition with respect to PLL. Intensity 
is measured in arbitrary units and area in (μm2). 
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Materials and methods: optimizations on NK-92 and primary NK cells. 
1. NK-92 cells 
1.1 Migration 
NK-92 cells were resuspended at 0.2, 0.4 and 1*106/ml in alpha-MEM + IL-2. 50μL of cell suspension 
was added on top of the 5 μM polycarbonate transwell membrane. 100 μLof 1, 10, 25, 50, 100, 500 
and 1000 ng/ml CXCL12 were added to the bottom wells. Negative and positive controls were added. 
The cells migrated for 4 hours at 37°C. Following migration, cells in the bottom wells were corrected 
and the number of cells that migrated was assessed using the MacsQaunt VYB. The percentage of 
migration in response to CXCL12 was calculated with respect to the negative control. 
Student’s t-test was used for statistical significance.  
1.2 Conjugate formation kinetics  
NK-92 cells were stained with CTV and K-562 cells were stained with CMFDA. 100μL of NK-92 
cells and 100μL of K-562 cells at 1*106 cells/ml for 15, 30, 45 and 60 minutes at 37°C. Cells were 
fixed with 1% PFA and results were read at the MacsQaunt VYB. Gentle automated sample mixing 
was performed, to ensure minimal conjugate disruption. The percentage of NK-92 cells involved in 
conjugates was calculated as the fraction of double positive cells with respect to the total CTV+ 
population.  
Student’s t-test was used for statistical significance. 
1.3 NK-92 – K562 conjugate assessment by microscopy 
Microscope slides were coated with Poly-L-Lysine overnight. NK-92 and K562 cells at 0.1*106/ml 
were incubated for 30 minutes at 37°C in U-bottom 96 well plates. The cells were gently mixed, and 
a 50 μL was deposited on each well. The cells were left to adhere for 5 minutes on the wells at 37°C. 
The cells were subsequently fixed with 3% PFA, permeabilized with 0.1% saponin and stained with 
mouse anti-human anti-perforin Ab for 1 hour at RT, followed by staining with phalloidin (AF-488) 
to reveal F-actin, goat-anti mouse IgG2b Ab (AF-647) to reveal perforin and DAPI to reveal nuclei. 
The sealed slides were images with the 63x oil-immersion objective at the LSM710, and the images 
were analyzed with ImageJ to calculate the mean distance of lytic granules to the IS. 
Student’s t-test was used for statistical significance. 
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1.4 NK-92 cytotoxicity 
NK-92 cell suspensions were prepared at 0.25 and 1.25*106 cells/ml. K562 cells stained with CMFDA 
were prepared at 0.25*106 cells/ml. NK-92 cells were incubated with K562 cells at a 1:1 and a 5:1 
effector: target ratio. Aphidicolin was added to prevent cell proliferation, and the cells were incubated 
at 37°C for 4 and 24h. 7AAD was added to the cell suspension prior to cytometry reading. Using the 
MacsQuant VYB, the number of residual alive target cells was assed to calculate lysis, by assessing 
the number of CMFDA+ 7AAD- cells.  
Student’s t-test was used for statistical significance 
1.5 TIRF microscopy 
NK-92 cells were loaded with LysoTracker Red for 30 min at 37 °C. Cells were then washed and 
transferred to µ-Slide 8-well chambers pre-coated with ICAM-1 and anti-NKp30Ab, and rapidly 
transferred to a pre-warmed microscope stage. TIRFM experiments were performed using a 100 × 1.45 
numerical aperture TIRF objective on a Nikon TE2000U microscope custom modified with a TIRF 
illumination module. The images were recorded at 1-sec intervals. Images were analyzed using ImageJ 
to quantify lytic granule position and movement within the TIRF plane.  
 
2. Primary NK cells 
2.1 Primary NK cell expansion 
Primary NK cells were isolated from blood PBMCs of two normal donors using a CD3 negative 
selection kit. The negative fraction was stimulated with irradiated PLH cells at a ratio of 4 PLH for 1 
NK cell, in RPMI 10% FCS containing 100U/ml IL-2 and 5ng/ml IL-15. The first cycle of stimulation 
was 5-7 days long, during which the cells were not used for experiment. The following cycles were 2-
3 days long and involved stimulation with 1PLH cell for each NK RPMI 10% FCS containing 100U/ml 
IL-2 and 5ng/ml IL-15. The number of NK cells was calculated by using CD16 and CD56Ab, and 
7AAD to exclude dead cells.  
2.2 Migration 
Primary NK cell cells were resuspended at 1*106/ml in RPMI 10% FCS + IL-2. 50μL of cell 
suspension was added on top of the 5 μM polycarbonate transwell membrane. 100 μLof 50 ng/ml of 
either CXCL10 or CXCL12 were added to the bottom wells. Negative and positive controls were 
added. The cells migrated for 2 hours at 37°C. Following migration, cells in the bottom wells were 
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corrected and the number of cells that migrated was assessed using the MacsQaunt VYB. The 
percentage of migration in response to CXCL10 and CXCL12 was calculated with respect to the 
negative control. 
Student’s t-test was used for statistical significance.  
2.3 Conjugate formation kinetics  
NK cells were stained with CTV and K-562 cells were stained with CMFDA. 100μL of NK-92 cells 
and 100μL of K-562 cells at 1*106 cells/ml for 15, 30, 45, 60 and 120 minutes at 37°C. The same 
protocol used for NK-92 cells was followed. 
2.4 Primary NK– K562 conjugate assessment by microscopy 
The same protocol used for NK-92 cells was applied. However, no calculations were performed on 
these cells. 
2.5 Primary NK cell cytotoxicity 
Primary NK cell suspensions were prepared at 0.1, 0.2, 0.4, 1 and 2*106 cells/ml. K562 cells stained 
with CMFDA were prepared at 0.2*106 cells/ml. NK-92 cells were incubated with K562 cells at a 1:2, 
1:1, 2:1, 5:1 and 10:1 effector: target ratio. The same procedure as for NK-92 was followed. 
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Discussion and perspectives 
The role of the cytotoxic lymphocytes in the immune response and host protection in undeniable, and 
their role is emphasized further by the consequences of the diseases in which they are 
defective165,397,398. Moreover, their capacities are highlighted further by the developing cancer 
immunotherapies399,400. Therefore, it is essential to understand the mechanisms governing the 
activation and the effector capabilities of these cells. Cytotoxicity involves several dynamic steps, of 
which the immunological synapse has been shown to play a crucial role66. Indeed, the immunological 
synapse has been proposed to be the sight of lytic granule convergence and their exocytosis in order 
to achieve target cell lysis44,147. Low throughput imaging approaches are traditionally used to study the 
IS assembly and architecture, and these approaches have helped shaped the current knowledge into IS 
regulation and the role of several genes in the dynamic process that is the formation of the lytic 
IS44,201,224.  
Given the crucial role that the immunological synapse plays in the process of cytotoxicity, we proposed 
a high content imaging approach coupled to robust morphological profiling to assess the IS architecture 
in various cytotoxic lymphocyte populations. We posit that such an approach could be relevant to 
determine the activation state of these cytotoxic lymphocytes, which may reflect on their cytotoxic 
functions.  
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 HCI as a methodological advance in imaging the immunological synapse 
assembly 
In our study, we provide a novel high content imaging and analysis pipeline of the immunological 
synapse in different cytotoxic lymphocyte subsets. We use a 2D imaging approach over 4 z planes 
which correspond to a 2μm slice encompassing the area of contact between the lymphocyte and a 
microwell surface coated with stimulatory molecules. We successfully manage to mimic the assembly 
of the immunological synapse, whereby the cells adhere successfully to the microwell surface, and that 
they are amenable to staining and imaging as such. In our study, the selection of the fields that are 
imaged is randomized, therefore eliminating the bias that may come into play when choosing the cells 
to image, which may in turn lead to the exclusion of “extreme” phenotypes that are a minority of the 
cells but may be of interesting biological relevance. This infers the need for an analysis pipeline which 
allows an extensive profiling of the IS. Coupling our imaging approach to robust statistics to evaluate 
the data on a per image (field of view basis) allows to account for the variability observed in each field 
of view. Therefore, this analysis pipeline comes as an intermediate between analyses of high content 
imaging screens on well/condition level and on a single cell level basis360,364,401.  
Our pipeline was applied to study the immunological synapse assembly and the use of robust statistics 
allowed us to draw conclusions that are statistically significant, and less sensitive to outliers while still 
able to identify distinct or striking morphologies. Moreover, such a pipeline allowed us to establish a 
classifier, which can discriminate treatment conditions and segregate normal donor from patient-
derived cells.  
It is to be noted that even though we imaged 8 z planes encompassing a height of 4 μm, we only opted 
for the assessment of the first 2 μm closest to the coated surface. Therefore, our data only captures the 
events at the synaptic plane and misses events occurring at higher planes. The large set of images 
generated might be of interest to study the 3D structure of the cells, which can provide a better 
understanding of granule positioning, and could potentially provide insight into granule polarization 
defects. 
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 HCI validates the role of the actin cytoskeleton in governing IS assembly 
As a first step, we validated our approach on the NK-92 and the Jurkat cell lines, and only considered 
a set of targeted morphological measurements that were compiled from previous knowledge about the 
IS assembly. These features include intensities of F-actin, the nucleus, perforin granules and LFA-1, 
as well as parameters pertaining to the size and morphology of the cell and the nucleus44,57,402. At the 
field of view and single cell levels, our results reveal a positive correlation between actin intensity and 
nucleus area and LFA-1 intensity. However, there amount of correlation varies, indicating that cells in 
a given population may behave differently in response to a certain stimulus. Therefore, despite the 
usefulness of population-averaged assays and their ability to report how a population can respond to 
perturbations, these assays assume that the entire population behaves similarly to the mean cell, which 
leads to the loss of valuable information. Population distributions also lead to the exclusions of extreme 
phenotype that represent a minority, but that may have valuable biological relevance. Since our 
analysis pipeline eliminates any field of view that has less than three cells, as well as cell clusters, we 
offer a statistical robustness that permits the study of individual cells and their behavior. Having more 
than three cells per field of view eliminates the doubt of poor coating conditions in that particular field 
which may have led to poor cellular adhesion, while removing clusters allows the study of individual 
rather than collective cell behavior. Therefore, combining the approach of imaging a large number of 
cells with robust statistics decrease the sensitivity of our approach to outliers and artifacts and allows 
for keeping “extreme” phenotypes if they have a biological relevance. 
Our results confirm the importance of the actin cytoskeleton in the assembly of the immunological 
synapse, whereby we show that synapse assembly entails actin accumulation and spreading. It also 
confirms that lytic granules polarize to the IS, and that LFA-1 accumulates there as well. There results 
highlight the importance of the actin cytoskeleton dynamics in the normal context, which led us to 
probe whether our approach identify changes to the immunological synapse assembly upon targeting 
the actin cytoskeleton whether it be by drug treatment or by using cells from patients presenting a 
genetic defect in an action-regulating gene. For that reason, we implemented an additional analysis 
approach, which goes beyond the analysis of a set of pre-defined morphological features to include a 
high-resolution analysis approach which includes a much larger set of morphological features.  
We show that affecting actin cytoskeleton dynamics with drugs targeting the processes of actin 
polymerization and depolymerization yields alterations on the lytic granules, which is expected, as 
lytic granule polarization to the IS requires rearrangements to the actin cytoskeleton53,64. However, the 
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changes caused by the drugs need to be considered in the context where these drugs may not be specific 
to only one mechanism, but could be affecting several mechanisms, as has recently been claimed for 
SMIFH2. Indeed, some recent data implies that SMIFH2 is not only a formin inhibitor but could also 
be targeting Myosins (unpublished data).  Interestingly, we note that even though the parameters 
pertaining to perforin appear to change upon drug treatment or in ARPC1B deficient patient cells, the 
morphological features pertaining to perforin in the robust morphological profiling do not appear to 
have a high importance in the prediction of the drug treatment or distinguishing patient cell from 
normal donors. This suggests that the changes underwent by perforin granules are a consequence of 
the defects of the actin cytoskeleton, rather than a direct consequence of the drug treatment or genetic 
defect. This hypothesis is backed up by previous findings that there is a specific interplay between the 
actin cytoskeleton and the lytic granules from their polarization until their exocytosis44,69,224,403. 
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 HCI coupled to robust statistics reveal important and sometimes unexpected IS 
morphological features 
Coupling our HCI approach to robust statistics has allowed us to perform a thorough morphological 
profiling of the IS, beyond the initial set of limited features. By performing a morphological analysis 
based on more than 300 morphological features, our results reveal the importance of some parameters 
which have been so far overlooked in the study of the IS. We show that targeting the IS with drugs 
that affect actin dynamics and analyzing cells from ARPC1B deficient patients reveals the importance 
of the shape of the cell, its radial distribution, its granularity as well as the shape of the nucleus are 
important determinants in the morphological profile of each treatment condition or deficiency. This 
finding is confirmed by the fact that the classifier performs with better accuracy when the model is 
trained to predict the treatment condition based on the 381 morphological features rather than only 13.  
Interestingly, robust morphological profiling results reveal that the nucleus increases in area upon IS 
assembly, indicating a role of the actin cytoskeleton dynamics in shaping the morphology of the 
nucleus. It has been shown that the MTOC must translocate around the nucleus to IS, and that the 
nucleus must form an open arch structure toward the IS to allow this translocation404,405. Robust 
morphological profiling highlights that the shape of the nucleus is indeed affected upon a defective IS 
assembly, and the morphological changes underwent by the nucleus upon IS formation may be linked 
to the formation of the open arch structure and facilitation of centrosome translocation. To explore 
further the effect of the changes of nuclear morphology on function, single cell RNA sequencing could 
be performed to check for a relationship between the nuclear morphology and transcription and try to 
answer whether changes in nucleus shape could relate to the changes in the IS assembly, and whether 
changes in the actin dynamics could impact on the functions of the nucleus. 
Therefore, our results show a clear need for a morphological analysis of the immunological synapse 
that encompasses a large set of morphological features in order to properly understand the effect and 
impact of a given drug treatment or a mutation. However, we also note that morphological profiling is 
not enough to answer questions pertaining to function. 
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 HCI could be indicative of a defect in the cytotoxic function 
Our results reveal clear differences in the immunological synapse assembly of each of the two 
ARPC1B deficient patients compared to that of normal donors. The role of the immunological synapse 
assembly in the steps leading to successful cytotoxicity has been inferred from genetic defects where 
a defective IS assembly impacts on the cytotoxic activity208,224,262. For that reason, it was evident that 
the cytotoxic activity of ARPC1B deficient CD8+ T cells was to be tested. We show that indeed, these 
cells harbor a defective cytotoxic activity at both a high and low anti-CD3 concentration. This could 
be due to a defect in the TCR signaling, since phenotyping analysis shows a normal expression of lytic 
molecules. Indeed, a recent study has confirmed that ARPC1B deficient CD8+ T cells have impaired 
TCR activation292. In agreement with our results, they also report a decreased cytotoxic activity in 
these cells. Our analysis of the IS in these patients reveals distinct responses to stimulation with ICAM-
1 and anti-CD3 Ab for each of these patients. While both of them display a reduced F-actin 
accumulation concordant with defective ARP2/3 and treatment with CK-869, we show that patient 1 
has decreased perforin accumulation at the IS, while patient 2 appears to have more perforin granules 
at the IS292,406. It could be inferred that patient 1 has a defect in granule polarization, which has been 
observed in a recent study, while for patient 2 it could be presumed that the defect lies in degranulation 
despite proper granule polarization, in agreement with the study by Randzavola et al. in which defects 
in granule polarization and degranulation were reported292. However, the differences between the two 
patients could be explained by the fact that they harbor two different mutations, indicating that nature 
of the mutation most likely impacts the IS assembly and therefore morphological features. For that 
reason, even though it might be hard in the field of rare diseases, it could be of interest to study how 
different mutations in one gene could affect IS morphology, and how the IS morphology could translate 
into functional defects.  
As introduced earlier, several PIDs caused by mutations is actin regulatory genes are often 
accompanied by a cytotoxic defect. Therefore, such an approach as the one developed during m PhD 
could be useful to screen samples from these patients in parallel and perform a robust morphological 
profiling to potentially determine the common traits observed during an impaired IS formation that 
may be causative of the cytotoxic defect. Creating such a database would not only be helpful in trying 
to establish the morphological features of a defective IS, but such a database could also be used to 
compare patients with unknown PID mutations to patients in said database, in an attempt to narrow 
down the potential gene mutations underlying their defects. The more patients that are added to such 
a database, the more accurate it would become to build a network of possible gene interactions of actin-
regulating genes.  
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 HCI of the immunological synapse reveals discrepancies in the regulation 
between cell lines and primary cells.  
In our assays, we denote a difference in the response of immortalized NK-92 cell lines treated with 
SMIFH2 and CK-869, and primary NK cells isolated from the PBMCs of three donors to the same 
drugs. This raises the question of discrepancies between the responses of cell lines and primary 
material. The use of immortalized cell lines is more advantageous, is these cells are easily grown and 
expanded in culture, and may be amenable to different manipulations such as gene knock-down and 
knock-in. However, the fact that cell lines are grown in culture over a long period of time has been 
shown to cause phenotypically altered populations407. The question of how actin dynamics may differ 
between immortalized cell lines and primary cells arises due to this fact.  
Our results show that NK-92 cells appear to be more affected by treatment with CK-869 than by 
SMIFH2 and Blebbistatin. This most likely indicates that retrograde actin flow in NK-92 cells is more 
dependent on the ARP2/3 complex than the formins. In primary NK cells, treatment with CK-869 and 
SMIFH2 lead to a decrease in actin intensity, most likely implying a control of actin dynamics by both 
the formins and the ARP2/3 complex. This could imply a difference in the regulation of the IS 
assembly between cell lines and primary cells isolated from PBMCs. A recent study has addressed this 
question and compared the actin dynamics between Jurkat cells and primary mouse CD4+ T cells, and 
they showed that Jurkat cells lack actin arcs, that primary cells are more dynamic at the lamellar leading 
edge, and that the cortical actin network in primary cells undergoes more undulation146,280. Moreover, 
upon treatment with CK-666 and SMIFH2, they show that the retrograde actin flow in primary cells is 
mainly generated by MyoII, while it is more dependent on nucleation and polymerization in Jurkat 
cells280. Therefore, it can be concluded that despite the advantages cell lines present, they may not 
always be the best model from which conclusions should be drawn. 
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 HCI reveals the lack of a standard “normal” or “disease” phenotype 
Our results reveal that treating primary NK cells isolated from the PBMCs of three normal donors 
leads to a unique response in each donor. We show that as a general response to CK-869 treatment, 
primary NK cells show a general increase in perforin-related parameters. However, when examined 
closely, we denote that in one donor, perforin-related parameters are decreased. This could imply that 
the regulation of the immunological synapse is fine-tuned with slight differences among healthy 
donors. Interestingly, our pipeline also reveals a difference is IS morphological features among the 
three different normal donors. This most likely indicates that the fine-tuning of the immunological 
synapse in normal conditions might differ among people based on differences in differentiation status, 
ongoing infection or treatments, as well as possibly the genetic background. Testing this hypothesis 
would require the analysis of much larger pools of donors. It should be noted that a solid conclusion 
cannot be made on inter-donor heterogeneity, and such a conclusion would require a larger number of 
donors to rule out the possibility that the differences observed are not due to different activation states.  
Previous studies have shown that differentiated CD8+ T cells from patients deficient in ARPC1B have 
aberrant IS morphologies288,292. Indeed, they reveal a defective radial spreading and a reduced cell 
area, and they appear to emit filopodia in response to TCR stimulation. Our images reveal the same IS 
morphology shown in that study (P1 and P2 are the P1 and P7 in that study), and our analysis confirms 
the reduced cell area. In addition, we observe different responses to stimulation with ICAM-1 and anti-
CD3 Ab for each patient, which shows in the radar plots, the UMAP and the performance of the 
classifier which can distinguish between the two patients. Patient one has a mutated ARPC1B, while 
patient 2 has no ARPC1B288,408. Our approach therefore confirms that the immunological synapse of 
two patients harboring different genetic mutations will have different morphologies. It is therefore 
possible that due to different expression levels or ARPC1B that different compensation mechanisms 
(such as by formins) acting at different levels may explain the difference in IS morphologies among 
the two patients. 
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  HCI as a first step preceding functional assays  
The immunological synapse has been referred to as a molecular machinery behind lymphocyte 
activation, as it involves a complex interplay between a myriad of signaling molecules 108. Our results 
show that a defective immunological synapse assembly distinguishes normal cells from cells drug 
treated or patient cells. By examining ARPC1B patient CD8+ T lymphocytes and performing 
cytotoxicity assays, we confirm that a defective immunological synapse relates to a defect in 
cytotoxicity. However, we only stained F-actin, perforin, LFA-1 and the nucleus, therefore we cannot 
conclude the molecular mechanism behind the defective cytotoxicity and answering that question 
would require analysis of the degranulation process in these cells, as our observation of the IS of these 
patients imply. Therefore, our approach, despite its usefulness in allowing us to extrapolate a functional 
defect, cannot be a replacement to functional assays, and must be coupled with them for an accurate 
depiction of the functional defect.  
Since our approach is versatile in terms of the cells that may be imaged and the molecules to be stained, 
one could stain for a multitude of signaling molecules and functional molecules (LFA-1, granzymes, 
granulysin, LAMP-1) as well as tubulin in cytotoxic cells from different PID patients in an effort to 
narrow down the source of the functional defect. Such an approach would be of high value if applied 
on patient cell material, as it has a low requirement of cell numbers. Indeed, with only half a million 
cells, one could potentially image a hundred different conditions.  
Additionally, a gene defect is usually determined by genetic sequencing. Once a mutation is confirmed, 
the expression of the normal proteins is usually determined by Western Blot analyses208,213,224,409. One 
potential application of our high content imaging pipeline is to, as an alternative to NGS and Western 
Blot, start by imaging patient lymphocytes. Indeed, if a patient presents with symptoms that are closely 
related to a known PID where the IS is also defective, one could image the immunological synapse of 
the lymphocytes of this patient by staining for the suspected defective protein and proteins from the 
same family or from the same signaling pathway. Such a process could aid in directing researchers 
towards where the mutation could lie.  
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 HCI of the immunological synapse as a useful tool in the field of personalized 
medicine 
Our results show that HCI can aid in shaping a morphological profile of the IS of each donor. Such 
interesting findings could be applied in cases of personalized medicine, where the response to 
treatments can be assessed on a per patient basis. This could be promising if applied to the 
immunological synapse as a pharmacological target. Indeed, pharmacological compounds that target 
the IS have been tested and are being optimized, and understanding the mechanisms underlying IS 
assembly and maintenance is essential for the development of new successful immunotherapeutic 
strategies. Namely, treatments with specific inhibitors of perforin activity are being tested as 
immunosuppressive treatment in autoimuunity410. Blocking CD3 by compounds such as chimeric, 
humanized and fully human anti-CD3 mAbs is being tested as potential treatment for patients with 
Crohn’s disease and hepatitis411. The blockade of co-stimulatory molecules such as binding of CTLA4-
IgG to CD80 to suppress CD28 co-stimulatory signaling is being employed to treat patients with 
autoimmune disorders412.  
Our HCI approach could be of value when determining responders from non-responders to these 
treatments, by the assessment of alterations occurring to there IS parameters upon treatment. Assessing 
the IS morphology in these patients could be an indicator of treatment impact on IS assembly, and 
examination of several patient responses in parallel could be carried out in an effort to draw 
conclusions. 
In fact, one project we are currently setting up in our lab is the high content imaging of CLL cells from 
patients before and after treatment with Ibrutinib, an agent that has been shown to destabilize IS 
assembly, as assess whether different responses to Ibrutinib treatment may be linked to its distinct IS 
morphologies of leukemic cells in each patient.  
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 HCI could be the method study different functional steps of cytotoxicity 
To successfully eliminate their targets, cytotoxic cells must migrate towards the site of infection, 
recognize target cells, form stable conjugates with them and secrete their lytic granule content into the 
target cells to ensure their elimination.  
Motility can be studied in several setups, including transwell assay and migration chambers where the 
cells migrate in response to a chemokine gradient. Such results would be assessed by flow cytometry 
and live microscopy respectively. The motility can also be predicted by stimulating the cells with 
chemokines and seeding them on a matrix, and the morphological changes can be captured by fixed 
confocal microscopy208. This has been done in a low throughput format, and our experimental 
approach offers the potential to assess the response to chemokines in a high content fashion, where the 
response to several chemokines and on different matrices can be tested in parallel. Testing several 
conditions in parallel while doing only one staining, imaging and analysis process not only saves time 
but would also allow for the parallel comparison of these different conditions, as the images would be 
acquired under the same conditions, decreasing variability in experimental settings. Robust 
morphological profiling allows to efficiently detect where the response is impaired and reveal intrinsic 
defects that may be due to the actin cytoskeleton. 
Conjugate formation between the cytotoxic cell and the target may be assessed by flow cytometry or 
low throughput confocal microscopy224,246. However, it could be more interesting to study it by 
microscopy, as staining for tubulin and lytic granules could be informative of the cells’ capacity to 
polarize their granules. Conjugate formation could be amenable to imaging by high content 
microscopy, and this would allow the parallel imaging of several patients and normal donors in 
parallel. When cells are imaged with low throughput confocal microscopy, the usual number of cells 
imaged per experiment is around 30, which can take around 3 hours and may be subject to bias as the 
cells are selected manually, and some extreme phenotypes may be ignored. HCI offers the potential to 
image a large number of cells in a much shorter time, and automated acquisition allows for the 
elimination of bias. The application of robust statistics allows a lesser sensitivity to extreme 
phenotypes while still revealing the different phenotypes that may exist within a population, and when 
comparing different conditions. Imaging of conjugates in expanded CD4 and CD8+ T cells has been 
implemented in our lab, and I have implemented it for primary NK cells. Therefore, one application 
of the pipeline set up could be the simultaneous imaging of T and NK cells from the same donors. 
Coupled to approaches of flow cytometry amenable to be assessed in plate formats, this approach 
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completes the lack that was present in assessing the function steps of cytotoxicity in a high throughput 
format. 
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 Limitations of HCI of the immunological synapse 
One limitation that I encountered during my PhD was the fact that coating the multiwell plates and 
seeding the cells had to be done manually, due to the absence of robotics. Had robotics been accessible, 
it would not only have saved time in coating plates, as well as seeding and staining cells, but would 
have most likely decreased the variation in the number of cells seeded in each well.  
It is to be noted that even though we imaged 8 z planes encompassing a height of 4 μm, we only opted 
for the assessment of the first 2 μm closest to the coated surface. Therefore, our data only captures the 
events at the synaptic plane and may be missing events occurring at higher planes. Indeed, a 3D study 
would be more comprehensive, and would reveal more information about the state of the lymphocyte, 
which can provide a better understanding of granule positioning, and could potentially provide insight 
into granule polarization defects.  
Moreover, our study captures the immunological synapse assembly in the context where the 
lymphocytes are seeded on an ICAM-1 and stimulatory antibody coated surface. In such a scenario, 
these ligands are fixed, while when expressed on a target cell, they exhibit intermediate motility, 
depending on the cell state413. For that reason, it might be of interest to optimize the HCI of the 
immunological synapse of lymphocytes when conjugated to target cells and assess the differences the 
IS morphology that may arise. Another alternative could also be the optimization of this approach on 
planar lipid bilayers. 
In our results upon drug treatment, we observed an increase in perforin-related parameters, implying 
that the perforin granules were at the IS surface at the time of imaging. However, since the images we 
captured were of fixed cells, one question that cannot be answered accurately is whether or not this 
increase in granules at the IS is due to an increased granule recruitment to the IS, or to a defect in 
granule exocytosis. To accurately answer this question our approach would need to be coupled to a 
degranulation assay, or a more resolutive live imaging microscopy to be more precise in determining 
whether the granules fail to fuse with the membrane or cannot exit through the actin clearances. In 
some instances, we also observed a decrease in perforin-related parameters. However, HCI of the IS 
could be helpful in this case but the whole height of the cell would be imaged to determine whether 
the cells have degranulated too fast (by a decreased lytic granule count) or if the cells fail to polarize.  
Despite the fact that we report different IS morphologies for each of the two patients, the end result 
for both is a defective cytotoxic activity. For that reason, it could be of interest to study the steps of 
cytotoxicity of these patients by live microscopy, in order to confirm at which step the defect lies, and 
confirm the results seen and the assumption made by examining IS morphology. Therefore, despite 
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the usefulness of HCI screens of the immunological synapse, it is not yet able to replace live 
microscopy. Additionally, it would be of high informative value to apply high content imaging to 
decipher ongoing at the nanoscale, and even determine single molecule localization. The compromise 
between high throughput and high resolution is slowly beginning to become narrower, as we are seeing 
developments in high throughput super resolution microscopy techniques414.  
The value of HCI is the ability to perform screens using this technology. In fact, an aspect of my PhD 
project that I have attempted to set up was an HCI screen of the IS of NK-92 cells that were knocked-
down with an arrayed library of 85 genes known to play a role in the actin cytoskeleton regulation, and 
their neighbors. The aim of that screen was to build an interactome of these genes, based on the 
obtained IS morphologies for the generated knock-downs. However, that project was discontinued due 
to the difficulty in transducing NK-92 cells with the lentiviral particles. An alternative that could make 
mapping these interactions possible would be imaging PID patient material. Additionally, if one could 
image the different cell types from several patients simultaneously, it could give an idea of the 
variations to this interactome in different cellular subsets. 
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Annexes 
I contributed to the Rey-Barrosso et al. paper by performing the immune phenotyping of JY cells for 
collagen and fibronectin (supplementary figure 1), as well as well as supplementary figure 4, in which 
the effect of extracellular matrix on the cells’ ability to cluster was assessed. 
Generating supplementary figure 4 was my first exposure to microscopy in a 96 well plate instead of 
slides or chambers. 
However, imaging 96 wells for the course of 7 hours was a tedious process, despite being able to 
“save” a specific location in the well to re-image at a later point. By doing this experiment I was made 
aware of the importance of automation when acquiring images from a large number of wells, whether 
it be for fixed or live microscopy assays.  
Discussions with Javier also exposed me to the different inhibitors of the actin/Myosin components, 
which was a basis for the drug screen performed during my PhD. 
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I contributed to the Guipouy et al. paper by performing the cytotoxicity assays for supplementary 
figure 2A, which serves as proof that the ova-specific Tregs can kill in an MHC dependent fashion. 
For this paper I could use the expertise in cytotoxicity that I had learned from Delphine and apply it to 
her own project, as well as mine. 
 
208 
 
209 
 
210 
 
211 
 
212 
 
213 
 
214 
 
215 
 
216 
 
217 
 
218 
 
219 
 
 
220 
 
221 
 
222 
 
223 
 
 
  
224 
 
High content cell imaging reveals actin cytoskeleton-mediated control of the immunological synapse 
Cytotoxic lymphocytes rely on actin cytoskeleton remodeling to achieve their function. In particular cytotoxic T lymphocytes and NK 
cells assemble the immunological synapse (IS), a complex actin-rich structure that allows the interaction with target cells, such as 
infected cells or tumor cells, and permits the polarized delivery of lytic granules. Although actin cytoskeleton remodeling is known to 
be a driving force of IS assembly and dynamics, our understanding of the molecular control of actin remodeling sustaining IS dynamics 
remains fragmented. This PhD project consisted in developing a high-content imaging approach to unbiasedly define the metrics of IS 
from human T and NK lymphocytes and to characterize the requirements for actin cytoskeleton integrity in organizing the IS architecture. 
For that purpose, the stimulation and staining of cell lines and primary cells in multiwell plates and acquisition of a unique set of >100.000 
confocal images with a fully automatized high-content imager was optimized. The images were analyzed with two complementary 
CellProfiler analytical pipelines to characterize the morphological features associated with different treatments and disease status. We 
first extracted 16 morphological features pertaining to F-actin, LFA-1 or lytic molecules based on prior knowledge of IS assembly, and 
included features pertaining to the nucleus. We show that IS assembly in Jurkat and NK-92 cells is characterized by increased F-actin 
intensity and cell area. For Jurkat cells, we report an increase in LFA-1 intensity and surface area, and for NK-92 cells an increase in 
lytic granule detection at the IS plane. We then treated NK-92 cells with seven drugs known to affect different aspects of actin dynamics 
and investigated the associated effects on IS features. We report concentration dependent effects, not only on F-actin intensity, as 
expected, but also on lytic granule polarization. Furthermore, using a high-resolution morphological profiling based on >300 features, 
we show that each drug inflicts distinct alterations of IS morphology. In a next step, we applied our experimental pipeline to primary 
NK cells isolated from the blood of healthy donors. Distinct morphological features were characterized among the NK cells from 
different donors, highlighting the sensitivity of our approach, but also revealing an unsuspected variability of immune cell morphologies 
among donors. We then further applied our approach to primary CD8+ T cells from patients with a rare immunodeficiency due to 
mutations in the gene encoding the actin regulator ARPC1B. ARPC1B deficiency results in decreased F-actin intensity, as well as in 
lytic granule polarization. This prompted us to assess the ability of these cells to kill target cells, which was markedly reduced. These 
results illustrate how the systematic analysis of the IS might be used to assist the exploration of fonctional defects of lymphocyte 
populations in pathological settings.  
In conclusion, our study reveals that although assembly of the IS can be characterized by a few features such as F-actin intensity and 
cell spreading, capturing fine alterations of that complex structure that arise from cytoskeleton dysregulation requires a high-content 
analysis. The pipeline we developed through this project holds promises for the morphological profiling of lymphocytes from primary 
immunodeficiency patients whose genetic defect has not yet been identified. Moreover, the discriminative power of our high-content 
approach could be exploited to characterize the response of lymphocytes to various stimuli and to monitor lymphocyte activation in 
multiple immune-related pathologies and treatment settings. 
L'imagerie cellulaire à haut débit révèle le contrôle de la synapse immunologique par le cytosquelette d'actine 
Les lymphocytes cytotoxiques dépendent du remodelage du cytosquelette d'actine pour atteindre leur fonction. En particulier, les 
lymphocytes T cytotoxiques et les cellules NK assemblent la synapse immunologique (SI), structure complexe riche en actine qui permet 
l'interaction avec des cellules cibles et la distribution polarisée de granules lytiques (GL). Bien que le remodelage du cytosquelette 
d'actine soit connu pour être une force motrice de l'assemblage et de la dynamique de la SI, la compréhension du contrôle moléculaire 
du remodelage de l'actine soutenant la dynamique de la SI reste fragmentée. Ce projet de thèse a consisté à développer une approche 
d'imagerie à haut débit pour définir de manière impartiale les métriques de la SI des lymphocytes T et NK et caractériser les exigences 
d'intégrité du cytosquelette d'actine dans l'organisation de l'architecture de la SI. 
À cette fin, la stimulation et coloration des lignées cellulaires et cellules primaires dans des plaques à puits multiples et l'acquisition d'un 
ensemble unique d'images confocales avec un imageur à haut contenu entièrement automatisé ont été optimisées. Les images ont été 
analysées avec deux pipelines complémentaires avec CellProfiler pour définir les caractéristiques morphologiques associées aux 
différents traitements et à l'état de la maladie. Nous avons d'abord extrait 16 caractéristiques morphologiques se rapportant à la F-actine, 
LFA-1 ou aux GL, sur la base d'une connaissance préalable de l'assemblage de la SI, et inclus des caractéristiques relatives au noyau. 
Nous montrons que l'assemblage de la SI dans les lignées est caractérisé par une augmentation de l'intensité de la F-actine et la surface 
cellulaire. Pour les cellules Jurkat, nous rapportons une augmentation de l'intensité et de la surface LFA-1, et de la de la détection des 
LG sur le plan SI pour les cellules NK-92. Le traitement des cellules NK-92 avec 7 drogues affectant différents aspects de la dynamique 
de l'actine et l’étude des effets associés sur les caractéristiques de la SI montrent des effets dépendants de la concentration sur l'intensité 
de l’actine et sur la polarisation des GL. De plus, un profilage morphologique à haute résolution basé sur> 300 caractéristiques montre 
que chaque drogue inflige des altérations distinctes sur la morphologie de la SI. Nous avons appliqué ce pipeline à des cellules NK 
primaires isolées du sang de donneurs sains. Des caractéristiques morphologiques distinctes définissent les cellules NK de différents 
donneurs, soulignant la sensibilité de notre approche, mais révélant également une variabilité insoupçonnée des morphologies des 
cellules immunitaires parmi les donneurs. Nous avons appliqué notre approche aux cellules T CD8+ primaires de patients présentant 
une immunodéficience rare due à des mutations dans le gène codant pour le régulateur d'actine ARPC1B. La carence en ARPC1B 
entraîne une diminution de l'intensité de l'actine et de la polarisation des GL. Cela nous a incités à évaluer la capacité lytique de ces 
cellules, qui a été considérablement réduite. Ces résultats illustrent comment l'analyse systématique de la SI pourrait être utilisée pour 
aider à l'exploration des défauts fonctionnels des populations de lymphocytes dans des contextes pathologiques. 
En conclusion, notre étude révèle que, bien que l'assemblage de la SI puisse être caractérisé par quelques caractéristiques telles que 
l'intensité de l'actine et la propagation cellulaire, la capture de fines altérations résultant de la dérégulation du cytosquelette nécessite une 
analyse à haut débit. Le pipeline développé est prometteur pour le profilage morphologique des lymphocytes de patients atteints 
d'immunodéficiences primaires dont le défaut génétique n'a pas encore été identifié. De plus, le pouvoir discriminant de notre approche 
pourrait être exploité pour caractériser la réponse des lymphocytes à divers stimuli et surveiller leur activation dans de multiples 
pathologies et traitements. 
